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Summary 
 
 Gene transcription in general can be subdivided into three main phases: 
transcription initiation, elongation and termination. The enzyme that accomplishes 
transcription of protein coding genes, snRNAs and snoRNAs is RNA polymerase II 
(RNAP II). During transcription, the nascent RNA is processed in several ways in 
order to generate a mature functional RNA. For this, the transcripts of protein coding 
genes are capped at the 5’ end, introns are spliced out and the 3’ ends are processed 
by endonucleolytic cleavage at the poly(A) site followed by poly(A) tail synthesis 
(polyadenylation). In yeast, the cleavage and polyadenylation reaction requires a 3’ 
end processing complex consisting of the cleavage and polyadenylation factor (CPF), 
cleavage factor IA (CF IA), cleavage factor IB (CF IB) and the poly(A) binding 
protein. In contrast to pre-mRNAs, most pre-snoRNAs are processed only at their 3’ 
end. Furthermore, snoRNAs are not polyadenylated.  
 CPF is not only involved in 3’ end processing, but distinct subunits of CPF 
have additional functions in transcription elongation and termination of mRNAs and 
snoRNAs.  
 In recent years affinity purification of the CPF complex has lead to the 
identification of several new subunits of CPF (Ohnacker et al., 2000). Among them is 
the essential protein phosphatase Glc7p, the yeast homologue of mammalian protein 
phosphatase 1 (PP1). Glc7p has diverse cellular functions (Stark, 1996). The 
specificity of a reaction that requires Glc7p is accomplished by targeting or regulatory 
factors that direct Glc7p to the location of the reaction or regulate its activity.  
 The aim of this thesis was to study the function of Glc7p as part of CPF. In 
Chapter 2 we show, that Glc7p is required for the polyadenylation but not for the 
cleavage step of pre-mRNA 3’ end processing in vitro and in vivo. In addition, Glc7p 
is needed for correct poly(A) site selection. Glc7p physically interacts with several 
subunits of CPF and CF IA. One of them, the CPF subunit Pta1p, has been reported to 
be dephosphorylated by Glc7p (He and Moore, 2005). Dephosphorylation of Pta1p 
stimulates the polyadenylation reaction. Thus, Glc7p regulates polyadenylation via 
the phosphorylation state of Pta1p (He and Moore, 2005). We also observed that in 
glc7 mutant strains, several subunits of CPF are underrepresented. This might indicate 
that the activity of Glc7p is required for the formation of stable CPF complexes.  
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 Analysis of several glc7 mutants also revealed that Glc7p is involved in 
transcription termination of snoRNAs (Chapter 3). Our data suggest that Glc7p 
functions in the Nrd1 complex-dependent pathway of snoRNA transcription 
termination. However, none of the Nrd1 complex subunits was found to be a target for 
dephosphorylation by Glc7p. In contrast, Glc7p is not involved in transcription 
termination of pre-mRNAs.  
 A reduction in poly(A)-dependent pausing in glc7 mutants indicated that 
Glc7p might also be involved in regulating transcription elongation (Chapter 4). 
Further investigation showed that Glc7p genetically interacts with the transcription 
elongation factors Spt4p, Leo1p and Rtf1p. In addition, several glc7 mutants are 
sensitive to the drug 6-azauracil (6AU). Sensitivity to 6AU is a phenotypic landmark 
of transcription elongation mutants. Interestingly, the snoRNA transcription 
termination defect observed in glc7 mutants is suppressed in glc7/spt4, glc7/leo1 and 
glc7/rtf1 double mutants. This suggests that Glc7p acts as a factor required for 
snoRNA transcription termination that modifies transcription elongation factors to 
facilitate transcription termination. Therefore, Glc7p might couple transcription 
elongation to transcription termination. 
 Microarray analysis of the temperature sensitive glc7-12 allele (Chapter 5) 
indicated that Glc7p is involved in transcription regulation of ribosomal protein (RP) 
and Ribi genes. Two signaling pathways control the transcription of RP and Ribi 
genes in response to environmental conditions: the target of rapamycin (TOR) and the 
Ras/PKA signaling pathway. These pathways regulate the localization of the 
transcription factors Fhl1p, Ifh1p, Crf1p and Sfp1p to RP or Ribi gene promoters. 
Epistasis experiments suggest that Glc7p acts downstream of the signaling component 
PKA to regulate the transcription of RP genes (Chapter 6). In addition, we found that 
Glc7p controls the nuclear localization of Yak1p and Crf1p. Yak1p is a downstream 
target of the kinase PKA. Crf1p in turn is phosphorylated by Yak1p, shuttles to the 
nucleus and represses transcription of RP genes. Regulation of the localization of the 
co-repressor Crf1p by Glc7 could represent one of several redundant ways to suppress 
transcription of RP genes.  
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1 Introduction: processing and transcription termination of 
mRNAs, snoRNAs and snRNAs 
1.1 Eukaryotic gene transcription and processing of messenger RNAs  
 In metazoans, three RNA polymerases (RNAPs) are responsible for the 
transcription of genes. RNAP I transcribes genes coding for ribosomal RNAs 
(rRNAs). RNAP III transcribes genes coding for transfer RNAs (tRNA) and in 
addition the 5S rRNA. RNAP II transcribes protein-coding genes and also genes for 
non-coding small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs). In 
the following introduction I will concentrate on transcripts generated by RNAP II.  
 The precursors of mRNAs (pre-mRNAs), snoRNAs and snRNAs have to 
undergo a number of processing events to become mature functional RNAs. 
Processing of pre-mRNAs includes capping, splicing and 3’ end processing (cleavage 
and polyadenylation), which all occur during the transcription process (co-
transcriptionally) in the nucleus of eukaryotic cells. Transcription of genes by RNAP 
II can be divided into three main phases: initiation, elongation and termination of 
transcription (Saunders et al., 2006). During transcription initiation RNAP II is 
recruited to the promoter with the help of general transcription factors and a 
transcription initiation complex is formed that is associated with the template stably 
enough to efficiently transcribe the full length of the gene. Transcription of the full 
length gene is referred to as transcription elongation and will be discussed in more 
detail below. Transcription terminates when RNAP II dissociates from the DNA 
template and from the 3’UTR of the RNA transcript.  
 Soon after transcription has initiated, the nascent pre-mRNA is capped at the 
5’ end (Shatkin and Manley, 2000). The 7-methylguanine cap is added to the 5’ 
triphosphate end of the pre-mRNA when the transcript is around 20-25 nucleotides 
long. In S. cerevisiae capping requires the action of three capping enzymes: Cet1p, an 
RNA triphosphatase, which hydrolyzes the 5’ triphosphate to a 5’ diphosphate; 
Ceg1p, an RNA guanylyltransferase, which adds GMP to the 5’ end; and finally 
Abd1p a methyltransferase that methylates the GMP at position N7 (Shatkin and 
Manley, 2000). 
 Another cotranscriptional event is splicing of pre-mRNAs, which removes 
introns from the newly transcribed pre-mRNA and joins exons together. A large 
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complex, the spliceosome, composed of small nuclear ribonucleoprotein particles 
(snRNPs) and non-snRNP proteins achieves splicing by two transesterification 
reactions (Kramer, 1996).  
 3’ end processing of pre-mRNAs is a two step reaction. The pre-mRNA is 
endonucleolyticaly cleaved and subsequently polyadenylated (Wahle and Rüegsegger, 
1999.; Figure 1.1). The cleavage and polyadenylation reaction is performed by the 
cleavage and polyadenylation factor (CPF) complex together with the cleavage factor 
IA (CF IA). Poly(A) tails are important for mRNA stabilization, mRNA export and 
also for translation of mRNAs (Long et al., 1995; Sachs and Wahle, 1993). Finally, 
transcription termination occurs at random positions within the 3’UTR and is coupled 
to 3’ end processing (Hirose and Manley, 2000). During transcription termination 
RNAP II dissociates from the template DNA and from the nascent RNA and can be 
recycled to start a new round of transcription.  
m7G 3’ OH
AAAAAAAAAAAAAnm7G
Cleavage
CF IA, CF IB
CPF
Polyadenylation
CF IA, CF IB, CPF, Pab1p
3’ OHm7G
Poly(A) Site 
 
Figure 1.1. The two steps of 3’ end processing 
The precursor mRNA (top of scheme) is cleaved at the poly(A) site. Factors required for the cleavage 
step are indicated. The upstream cleavage product is subsequently polyadenylated. Factors required for 
polyadenylation are indicated. 
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1.2 3’ end processing of pre-mRNAs 
1.2.1 Cis-acting signals are required for 3’ end processing of pre-mRNAs   
 3’ end processing (endonucleolytic cleavage and subsequent polyadenylation 
of pre-mRNAs) of pre-mRNA occurs in the 3’ UTRs of pre-mRNAs and is guided by 
a number of cis-acting signals. In yeast, up to four separate cis-acting elements were 
found. All cis-acting elements contribute to the correct recognition of the processing 
site thus ensuring the accuracy and efficiency of cleavage and polyadenylation 
(Graber et al., 1999a; Graber et al., 1999b). In contrast to higher eukaryotes, cis-
acting signals in S. cerevisiae are of statistical nature meaning they lack strong 
consensus sequences.  
 The four cis-acting signals are: the efficiency element (EE), the positioning 
element (PE), the poly(A) site and the U-rich element (Graber et al., 1999a; Guo et 
al., 1995; Wahle and Rüegsegger, 1999; Zhao et al., 1999a; Figure 1.2). The EE is 
composed of versions of the sequence UAUAUA which is the most efficient version 
of the EE (Guo et al., 1995; Guo and Sherman, 1996). Moreover, in yeast the EE has 
been demonstrated to be more important than the PE in selecting the processing site 
(Guo and Sherman, 1996). EEs appear to be used only rarely in mammals (Graber et 
al., 1999a). 
 The PE is an A-rich element, frequently AAUAAA, centered approximately 
20 nucleotides upstream of the poly(A) site (Graber et al., 1999b). This element is 
found in all organisms investigated to date. Whereas the sequence AAUAAA is 
highly conserved in mammals, the PE in yeast and plants varies significantly (Graber 
et al., 1999a).  
 Mapping of the poly(A) site, which is equal to the cleavage site, revealed that 
polyadenylation occurs most frequently at a Py(A)n sequence (Py = pyrimidine; 
Heidmann et al., 1994). In contrast to animal genes, in which a single poly(A) site is 
found downstream of AAUAAA, in many yeast genes a cluster of poly(A) sites 
downstream of the EE and PE are found (Zhao et al., 1999a). In vivo, mutations in the 
PE most often do not affect the overall efficiency of processing but instead cause a 
defocusing of the endonucleolytic activity from the native poly(A) site to cryptic 
poly(A) sites (Guo and Sherman, 1996).  
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 The poly(A) site is often preceded by U-rich elements in yeast, motifs that do 
not have counterparts in animals. In addition, the poly(A) site is also commonly 
followed by a downstream U-rich signal. It was recently reported, that the U-rich 
signals contribute to the cleavage/poly(A) site selection and enhance 3’ end 
processing efficiency in vitro (Dichtl and Keller, 2001). 
 
Clp1p
Rna15p
Rna14p
Pcf11pYhh1p /Cft1p
Ysh1p /Brr5p
Ydh1p /
Cft2p Yth1p
Pfs2p
Pta1p
Pap1p
Fip1p
Swd2p
Nab4p/
Hrp1p
?
CPF
CF IA
CF IB
PE EE 
Mpe1p
UUE Py(A)n DUE 
Pti1p Ssu72p
Glc7p
Ref2p
 
Figure 1.2. Cis- and trans-acting factors required for 3’ end processing of pre-mRNAs 
Schematic illustration of the polypeptide composition of the trans-acting factors involved in 3’ end 
formation and their relative position to the cis-acting sequenes required for this reaction. EE efficiency 
element; PE positioning element; UUE upstream U-rich element; Py(A)n poly(A) site; DUE 
downstream U-rich element;  
 
 
1.2.2 Trans-acting factors required for 3’ end processing of pre-mRNAs  
 Cleavage and polyadenylation of pre-mRNAs is a two step reaction. At first 
view one might consider two enzymes to be sufficient for this reactions: an 
endonuclease that cleaves the pre-mRNA at the poly(A) site and a poly(A) 
polymerases (PAP) that synthesizes the poly(A) tail. However, intensive biochemical 
characterization of yeast and mammalian trans-acting factors uncovered a large 
number of factors required for 3’ end processing of pre-mRNAs (Keller and 
Minvielle-Sebastia, 1997; Wahle and Rüegsegger, 1999; Zhao et al., 1999a). While 
the polyadenylation signals used by mammals and yeast are rather different in 
consensus sequence and organization, the factors which comprise the 
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cleavage/polyadenylation apparatus in these two organisms are conserved to a high 
degree (Zhao et al., 1999a).  
 Fractionation of whole-cell yeast extracts has identified five functionally 
distinct activities involved in cleavage and polyadenylation (Chen and Moore, 1992; 
Kessler et al., 1996). Cleavage and polyadenylation factor IA (CF IA), IB (CF IB) and 
II (CF II) are sufficient for the cleavage reaction, while specific poly(A) addition 
requires CF IA, CF IB, Pap1p, the poly(A) binding protein (Pab1p) and the 
polyadenylation factor I (PF I). A multi-protein complex, designated cleavage and 
polyadenylation factor (CPF), where PF I/Pap1p and CF II activities are combined has 
recently been isolated from yeast extracts by an one-step affinity purification 
(Ohnacker et al., 2000). It is now generally accepted that PF I and CF II form a 
functional unit in vivo.  
 CF IA consists of four polypeptides, Rna14p, Rna15p, Pcf11p and Clp1p 
(Amrani et al., 1997a; Kessler et al., 1996; Minvielle-Sebastia et al., 1994). 
Temperature-sensitive rna14 and rna15 mutant strains are defective in both cleavage 
and polyadenylation of a synthetic precursor RNA (Minvielle-Sebastia et al., 1994). 
In addition, these alleles are synthetic lethal with mutations in the PAP1 gene 
(Minvielle-Sebastia et al., 1994). Rna15p has a N-terminal RNA-recognition motif 
(RRM) and has affinity to U-rich sequences (Kessler et al., 1996; Minvielle-Sebastia 
et al., 1991; Takagaki and Manley, 1997). Recently, it was demonstrated that Rna15p 
recognizes the PE (Gross and Moore, 2001a). The interaction of Rna15p with PE 
requires the presence of Rna14p and Nab4p/Hrp1p (Gross and Moore, 2001a). Pcf11p 
mutant cells display a deficiency in both cleavage and polyadenylation in vitro and 
the poly(A) length is strongly reduced in vivo (Amrani et al., 1997a). Pcf11p has a N-
terminal CTD-interaction domain (CID) that is common to CTD-binding proteins like 
yeast Nrd1p (Barilla et al., 2001; Steinmetz et al., 2001). In addition to its role in 3’ 
end processing, Pcf11p is also involved in transcription termination of pre-mRNAs 
(Sadowski, 2003). Clp1p contains Walker A and B motifs, which have been 
implicated in ATP-GTP binding (Preker et al., 1997). Mutant Clp1p extracts are 
deficient in cleavage and polyadenylation (T. Wiederkehr, unpublished result).  
 Purified CF IB is a single polypeptide encoded by the NAB4/HRP1 gene 
(Kessler et al., 1997). This gene was previously identified as a suppressor of a 
temperature-sensitive npl3 allele, a gene encoding a protein which is involved in 
mRNA export (Henry et al., 1996). Nab4p contains two RNA binding domains in its 
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middle region and RNA-binding and SELEX analyses suggest that it interacts with 
the EE (Chen and Hyman, 1998; Henry et al., 1996; Valentini et al., 1999). Nab4 is 
essential for the polyadenylation but is not required for the cleavage step. 
Furthermore, selection of the correct cleavage site requires Nab4 in a concentration-
dependent manner (Minvielle-Sebastia et al., 1998). Synthetic lethality and two-
hybrid analyses indicate that Nab4p interacts with Rna14p and Rna15p (Kessler et al., 
1997). Interestingly, Nab4p is also required for nonsense-mediated mRNA decay 
(NMD) in the cytoplasm (Gonzalez et al., 2000). NMD is a surveillance mechanism 
that monitors premature translation termination and degrades aberrant mRNAs 
(Hentze and Kulozik, 1999). 
 Pab1p has four N-terminal RNA-binding domains and associates with the 
poly(A) tails of mRNAs in both the nucleus and the cytoplasm (Adam et al., 1986; 
Burd and Dreyfuss, 1994; Swanson and Dreyfuss, 1988). The main functions of 
Pab1p include the poly(A)-dependent translation initiation (Tarun and Sachs, 1996), 
the deadenylation-dependent mRNA turnover (Caponigro and Parker, 1996) and the 
poly(A) tail length control (Minvielle-Sebastia et al., 1997).  
 CPF is comprised of the subunits Yhh1p, Ydh1p, Ysh1p, Pta1p, Pap1p, 
Ref2p, Mpe1p, Fip1p, Pfs2p, Pti1p, Glc7p, Swd2p, Yth1p and Ssu72p (Dichtl et al., 
2002b). Yhh1p is an RNA-binding protein which is involved in poly(A) site 
recognition (Dichtl and Keller, 2001). In addition to its requirement in the cleavage 
and polyadenylation reaction, Yhh1p is involved in transcription termination of pre-
mRNAs (Dichtl et al., 2002b). Interestingly, Yhh1p specifically interacts with the 
phosphorylated CTD. The direct interactions of Yhh1p with nascent RNA and the 
CTD suggests that it communicates poly(A) site recognition to the elongating RNAP 
II to initiate transcription termination (Dichtl et al., 2002b).  
 Mutations in Ydh1p inhibit both the cleavage and the polyadenylation step of 
pre-mRNA 3’ end processing (Kyburz et al., 2003). In addition, RNA-binding 
experiments showed that Ydh1p binds with high affinity to sequences around the 
poly(A) site and more weakly to the EE (Dichtl and Keller, 2001). Subsequently, it 
was shown that ydh mutant strains are deficient in poly(A) site recognition (Kyburz et 
al., 2003) suggesting that binding of Ydh1 to sequences around the poly(A) site is 
important for poly(A) site selection.  
 Ysh1p has a β-lactamase motif, which is common to metal-dependent 
hydrolases (Callebaut et al., 2002). Because of its similarity to other nucleases in the 
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metallo-beta-lactamase family, the Brr5/Ysh1 subunit has been proposed to be the 
endonuclease.  
 Pta1p is exclusively required for the polyadenylation step in pre-mRNA 3’ 
end processing (Preker et al., 1997). The phosphorylation state of Pta1p is regulated 
by the phosphatase Glc7p and an unknown kinase (He and Moore, 2005). He and co-
workers demonstrated that a phosphorylated form of Pta1p inhibits polyadenylation 
whereas unphosphorylated Pta1p does not (He and Moore, 2005). This suggests that 
yeast mRNA polyadenylation is regulated by phosphorylation. 
 Pap1p is the enzyme that synthesizes the poly(A) tail. Unlike in the 
mammalian system, yeast Pap1p is not required for cleavage of pre-mRNAs in vitro 
(Patel and Butler, 1992). Interestingly, Pap1p is phosphorylated and ubiquitinated 
during transition of late S to G2 phase in the cell cycle (Mizrahi and Moore, 2000). 
Since phosphorylation inhibits Pap1p, the poly(A) adding activity of Pap1p is cell 
cycle-dependent.  
 Fip1p physically interacts with Pap1p and is exclusively required for the 
polyadenylation step of 3’ end processing (Preker et al., 1995). It was shown that 
Fip1p increases the KM of Pap1p for RNA around 50 fold and shifts its activity to a 
slow and distributive mode (Zhelkovsky et al., 1998). 
 Pfs2p contains seven WD-repeats and deletion of a single repeat is lethal 
(Ohnacker et al., 2000). pfs2 mutant strains display 3' end processing defects, 
indicating an essential function for Pfs2p in cleavage and polyadenylation. With a 
one-step affinity purification method, which exploits protein A-tagged Pfs2p, 
Ohnacker and co-workers showed that this protein is part of CPF. Since Pfs2p shows 
numerous interactions with subunits of CPF it likely promotes assembly of CPF 
(Ohnacker et al., 2000). Due to this finding, CPF is now commonly affinity purified in 
our lab via protein A-tagged Pfs2p.  
 Pti1p has been shown to be dispensable for both cleavage and polyadenylation 
(W. Hübner, unpublished). However, mutations of Pti1 or Ctk1 (a kinase that 
phosphorylates Ser2 of the C-terminal domain of RNAP II) affect 3' cleavage site 
choice and transcript abundance of particular genes (Skaar and Greenleaf, 2002). 
Therefore it is possible that coupling of transcription to 3' processing of pre-mRNAs 
is mediated by a Pti1p-containing complex (Skaar and Greenleaf, 2002). Furthermore, 
Pti1p is essential for yeast snoRNA 3' end maturation (Dheur et al., 2003; Nedea et 
al., 2003). Dheur and co-workers propose that Pti1p acts by uncoupling cleavage and 
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polyadenylation and functions in coordination with the Nrd1p-dependent pathway for 
3' end formation of non-polyadenylated transcripts (Dheur et al., 2003).  
 Ref2p encodes a non-essential RNA-binding protein that has specific affinity 
for pyrimidine bases (Russnak et al., 1995). In addition, Ref2p was found to be 
essential for snoRNA 3’ end termination (Dheur et al., 2003). Two-hybrid analysis 
and affinity purification revealed that Ref2p interacts with Glc7p (Nedea et al., 2003; 
Uetz et al., 2000).  
 Mpe1p is an RNA-binding protein and its RNA-binding property may 
contribute to poly(A) site selection (M. Sadowski, unpublished). By immunodepletion 
experiments it was demonstrated that Mpe1p is exclusively required for the 
polyadenylation reaction (M. Sadowski, unpublished). 
 Glc7p is a protein phosphatase and is the main subject of investigation of this 
thesis. We and others (He and Moore, 2005) found that Glc7p is required for 
polyadenylation of pre-mRNAs. In addition we found that Glc7p is involved in 
snoRNA transcription termination (Chapter 3). Furthermore, Glc7p genetically 
interacts with transcription elongation factors thereby affecting RNAP II during 
transcription elongation (Chapter 4).  
 Yth1p is required for both steps of pre-mRNA 3’ end processing (Barabino et 
al., 2000). It is an RNA-binding protein and binds to pre-mRNA in the vicinity of the 
cleavage site, thus participating in its recognition (Barabino et al., 2000). 
 Ssu72p is required for 3' end cleavage of pre-mRNA but is dispensable for 
poly(A) addition and RNAP II termination (He et al., 2003). In addition, several other 
reports implicate Ssu72 in transcription termination not only of pre-mRNAs but also 
of snoRNAs (Dichtl et al., 2002a; Ganem et al., 2003; Nedea et al., 2003; Steinmetz 
and Brow, 2003). Furthermore, analyses of ssu72-2 mutant cells revealed defects in 
RNAP II transcription elongation (Dichtl et al., 2002a). 
 Swd2p is a WD-40 repeat protein and associates with two functionally distinct 
multiprotein complexes: the cleavage and polyadenylation factor (CPF) and the SET1 
complex (SET1C) that methylates histone 3 lysine 4 (Cheng et al., 2004; Dichtl et al., 
2004). swd2 mutant strains are defective in 3' end formation of specific mRNAs and 
snoRNAs. Furthermore, histone 3 lysine 4 di- and tri-methylation are adversely 
affected. In addition, telomeres are shortened in swd2 mutants. However, the 
functions of Swd2p in CPF and SET1C are independent (Dichtl et al., 2004). In 
conflict to these findings, Cheng and co-workers found that cleavage and 
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polyadenylation of the mRNA precursor in vitro are normal in Swd2 depleted extracts 
(Cheng et al., 2004). 
1.3 Transcription termination of mRNAs 
 Termination of pre-mRNA transcription is defined as the process by which 
RNAP II dissociates from the DNA template and the nascent RNA preventing further 
transcription. The importance of transcription termination is to avoid the inappropriate 
transcription of downstream genes. A failure to terminate transcription is not only a 
waste of energy, but also disturbs normal patterns of gene expression. In particular, 
transcription towards promoters of downstream genes can interfere with recruitment 
of RNAP II to these promoters thereby preventing the normal transcription of these 
downstream genes (Greger et al., 2000). In addition, the release of RNAP II 
molecules during termination recycles polymerases for new rounds of transcription 
(Dye and Proudfoot, 1999; Greger and Proudfoot, 1998). 
 The molecular mechanism of transcription termination by RNAP II is still not 
completely understood. Part of the problem is that in contrast to RNAP I and III, 
transcription of protein-coding genes by RNAP II terminates at ill-defined positions in 
the 3’ UTR downstream of the poly(A) site, which directs cleavage and 
polyadenylation of pre-mRNAs (Proudfoot, 1989). By transcriptional run-on (TRO) 
analysis it was shown that transcription termination by RNAP II occurs rather 
randomly, at sites between 200-2000 bp downstream of the poly(A) site (Proudfoot, 
1989). Nevertheless, it was demonstrated that the efficiency of transcription 
termination correlates with the strength of the poly(A) site (Edwalds-Gilbert et al., 
1993; Orozco et al., 2002). Moreover, mutations in the poly(A) signal lead to 
transcription termination defects, indicating that the poly(A) signal itself is a cis-
acting element required for transcription termination (Proudfoot, 1989). However, 
since the poly(A) signal can be far away from the actual site where RNAP II is 
released from the DNA template and the RNA transcript, the poly(A) site is probably 
not the direct trigger for the transcription termination. It remains to be elucidated 
whether there exists a sequence motif that triggers termination in addition to the 
poly(A) site.  
 Several reports indicate that sequence motives downstream of the poly(A) site 
are required for transcription termination by RNAP II (Birse et al., 1997; Connelly 
and Manley, 1989a; Connelly and Manley, 1989b; Yonaha and Proudfoot, 1999). 
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Moreover, the presence of specific G-rich sequences (pause sites) located downstream 
of a strong poly(A) site lead to transcriptional pausing that could facilitate termination 
(Yonaha and Proudfoot, 1999). This pausing of RNAP II downstream of the poly(A) 
site may contribute to the process of termination (Yonaha and Proudfoot, 1999). Also, 
studies in mammalian cells indicate that pausing might be important for transcription 
termination (Park et al., 2004). There is evidence that transcription termination can be 
divided into two steps: pausing of RNAP II and  release of RNAP II from the 
template. Interestingly, pausing of RNAP II is CTD-independent whereas release of 
RNAP II is not (Park et al., 2004).  
 Chromatin structure across the termination region was also found to affect 
termination efficiency (Alen et al., 2002). Cells lacking the Chd1 chromatin 
remodeling factor did not only show defects in chromatin structure at termination 
regions but also in transcription termination itself (Alen et al., 2002). Therefore, 
chromatin remodeling at sites downstream of the poly(A) site might be important to 
facilitate pausing or even template release by RNAP II. 
 Besides a functional poly(A) site, there are several trans-acting factors known 
to be essential for transcription termination of pre-mRNAs that are involved in 3’ end 
processing of pre-mRNAs. These include subunits of CFI A (Gross and Moore, 
2001a; Minvielle-Sebastia et al., 1997), in particular Pcf11p, Rna14p and Rna15p 
(Birse et al., 1998b) and the CPF subunits Ssu72p (Steinmetz and Brow, 2003), 
Yhh1p (Dichtl et al., 2002b), Swd2p (Dichtl et al., 2004) and Ysh1p (M. Garras, 
personal communication). Although the mechanism, which links 3’ end processing to 
RNA polymerase release remains unclear, the poly(A) signal is important in coupling 
of 3’ end processing and transcription termination (see below). 
 
1.4 Coupling of 3’ end processing and transcription termination 
 Direct support for a connection between pre-mRNA 3’ end processing and 
transcription termination came from studies demonstrating that the poly(A) site, a 
cleavage- and polyadenylation directing signal, is also a cis-element required for 
normal transcription termination (Connelly and Manley, 1988; Logan et al., 1987; 
Russo, 1995). It was shown that mutation of the poly(A) signal inhibited not only 
cleavage and polyadenylation at the poly(A) site but also transcription termination of 
RNAP II (Proudfoot, 2000b). Coupling of these two processes is further evident by 
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the fact that several yeast subunits of CFIA and CPF which are indispensable for 
cleavage and polyadenylation are also required for normal transcription termination 
(Aranda and Proudfoot, 2001; Proudfoot, 2004). These include the CFIA subunits 
Rna14p, Rna15p and Pcf11p (Birse et al., 1998b; Kim et al., 2004a; Sadowski, 2003) 
and CPF subunits Yhh1p (Dichtl et al., 2002b) and Ssu72p (Ganem et al., 2003; 
Steinmetz and Brow, 2003), Swd2p (Dichtl et al., 2004) and Ysh1p (M. Garras 
personal communication). In addition, the efficiencies of pre-mRNA 3’ end 
processing and transcription termination correlate with the strength of the poly(A) site 
(Edwalds-Gilbert et al., 1993). Therefore, the poly(A) signal directly affects RNAP II 
transcription termination.  
 To address the mechanistic basis for the connection between termination and 
3’ end processing of pre-mRNAs, two models have been proposed: the allosteric 
model and the so-called torpedo model (Buratowski, 2005; Figure 1.3). The allosteric 
model suggests that upon recognition of the poly(A) site by the transcription complex, 
the enzymatic activity of RNAP II is modified, making it “termination-competent”. 
Modification of RNAP II could include a conformational change or the loss of anti-
termination factors, which where associated with the RNAP II. This would then lead 
to a loss of RNAP II processivity and eventually to transcription termination (Calvo 
and Manley, 2005; Greenblatt et al., 1993; Logan et al., 1987; Sadowski, 2003). The 
torpedo model, unlike the allosteric model, requires transcription termination to be 
preceded by the endonucleolytic cleavage at the poly(A) site. Cleavage of the pre-
mRNA exposes an uncapped 5’ end of the downstream cleavage product that serves 
as substrate for a 5’-to- 3’ exonuclease. The exonuclease degrades the downstream 
cleavage product while it is still tethered to RNAP II until catching up with the RNAP 
II and somehow destabilizing it, ultimately terminating RNAP II (Connelly and 
Manley, 1988; Kim et al., 2004b; Luo and Bentley, 2004). Although both models rely 
on recognition of the poly(A) site, a fundamental difference is that only the torpedo 
model depends on cleavage of the nascent RNA to create the entry site for the 5’-to- 
3’ exonuclease. 
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Fig. 1.3. Pre-mRNA transcription termination models 
On the left hand side: the RNAP II transcription complex approaches the poly(A) site, which is 
required for transcription termination. The allosteric transcription termination model (right hand side, 
top) proposes that termination occurs cleavage-independent due to a change in the processivity of 
RNAP II. In the torpedo model (right hand side, bottom) a prerequisite for termination is cleavage of 
the pre-mRNA. The cleavage reaction generates an entry side for the exonuclease Rat1, which 
“torpedos” RNAP II. 
 
 
There is evidence supporting either of these models. For example, the 
allosteric model is supported by a study showing that the 3’ end processing and the 
termination function of Pcf11p are separable (Sadowski, 2003). Pcf11p associates 
directly with the nascent RNA and the CTD via its CTD-interacting domain (CID). 
Although the intact CID of Pcf11p is required for efficient termination, mutations in 
this domain have no effect on cleavage in vitro (Sadowski, 2003). This implies that 
cleavage of the pre-mRNA is not an obligatory step for transcription termination as 
proposed by the torpedo model. In addition, Pcf11p can force the dissociation of an in 
vitro assembled RNAP II elongation complex (Zhang et al., 2005; Zhang and 
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Gilmour, 2006). The authors propose that by bridging the CTD and the nascent RNA 
a conformational change in the CTD is induced that is transduced through Pcf11 to 
the nascent transcript causing transcription termination (Zhang et al., 2005; Zhang and 
Gilmour, 2006).  
 Strong evidence in support of the torpedo model comes from the recent 
identification of yeast Rat1 and human Xrn2, both 5’-to-3’ RNA exonucleases, which 
are necessary for efficient transcription termination (Kim et al., 2004b; West et al., 
2004). Inactivation of Rat1 does not affect cleavage or polyadenylation. However, 
inactivation of Rat1 results in deficient transcription termination. Moreover, the 
downstream cleavage products are stabilized in a rat1-1 mutant strain, suggesting that 
Rat1 exonuclease activity is required for the degradation of such products (Kim et al., 
2004b). 
 A new study by Luo and co-workers (Luo et al., 2006) presents evidence that 
both models can be linked together. They propose a unified allosteric/torpedo model 
based on the following findings: (1) Rat1p degrades nascent RNA co-
transcriptionally. However this degradation does not elicit termination, showing that it 
is not sufficient to cause RNAP II release from the template (2) Rat1p is required for 
the recruitment of 3’ end processing factors and for correct 3’ end formation. 
Conversely, 3’ end factors are also required for normal Rat1p recruitment. Therefore 
it seems that Rat1p is not a dedicated termination factor, but instead, like conventional 
3’ end processing factors contributes to both poly(A) site cleavage and termination. 
 Altogether, this suggests that in addition to the exonucleolytic activity of 
Rat1p, Rat1p might influence termination through interactions with the cleavage and 
polyadenylation factors. Accordingly, Luo and co-workers proposed that Rat1 is an 
essential component of a RNAP II complex, which achieves cleavage at the poly(A) 
site, degradation of the nascent downstream RNA, and undergoes allosteric changes 
that promote RNAP II release from the template.  
 
1.5 Processing and transcription termination of snoRNAs 
 snoRNAs are a class of non-coding RNAs that are transcribed by RNAP II. 
These metabolically stable RNAs, which are 60 to 300 nucleotides long, associate 
with a number of proteins to form small nucleolar RNPs (snoRNPs; Kiss, 2001). In 
the nucleolus, the majority of snoRNAs function as guide RNAs in the post-
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transcriptional synthesis of 2’-O-methylated nucleotides and pseudouridines in 
rRNAs, tRNAs and snRNAs and most likely other cellular RNAs (Kiss, 2002). These 
modified nucleotides are important to ensure the proper function of rRNAs, tRNAs 
and snRNAs.  
 snoRNAs can be subdivided into two main classes according to evolutionarily 
conserved structural and sequence elements: the box C/D snoRNAs and the box 
H/ACA snoRNAs (reviewed by Kiss, 2001). While methylation of the 2’–hydroxyl 
groups is directed by box C/D snoRNAs, box H/ACA snoRNAs guide the conversion 
of uridines to pseudouridines (Kiss, 2001). They do so by base-pairing with the target 
RNA, specifying the nucleotides that have to be modified by the respective enzymes. 
 Whereas most vertebrate snoRNAs are encoded in introns of RNAP II genes, 
the majority of S. cerevisiae snoRNAs are independently transcribed monocistronic or 
polycistronic genes (Weinstein and Steitz, 1999). However, there are also a few 
intron-encoded snoRNAs in yeast (Qu et al., 1995; Villa et al., 1998).  
 Most precursor snoRNAs are processed at the 5’ and 3’ end resulting in 
mature, functional snoRNAs. Some snoRNAs are not processed at their 5’ end, like 
U3, snR4 and snR13 (Samarsky and Fournier, 1999). Those, that undergo 5’ end 
processing, as snR39b, snR40, snR47 and snR79, will loose their trimethylguanosine 
cap structure  by cleavage by the endonuclease Rnt1p (Chanfreau et al., 1998). This 
event creates an entry site for Rat1 and/or Xrn1p exonucleases, which trim the 5’ 
extensions (Lee et al., 2003). 3’end-processed snoRNAs differ in several aspects from 
3’ end-processed pre-mRNAs. The main difference is that mature snoRNAs are not 
polyadenylated. A reason for this might be the diverse genomic organization of 
snoRNAs that requires case-specific actions and factors. However, despite this 
heterogeneous organization of snoRNAs, processing of most snoRNAs relies on one 
general mechanism: endonucleolytic cleavage in the 5’ and 3’ extensions generates 
entry sites for exonucleases that trim the ends and release the mature snoRNAs 
(Allmang et al., 1999; Petfalski et al., 1998). The exonucleases that remove the 3’ 
extensions belong to the nuclear exosome. The entry sites are often created by the 
Rnt1 endonuclease (Chanfreau et al., 1997; Chanfreau et al., 1998). However, Rnt1 
cleavage sites are not present in all snoRNA precursors. Several snoRNAs contain 
sequences in their 3’ portion which direct cleavage of the primary transcript by CF IA 
(Morlando et al., 2002). Since the cleaved precursor is not subsequently 
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polyadenylated, it is likely that CF IA can work in cooperation with factors different 
from CPF in the 3’ end processing of snoRNAs. 
 A small number of primary snoRNA transcript is not endonucleolytically 
cleaved, but processed simply through trimming the ends by 3’-to-5’ exonucleases 
(Bachellerie et al., 2002). This mode of processing requires prior transcription 
termination.  
 Seven snoRNAs in yeast are encoded in the intron of a gene. A well studied 
example is the U18 snoRNA, which is encoded in the intron of EFB1 (Villa et al., 
1998). It was shown that two processing modes exist for these intron encoded 
snoRNAs. The major type of processing is splicing-dependent. The spliced host intron 
is first debranched and subsequently exonucleolytically trimmed resulting in the 
mature snoRNA. In the alternative pathway the snoRNA is endonucleolytically cut 
out of the intron. This second pathway is not dependent on splicing and might be the 
dominant form when the splicing efficiency is reduced (Villa et al., 1998). 
Endonucleolytic processing of snoRNAs is also required in all of the poly-snoRNA 
precursor transcripts that have been reported in yeast (Zagorski et al., 1988). 
 The transcription termination of individually transcribed snoRNAs is coupled 
to the recognition of cis-acting signals, as it is the case for transcription termination of 
pre-mRNAs. Similarly, transcription termination of snoRNAs, like in the case of 
termination of pre-mRNAs requires the action of CTD and RNA-interacting factors 
(Carroll et al., 2004; Steinmetz et al., 2001). However, the actual mechanism of 
snoRNA transcription termination might be different from the one of pre-mRNAs, 
since termination of snoRNA crucially involves the Nrd1 complex, which is not 
engaged in transcription termination of mRNAs. Components of the Nrd1 complex, 
the RNA-binding proteins Nrd1p and Nab3p, recognize specific RNA sequences in 
the 3’ non-coding regions of snoRNAs (Carroll et al., 2004). It is to date unclear, how 
recognition of the termination signals is transmitted to the transcribing RNAP II and 
what actually forces RNAP II to terminate transcription.  
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1.5.1 Cis and trans-acting factors in S. cerevisiae snoRNA processing and 
transcription termination 
1.5.1.1 Cis-acting signals 
 A well-characterized cis-acting signal in the 5’ and 3’ flanking regions of 
around 50% of snoRNAs is a stem-loop structure that is recognized by the 
endonuclease Rnt1p (Chanfreau et al., 1998). This hairpin structure is capped by a 
terminal tetraloop showing the consensus AGNN. Rnt1p recognizes and cleaves the 
hairpin within 13-16 bp of the tetraloop (Chanfreau et al., 2000; Wu et al., 2004). In 
cases where there are no Rnt1p cleavage sites, cis-acting signals for 3’ end processing 
are dubious. It has been suggested that the nascent transcript is cleaved at sites that are 
often found downstream, close to predicted Nrd1 and Nab3 binding sites, which are 
required for snoRNA transcription termination (Fatica et al., 2000; Morlando et al., 
2002). It is not clear whether recognition of the 3’ end processing sequence is coupled 
to transcription termination of the snoRNA, as it is the case for pre-mRNA.  
 Termination of snoRNAs by RNAP II in S. cerevisiae requires two common 
RNA sequence motifs in the snoRNA 3’ downstream region: GUA[AG] and UCUU 
(Carroll et al., 2004; Steinmetz et al., 2001; Steinmetz et al., 2006). These two motifs 
are bound by subunits of the Nrd1 complex, Nrd1p and Nab3p. Nrd1p binds to 
GUA[AG], whereas Nab3p binds to UCUU. Interestingly, Nrd1p and Nab3p binding 
sites are also found in the 5’UTR and 5’ coding region of the Nrd1 mRNA. There, 
they direct the autoregulation of Nrd1 expression by premature transcription 
termination (Arigo et al., 2006a). As for the poly(A) signal, there is no strong 
consensus for these non-poly(A) terminators in S. cerevisiae and in addition, the 
arrangement of Nrd1p and Nab3p binding sites varies considerably in number and 
location. There are also indications that these sequence motifs work in a synergistic 
manner, with one motif alone being insufficient to trigger termination. Moreover, the 
organization of these sequences is not strongly conserved among even closely related 
yeasts, which indicates a high degree of genetic variability (Carroll et al., 2004). For 
some snoRNAs, such as snR13, snR47 and snR65, the terminator region is arranged 
in a bipartite fashion (Steinmetz et al., 2006). Interestingly, region I of the snR13 and 
snR65 terminators and the Nrd1 autoregulatory element show some sequence 
similarity. This suggests that regular terminators are more than just a collection of 
low-affinity Nrd1 and Nab3 binding sites (Steinmetz et al., 2006). Furthermore, 
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region II of the snR13 and snR65 terminators have sequence similarity to yeast 
cleavage and polyadenylation sites and can direct polyadenylation, indicating that 
protein-coding and non-coding RNAP II transcribed genes might use similar 
mechanisms to direct termination (Steinmetz et al., 2006).  
 
1.5.1.2 Trans-acting factors 
 The endonuclease Rnt1p, which is the yeast homolog of RNase III, cleaves 
stem-loop structures in the 5’ and 3’ flanking regions of snRNA and many snoRNAs 
(Chanfreau et al., 1998). Cleavage of the stem-loops generates entry sites for 
exonucleases to digest 5’ and 3’ overhangs resulting in the mature form of the snRNA 
and snoRNA. The 3’ overhangs are trimmed by the nuclear exosome, which consists 
of a number of 3’ to 5’ exonucleases. Since many snoRNAs do not have Rnt1p 
cleavage sites in their 5’ and 3’ flanking regions, there must be other factors that 
generate entry sites for these exonucleases. Indeed, snoRNAs can contain sequences 
in their 3’ portions which direct cleavage of the primary snoRNA transcript involving 
CFI A (Morlando et al., 2002). However, none of the subunits of CFI A is known to 
have endonucleolytic activity, implying that CFI A has to work together with some 
other factor(s) to accomplish the cleavage reaction (Morlando et al., 2002). CFI A 
normally functions in combination with CPF in the cleavage and polyadenylation 
reaction of pre-mRNAs. It is anticipated that Ysh1p, a subunit of CPF, is the 
endonuclease that cleaves the pre-mRNA because it contains sequence motifs 
common for proteins acting on nucleic acid substrates (Callebaut et al., 2002). 
Morlando and co-workers showed, that a ysh1-1 mutant strain is not involved in 3’ 
end processing of snoRNAs (Morlando et al., 2002). However, ysh1-1 is a very 
hypomorphic allele of Ysh1p that also does not show a cleavage defect in 3’ end 
processing of pre-mRNAs (M. Garras, personal communication). We therefore 
consider the possibility that CFI A joins together with CPF in the 3’ processing of 
snoRNAs. 
 The nuclear exosome is a protein complex consisting of at least 10 different 3’ 
to 5’ exonucleases involved in the 3’ processing of rRNAs, snRNAs and many 
snoRNAs (van Hoof et al., 2000). It was shown that the yeast exosome mutant strains 
rrp6 and mtr4 accumulate 3’-extended polyadenylated forms of independently 
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transcribed snoRNAs, indicating that the nuclear exosome is required for 3’ end 
processing of snoRNAs.  
 Recently, Egecioglu and co-workers (Egecioglu et al., 2006) discovered that 
the polyadenylation of these snoRNA processing intermediates is dependent on the 
activity of Trf4p and Trf5p, two variant poly(A) polymerases (Vanacova et al., 2005). 
Polyadenylation by Trf4p might stimulate the nuclear exosome to process the 3’ ends 
of snoRNAs. 
 The 5’ ends of snoRNAs are processed by the Rat1p/Rai1p nuclease complex. 
The complex contains 5’-to-3’ exonucleases that play also a role in trimming of 
several ribosomal RNAs (Kim et al., 2004b). In this context, it is interesting that 
Rat1p is also a crucial component in transcription termination of pre-mRNAs (Kim et 
al., 2004b; Luo et al., 2006). 
 Previous studies have described a yeast pathway for transcription termination 
of snRNA and snoRNA genes which require the Nrd1 complex, the CTD kinase Ctk1 
and the CTD of RNAP II (Conrad et al., 2000; Steinmetz et al., 2001). More recent 
studies have also implicated several components of APT (see below), a sub complex 
of CPF, in this pathway (Dheur et al., 2003; Nedea et al., 2003; Steinmetz and Brow, 
2003). Mutations in any of these genes lead to read-through transcription at certain 
snRNA and snoRNA genes (Dheur et al., 2003; Dichtl et al., 2002a; Ganem et al., 
2003; Steinmetz et al., 2001 and this study). 
 The RNA-binding proteins Nrd1p and Nab3p, and the helicase Sen1p have 
been assigned to the Nrd1 complex. Both Nrd1 and Nab3 contain a single conserved 
RNA recognition motif (RRM), a domain common to proteins involved in RNA 
processing (Conrad et al., 2000), with which they bind to the cis-acting terminator 
sequence elements. In addition, Nrd1p exists in two different phosphoisoforms 
(Conrad et al., 2000). Overexpression of Nab3p leads to the predominance of the 
slower migrating phosphoisoform (Conrad et al., 2000). Moreover, Nrd1p physically 
and genetically interacts with the CTD of RNAP II. The CTD interaction domain 
(CID) of Nrd1 has sequence similarity to two other yeast proteins that function at 3’ 
ends: Pcf11p and Rtt103p (Kim et al., 2004b). They are involved in transcription 
termination of protein-coding genes. Therefore, it is tempting to speculate that 
mechanistic similarities in the process of transcription termination of snoRNAs and 
mRNAs may exist: Nrd1p similar to Pcf11p could dismantle the RNAP II complex 
from the template. 
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 Interestingly, Nrd1p and Nab3p are also required for transcription termination 
of cryptic unstable transcripts (CUTs), which are RNAs that are derived from non-
annotated regions of the genome (Arigo et al., 2006b; Thiebaut et al., 2006). The 
result of Arigo, Thiebaut and co-workers suggests that transcription termination of 
CUTs due to Nrd1 and Nab3 is necessary for the subsequent degradation of the CUTs 
by the nuclear exosome (Arigo et al., 2006a; Thiebaut et al., 2006).  
 It was reported previously, that the Nrd1 complex physically interacts with the 
nuclear exosome and stimulates the RNA degradation activity of the exosome in vitro 
for 3’ end processing of snoRNAs (Vasiljeva and Buratowski, 2006). In the same 
study, additional interactions with factors of the TRAMP complex, the endonuclease 
Rnt1p, RNAP II subunits and the transcription elongation factor Spt5p were reported. 
This suggests that Nrd1 may link transcription and RNA 3’ end formation of 
snoRNAs. 
 Sen1p is a Type I DNA/RNA helicase and has been implicated in processing 
of pre-tRNAs, pre-rRNAs and some snoRNAs (Rasmussen and Culbertson, 1998; 
Ursic et al., 2004; Ursic et al., 1997). Intriguingly, Sen1p is a phosphoprotein and co-
purifies with Glc7p (Ho et al., 2002; Walsh et al., 2002) making it likely that Glc7p 
regulates the activity of Sen1p in the process of transcription termination of 
snoRNAs. Sen1p also interacts physically and functionally with the Rnt1p 
endonuclease (Ursic et al., 2004) thereby linking 3’ end processing and termination. 
 Nrd1p, Nab3p and Sen1p are also required for maintaining normal levels of 
the Nrd1 mRNA. It was shown that at least Nrd1p and Nab3p do so by binding to 
Nrd1/Nab3 binding sites in the 5’ UTR and 5’ coding region of Nrd1 causing 
premature transcription termination (Arigo et al., 2006a). 
 It was proposed that the CPF complex can be subdivided into the holo-CPF 
complex, which includes the subunits Pta1p, Yhh1p, Ydh1p, Ysh1p, Mpe1p, Pap1p, 
Pfs2p, Yth1p, Fip1p and the APT sub complex comprising the subunits Syc1p, 
Ssu72p, Pti1p, Ref2p, Swd2p and Glc7p (Nedea et al., 2003; Figure 1.4). APT stands 
for associated with Pta1 to account for Pta1p’s role in bridging the two sub complexes 
(Nedea et al., 2003). Based on the fact that Ssu72p, Ref2p and Pta1p revealed a 
transcription termination defect of snoRNAs, Nedea and co-workers suggested that 
APT is involved in the snoRNA 3’ end formation (Nedea et al., 2003). This 
assumption was further corroborated by the findings that Swd2p and Ssu72p are 
required for transcription termination of snoRNAs. 
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Fig. 1.4. Glc7p is part of the cleavage and polyadenylation factor subcomplex APT 
 
 
 Temperature sensitive swd2 strains were defective in 3’ end formation of 
specific snoRNAs and also some mRNAs (Dichtl et al., 2004). Interestingly, Swd2p 
associates with two functionally distinct multiprotein complexes: the SET1 complex, 
which methylates histone 3 lysine 4 and the CPF complex (Dichtl et al., 2004). 
 Ssu72p is a phosphatase and mediates both, termination of snoRNAs and 
mRNAs (Dichtl et al., 2002a; Ganem et al., 2003; Steinmetz and Brow, 2003). 
Steinmetz and co-workers (Steinmetz and Brow, 2003) showed that a ssu72 mutant 
strain in which Nrd1-dependent termination was disrupted, also resulted in deficient 
poly(A)-dependent termination. Ssu72 might influence transcription termination via 
regulating the CTD phosphorylation, since it dephosphorylates Ser 5 of the CTD and 
also physically interacts with the CTD kinase Kin28p and functionally with the CTD 
phosphatase Fcp1p (Ganem et al., 2003; Krishnamurthy et al., 2004). 
 Pti1p and Ref2p were found to be required for the 3’ end formation of 
snoRNAs, however not for 3’ end processing of pre-mRNAs (Dheur et al., 2003). 
Additionally, Pti1p and Ref2p act as multicopy suppressors in a pcf11-2 mutant strain 
(Dheur et al., 2003). Pcf11p is a subunit of CF IA and it has been reported that CF IA 
contributes to snoRNA and snRNA 3’ end formation (Fatica et al., 2000; Morlando et 
al., 2002). Intriguingly, the authors suggest that Pti1p and probably also Ref2p 
function in the uncoupling of cleavage and polyadenylation during snoRNA 3’ end 
formation based on the finding that overexpression of Pti1p inhibits polyadenylation. 
 31
 Our own analysis on the function of Glc7p in snoRNA transcription 
termination  extends the current knowledge on the role of the APT subunits (Chapter 
3). We present evidence that Glc7p is crucial for snoRNA transcription termination. 
 Since no holo-CPF subunit has been shown to be involved in the 3’ end 
formation of snoRNAs so far, the subdivision of CPF into holo-CPF and APT could 
not only be for physical but also for functional reasons. 
 Recently, the Paf1 complex, which also functions in transcription elongation 
and histone modification was shown to be involved in 3’ end formation of snoRNAs 
(Sheldon et al., 2005). Deletion of Paf1p, a subunit of the Paf1 complex, leads to the 
accumulation of snoRNA transcripts that are extended at their 3’ ends. The Paf1 
complex also facilitates Nrd1 recruitment to the snR47 gene. Therefore, it was 
proposed that the Paf1 complex is directly involved in 3’ end formation of snoRNAs 
(Sheldon et al., 2005). 
 A screen for trans-acting factors that induce readthrough of both snoRNA and 
mRNA terminators identified two RNAP II subunits, Rpb3p and Rpb11p (Steinmetz 
et al., 2006). The two subunits define a discrete surface at the trailing end of RNAP II 
(Steinmetz et al., 2006). This suggests that the signal for RNAP II to release the 
template and thus to terminate transcription is mediated by the Rpb3/Rpb11 
heterodimer. In addition, this finding supports the idea that protein-coding and non-
coding RNAP II-transcribed genes might use a similar mechanism to direct 
transcription termination. The fact that some factors involved in cleavage and 
polyadenylation of pre-mRNAs are required for 3’ end formation of snoRNA further 
substantiates that there are parallels between the poly(A) and the non-poly(A) 
termination mechanisms. 
 
 
1.6 The C-terminal domain of RNAP II, an important player in coupling 
transcription to capping, splicing and 3’ end processing of pre-mRNAs  
 A striking feature that distinguishes RNAP II from RNAP I and III, is the 
extended carboxyl-terminal domain (CTD) of the largest RNAP II subunit Rpb1. The 
CTD consists of multiple heptapeptide repeats of the consensus sequence 
Y1S2P3T4S5P6S7 (Prelich, 2002). The number of repeats increases with the complexity 
of the organism, for example, the yeast CTD has 26 repeats, whereas the human CTD 
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has 52 repeats (Prelich, 2002). In addition, the number of repeats that exactly match 
the consensus sequence varies among species (Prelich, 2002). The inherently 
unstructured CTD protrudes from the RNAP II enzyme and therefore can be easily 
accessed by numerous factors that bind to it (Prelich, 2002). As will be discussed 
below, the factors that bind the CTD are mostly RNA processing factors and 
elongation factors that act co-transcriptionally to mature the RNA and allow the 
transcription of the respective gene. Therefore, the CTD is crucial in coupling RNA 
processing events to the transcription of pre-mRNAs by attracting and transporting 
many factors that are involved in the production of mature mRNAs. 
 The CTD can be modified by phosphorylation, glycosylation and cis/trans 
isomerization of prolines (Meinhart et al., 2005). Modification of the CTD markedly 
affects its conformation and ability to associate with factors that are involved in 
transcription elongation, RNA processing and transcription termination. Therefore, 
modification of the CTD is important for the coordination of transcription events, and 
different modification states of the CTD are characteristic of different transcriptional 
stages (Prelich, 2002). 
 Phosphorylation of the CTD occurs predominantly at serine 2 (Ser2) and 
serine 5 (Ser5) (Dahmus, 1996). There are basically three phosphorylation states of 
the CTD: the unphosphorylated CTD, the CTD phosphorylated at Ser2 and the CTD 
phosphorylated at Ser5. The current paradigm is that different phosphorylation 
patterns predominate at different stages in the transcription cycle and that different 
proteins bind to specific phosphorylated forms of the CTD (Figure 1.5). This model is 
based on results from chromatin immunoprecipitation (ChIP) experiments, which 
suggested that the CTD is unphosphorylated during the assembly of the transcription 
complex at the promoter. Following transcription initiation, the level of Ser5 
phosphorylation increases rapidly. It remains unclear whether the levels of Ser5 
phosphorylation during transcription elongation remain constant or decrease towards 
the 3’ end of the gene. Ser2 phosphorylation levels appear to increase during 
elongation, reaching a peak near the poly(A) site after which the level of Ser2 
phosphorylation drops again (Ahn et al., 2004; Kim et al., 2004a; Komarnitsky et al., 
2000; Morris et al., 2005). 
 Probably at least some repeats remain unphosphorylated. In addition, Ser5 
phosphorylation levels do not drop to zero during elongation indicating that not all 
repeats of the CTD are phosphorylated in the same way (Ahn et al., 2004). 
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Furthermore, different findings indicate that during the elongation stage repeats, 
which are phosphorylated at both Ser2 and Ser5 must exist. First, Ctk1p, the CTD 
Ser2 kinase, efficiently uses Ser5 phosphorylated repeats to generate Ser2/Ser5-
phosphorylated repeats in vitro (Jones et al., 2004). Second, the histone 
methyltransferase Set2p, which remodels chromatin during transcription elongation, 
requires repeats phosphorylated on both Ser2 and Ser5 for optimal binding (Kizer et 
al., 2005; Li et al., 2005). Finally, the monoclonal Antibody (mAb) H5, which is used 
to detect Ser2 phosphorylation, binds better to repeats concomitantly phosphorylated 
at Ser2 and Ser5 (Jones et al., 2004). This indicates that what was interpreted as Ser2 
phosphorylation might actually be phosphorylation on both Ser2 and Ser5. 
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Fig. 1.5. Linking RNAP II transcription and RNA processing: a central role for the CTD 
The phosphorylation pattern of the CTD changes during different transcription phases indicated by the 
purple (for Ser 5 phosphorylation) and blue (for Ser 2 phosphorylation) bars. As a consequence distinct 
processing factors (capping enzymes, the Spt4/Spt5 complex, the Paf complex, CPF and CFIA) are 
attracted to the CTD during the different phases of transcription.  
 
 
 Several CTD kinases and phosphatases are know to modify the 
phosphorylation state of the CTD of RNAP II (Phatnani and Greenleaf, 2006). The 
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known CTD phosphatases include Ssu72p, small CTD phosphatases (SCPs) and 
Fcp1p. Kinases required for CTD phosphorylation are Kin 28 and Ctk1.  
 Ssu72 has been shown to be a Ser5 phosphatase (Krishnamurthy et al., 2004). 
The depletion of Ssu72 and concomitant elevation of Ser5 phospho-levels inhibit 
transcription in vitro (Krishnamurthy et al., 2004). Interestingly, Ssu72p is a member 
of the CPF complex and has functions in all stages of transcription from initiation 
over elongation to termination (Dichtl et al., 2002a; Ganem et al., 2003; Pappas and 
Hampsey, 2000; Steinmetz and Brow, 2003), (Meinhart et al., 2005). The essential 
role of Ssu72p in 3’ end processing of pre-mRNAs however, is independent of its 
phosphatase activity (Krishnamurthy et al., 2004). 
 Small CTD phosphatases (SCPs), which are specific to higher eukaryotes, 
preferentially dephosphorylate Ser5 (Yeo et al., 2003).  
 FCP1 can dephosphorylate both Ser2 and Ser5 in vitro (Lin et al., 2002). 
However, there are discrepancies as to which substrate is preferred in vivo. Mutations 
in yeast Fcp1p preferentially cause an increase in the levels of phospho-Ser2 (Cho et 
al., 2001). Dephosphorylation of the CTD by Fcp1p might facilitate recycling of the 
hyperphosphorylated form of the polymerase for a new round of transcription (Cho et 
al., 1999). FCP1 might also be required to regulate phosphorylation of the CTD 
during transcription (Cho et al., 2001). CTD dephosphorylation by Fcp1 can also be 
stimulated by Ess1, a peptidylprolyl isomerase (Kops et al., 2002; Xu et al., 2003). 
Ess1 catalyzes the conversion of the Ser-Thr-Pro moiety from the cis to the trans 
conformation (Kops et al., 2002). 
 In S. cerevisiae, four cyclin-dependent kinases have been identified as being 
important for transcription, however only two of them have unambiguously been 
shown to phosphorylate the CTD. Among the latter is the Kin28 (Cdk7) subunit of 
TFIIH, which phosphorylates the CTD on Ser5, when transcription is initiated 
(Rodriguez et al., 2000). Ctk1 (Cdk9) associates with elongating RNAP II and 
phosphorylates the CTD on Ser2 (Cho et al., 2001). 
 Capping of pre-mRNAs occurs soon after transcription initiation and before 
other processing events. Phosphorylation of Ser5 of the CTD heptapeptide repeats is 
important for the recruitment and the enzymatic activity of the mRNA capping 
enzyme guanylyltransferase (Cho et al., 1998; Cho et al., 1997; Ho et al., 1998; 
Komarnitsky et al., 2000; Rodriguez et al., 2000). Interestingly, levels of the 
polyadenylation factor Pta1p are reduced in kin28 mutants in which Ser5 
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phosphorylation is poor, indicating that this polyadenylation factor might be recruited 
to the transcription complex already at early stages of transcription. Several other 
polyadenylation factors remain stable in the kin28 mutant (Rodriguez et al., 2000). In 
addition, Pta1p binds specifically to the phosphorylated CTD. This suggests that 
polyadenylation and transcription are coupled through this interaction (Rodriguez et 
al., 2000). 
 Phosphorylation of Ser2 by Ctk1 is required for the recruitment of 
polyadenylation factors (Rna14p, Rna15p, Yhh1p and Ydh1p) to the 3’ end of genes 
in vivo (Ahn et al., 2004). Also Pcf11p, a subunit of cleavage factor CF IA, was found 
to bind efficiently to a Ser2-phosphorylated CTD peptide in vitro (Licatalosi et al., 
2002). Furthermore, deletion of Ctk1 leads to changes in polyadenylation site choice, 
presumably due to the loss of co-transcriptional polyadenylation,  but does not affect 
transcription termination in vivo (Ahn et al., 2004). Ahn and co-workers also showed 
that Ctk1 and therefore Ser2 phosphorylation is not required for the recruitment of the 
elongation factors Spt5p, Spt4p, Spt6p and the PAF complex (Ahn et al., 2004). In 
contrast, the chromatin remodeling factors Set1p and Set2p bind to the 
phosphorylated CTD (Krogan et al., 2003a; Krogan et al., 2003b; Ng et al., 2003b). 
As mentioned above, the optimal binding conditions, at least for Set2p, might be 
heptapeptide repeats phosphorylated at both serines (Kizer et al., 2005; Li et al., 
2005). 
 Interestingly, deletion of Ctk1 leads to a defect in snoRNA transcription 
termination (Steinmetz et al., 2001), suggesting that phosphorylation of Ser2 is 
necessary for efficient snoRNA transcription termination. 
 The RNAP II CTD itself is essential for 3’ end cleavage of metazoan pre-
mRNAs (McNeil et al., 1998), since deletion of the yeast CTD reduces the efficiency 
of cleavage at poly(A) sites and the length of poly(A) tails. This suggests that it helps 
to couple 3’ end formation with transcription (Licatalosi et al., 2002).   
 Normal mRNA splicing and 3’ end processing are disrupted in mammalian 
cells expressing RNAP II lacking the CTD (Fong and Bentley, 2001; McCracken et 
al., 1997). In yeast, splicing appears unaffected when the CTD is deleted form RNAP 
II (Licatalosi et al., 2002). Moreover, it was shown that whereas the carboxyl-terminal 
part of the mammalian CTD consisting of heptads 27-52, supports capping, splicing 
and 3’ end processing, the amino-terminus supports only capping (Fong and Bentley, 
2001). This indicates that the CTD as a whole stimulates all three major pre-mRNA 
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processing steps but that different regions of the CTD serve distinct functions in the 
different subprocesses. 
 Although many functional aspects concerning the CTD of RNAP II have been 
solved, still many questions remain open, e.g.: what initiates CTD phosphorylation? 
What causes the dissociation of factors from the CTD? Is there a particular order of 
factors bound along the length of the CTD?  
Therefore, the CTD of RNAP II continues to be an exciting field of investigation.  
 
1.7 Transcription elongation 
 Transcription of a gene by RNAP II can be divided into three main phases: 
initiation, elongation and termination of transcription (Saunders et al., 2006). For 
many years, the focus of how gene expression is regulated, was concentrated on the 
process of transcription initiation. The subsequent transcription elongation was 
thought of as the simple addition of ribonucleotide triphosphates to the growing RNA 
chain (Saunders et al., 2006). Only since recently, it is appreciated that also during 
transcription elongation mechanisms exist that allow the regulation of gene expression 
(Saunders et al., 2006; Sims et al., 2004b). This is due to the identification of a 
number of transcription elongation factors that affect mRNA production at particular 
stages during transcription (Saunders et al., 2006).   
 Transcription elongation is divided into three distinct stages: promoter escape 
(or promoter clearance), promoter-proximal pausing and productive elongation 
(Saunders et al., 2006). Each stage is defined by a marked difference in the stability 
and behavior of the RNAP II transcription complex as well as by a distinct repertoire 
of factors that associate with it (Saunders et al., 2006).  
 During promoter escape, some of the general transcription factors dissociate 
from the RNAP II transcription complex and RNAP II breaks its contacts to 
promoter-sequence elements (Saunders et al., 2006; Sims et al., 2004a). These actions 
lead to the release of the RNAP II transcription complex from the promoter and the 
start of transcription of the gene. However, to acquire full processivity, the RNAP II 
transcription complex has yet to be further transformed. Full transformation into a 
highly productive transcription elongation complex is only achieved after a process 
known as promoter-proximal pausing (Saunders et al., 2006; Sims et al., 2004b). 
Promoter-proximal pausing is a phenomenon where RNAP II pauses at the 5’ region 
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of the transcription unit and only progresses efficiently into productive elongation 
upon stimulation by appropriate signals. Pausing can be considered as a  checkpoint 
before committing to productive elongation. During this pausing, capping enzymes 
are recruited to the stalled transcription elongation complex and the nascent RNA is 
capped (Saunders et al., 2006; Sims et al., 2004a). Escape from the pause site and 
promoter escape are the rate-limiting steps in RNAP II transcription elongation (Lis, 
1998). In addition, gene expression can be regulated at these points (Lis, 1998). 
 RNAP II encounters only a few obstacles during the productive elongation 
stage. However, to smoothly operate during this stage, RNAP II is dependent on 
transcription elongation factors that help to overcome intrinsic arrest sites or remodel 
the chromatin structure that would otherwise impair further transcription (Saunders et 
al., 2006; Sims et al., 2004a).    
 A crucial player in all stages of transcription elongation is the CTD of RNAP 
II (Hirose and Manley, 2000; Orphanides and Reinberg, 2002; Proudfoot et al., 2002). 
It acts as a platform that attracts and binds many factors involved in transcription 
elongation as well as factors involved in mRNA maturation, surveillance and export 
(Hirose and Manley, 2000; Orphanides and Reinberg, 2002; Proudfoot et al., 2002) 
(see also Chapter CTD). The highly dynamic phosphorylation pattern of the CTD acts 
as a code that ensures the stage-specific recruitment of a subset of transcription 
elongation factors (Buratowski, 2003; Conaway et al., 2000; Howe, 2002). Once 
recruited, they travel along with RNAP II and act co-transcriptionally to modulate the 
processivity of RNAP II or remodel chromatin until they are no longer needed 
(Maniatis and Reed, 2002; Orphanides and Reinberg, 2002). 
 
1.7.1 Elongation factors that modulate the catalytic activity of RNAP II 
 Many elongation factors that modulate the catalytic activity of RNAP II do so 
by counteracting or alleviating three major impediments to transcription elongation: 
transcriptional pausing, transcriptional arrest and transcription termination (Sims et 
al., 2004a). Transcriptional pausing occurs when the RNAP II halts the addition of 
NTPs to the nascent RNA transcript for a time before resuming productive elongation 
on its own (Sims et al., 2004a). Transcriptional arrest can be defined as an irreversible 
halt to RNA synthesis, whereby the RNAP II cannot resume productive elongation 
without accessory factors (Sims et al., 2004a). Transcription termination is described 
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as the process in which RNAP II is released from the template DNA and the RNA 
transcript thereby ending the elongation stage of transcription. 
 
1.7.1.1 Factors that influence transcriptional pausing 
 Factors that influence transcriptional pausing of RNAP II are the general 
transcription factor TFIIF, the positive transcription elongation factor b (P-Tefb) and 
the DRB-sensitivity-inducing factor (DSIF).  
 
1.7.1.1.1 TFIIF 
 Of all the general transcription factors, only TFIIF can be found in the RNAP 
II transcription elongation complex (Zawel et al., 1995). It was shown that the human 
general transcription factor TFIIF diminishes the time RNAP II is paused and 
stimulates the rate of RNAP II transcription elongation (Tan et al., 1994). However, 
TFIIF does not move along with RNAP II, but re-associates with the polymerase 
when encountering a block to elongation. It was postulated that the transient 
association of TFIIF with paused RNAP II induces a conformational change in the 
polymerase necessary for optimal elongation. Once this is accomplished, TFIIF is 
released from the transcription elongation complex (Zawel et al., 1995). Moreover, 
TFIIF directly interacts with and stimulates the CTD Ser2 phosphatase Fcp1 (Kamada 
et al., 2003). Fcp1 stimulates transcription elongation in vitro (Mandal et al., 2002). 
The stimulatory activity of TFIIF and Fcp1p on elongation is additive (Mandal et al., 
2002). Interestingly, TFIIF also associates with the transcription elongation factors 
Spt5 and components of the PAF complex (Lindstrom et al., 2003; Shi et al., 1997).  
 
1.7.1.1.2 P-TEFb 
 Treatment of mammalian cells with the nucleotide analog DRB (5,6-dichloro-
1-b-D-ribofuranosylbenzimidaole) results in the formation of truncated transcripts 
indicating that RNAP II ceased transcription before the end of the gene (Chodosh et 
al., 1989). P-TEFb (positive transcription elongation factor b) was originally 
identified as a factor that was able to alleviate the effect of DRB on transcription of 
long transcripts in vitro (Marshall et al., 1996). It consist of the Cdk9 kinase that 
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associates with different cyclins (Peng et al., 1998). The yeast homolog of Cdk9 is the 
kinase Ctk1. P-TEFb phosphorylates Spt5 and Ser2 of the RNAP II CTD  and this 
phosphatase activity is important for the elongation activity of P-TEFb (Fujinaga et 
al., 2004; Yamada et al., 2006). Spt5 together with Spt4 forms the DSIF transcription 
elongation complex (Hartzog et al., 1998; Wada et al., 1998a). DSIF contributes to 
promoter-proximal pausing of RNAP II. P-TEFb counteracts the negative effect of 
DSIF on transcription elongation by phosphorylating Spt5 and full-length 
transcription is resumed (Yamada et al., 2006). Phosphorylation of Ser2 of the CTD 
by p-TEFb is a further hallmark of the transcription elongation phase of transcription. 
In addition, inhibition of P-TEFb culminates in incorrect RNA 3’ end processing, 
consistent with the important role for the Ser2-phosphorylated CTD in the recruitment 
of 3’end processing factors (Ahn et al., 2004; Ni et al., 2004). 
 
1.7.1.1.3 DSIF 
 DRB-sensitivity-inducing factor (DSIF) was identified based on its ability to 
confer DRB sensitivity to a transcription reaction (Wada et al., 1998a). The 
heterodimeric DSIF complex is composed of the proteins Spt5 and Spt4. DSIF was 
originally reported to inhibit transcription elongation, more recent findings however 
also implicate a positive function for Spt4 and Spt5 in transcription elongation 
(Lindstrom et al., 2003; Rondon et al., 2003). In vitro transcription assays and genetic 
studies in yeast revealed Spt4 as positive transcription elongation factor (Rondon et 
al., 2003). Furthermore, Spt4 can antagonize pausing of RNAP II imposed by the 
chromatin-remodeling factor Isw1p (Morillon et al., 2003a). 
 Studies on Spt5 showed that early in transcription Spt5 is inhibitory to 
transcription, whereas later in transcription, after promoter-proximal pausing, Spt5 
stimulates the transcription process by preventing premature termination and pausing 
(Bourgeois et al., 2002; Wada et al., 1998b). Biochemical and genetic evidence 
supports interactions between Spt4, Spt5 and RNAP II (Wada et al., 1998a). Further 
interaction studies demonstrated that DSIF genetically and physically associates with 
TFIIF as well as with the chromatin-related factors Spt6, FACT, Chd1 and the PAF 
complex (Costa and Arndt, 2000; Hartzog et al., 1998; Krogan et al., 2002; Lindstrom 
et al., 2003; Mueller and Jaehning, 2002; Squazzo et al., 2002). 
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1.7.1.2 Factors that influence transcriptional arrest 
 Arrested RNAP II complexes resume productive elongation via an 
evolutionarily conserved mechanism that requires cleavage of the RNA transcript 
(Sims et al., 2004a). TFIIS was identified as factor that promotes RNAP II read-
through at arrest sites (Conaway et al., 2003) and therefore stimulates elongation by 
reducing RNAP II pausing. In addition, it enhances the cleavage reaction, which is an 
intrinsic property of RNAP II itself  (Orlova et al., 1995). Recently, the structure of 
RNAP II in combination with TFIIS could be solved (Kettenberger et al., 2003).  
From this structure, Kettenberger and colleagues could determine that the active site 
of RNAP II undergoes extensive structural changes during TFIIS binding and these 
structural changes are consistent with a realignment of the RNA in the active center 
(Kettenberger et al., 2003). The yeast homolog of TFIIS is termed Ppr2p.  ppr2 
mutants were shown to be sensitive to the drug 6-azauracil (6AU). Sensitivity to 6AU 
is a hallmark of transcription elongation mutants. In addition, TFIIS genetically 
interacts with elongation factors like DSIF and also with the PAF complex, FACT, 
Spt6 and SWI/SNF, which are chromatin remodelers (see below; Costa and Arndt, 
2000; Davie and Kane, 2000; Hartzog et al., 2002; Lindstrom and Hartzog, 2001; 
Orphanides et al., 1999).  
 
1.7.2 Elongation factors that remodel chromatin 
 In eukaryotes, DNA is packaged into chromatin. An important structural unit 
of chromatin is the nucleosome. The nucleosome consists of an octameric complex of 
histone proteins formed of an H3-H4 tetramer and two H2A-H2B dimers around 
which 147 bp of DNA are wrapped (Saunders et al., 2006). A linker DNA connects 
the nucleosomes. H1, a fifth histone protein can bind to the linker DNA and helps to 
stabilize higher order chromatin (Khorasanizadeh, 2004).  
 Chromatin represents a major block for RNAP II transcription (Sims et al., 
2004a) and therefore has to be remodeled during transcription elongation. Models that 
explain how RNAP II can transcribe in a chromatin environment have been put 
forward. They propose that both nucleosome mobilization and histone depletion occur 
as RNAP II progresses along the chromatin template (Studitsky et al., 2004). 
However, it still remains to be elucidated how the elongation factors that remodel or 
modify the chromatin structure work together and how histone modifications 
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influence the chromatin structure and thus transcription elongation (Sims et al., 
2004a). Elongation factors that remodel chromatin can be further subdivided in ATP-
dependent remodeling factors, histone chaperones and factors that modify histones.  
 
1.7.2.1 ATP-dependent remodeling 
 SWI/SNF and Chd1 are two factors that share a conserved ATPase domain 
(Lusser and Kadonaga, 2003). SWI/SNF is an ATP-dependent chromatin-remodeling 
complex whose ATPase activity is required for transcription on nucleosomal 
templates (Narlikar et al., 2002; Sullivan et al., 2001). The ATPase Chd1 remodels 
nucleosomes in vitro and appears to function in both elongation and termination (Alen 
et al., 2002; Tran et al., 2000). Chd1 interacts genetically with the SWI/SNF complex 
(Tran et al., 2000) and physically with the PAF complex, DSIF and FACT (Kelley et 
al., 1999; Krogan et al., 2002; Simic et al., 2003). All these factors have been 
implicated in transcription elongation (see below).  
 
1.7.2.2 Histone Chaperones 
 Two factors in particular have been linked with histone disassembly and 
reassembly: FACT and Spt6. FACT facilitates the displacement of H2A-H2B dimers 
during in vitro transcription and facilitates RNAP II elongation through chromatin 
(Belotserkovskaya et al., 2003; Sims et al., 2004a). Spt6 interacts physically with 
histones in vitro, most strongly with H3 and H4, and also helps to disassembly the 
H2A-H2B dimer (Bortvin and Winston, 1996). After RNAP II has passed by a 
nucleosome, FACT and Spt6 help to reassemble the nucleosome (Saunders et al., 
2006). Reassembly of the nucleosome after RNAP II transcription is important for 
preventing aberrant transcription initiation from cryptic promoter sites that contain a 
TATA element and a proximal initiation site (Saunders et al., 2006).  
 
1.7.2.3 Histone modification factors 
 Histone proteins are posttranslationally covalently modified by a wide variety 
of enzymes. The highly accessible N-terminal histone tails undergo several covalent 
modifications including acetylation, methylation, ubiquitination, phosphorylation and 
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ADP-ribosylation (Vaquero et al., 2003; Zhang, 2003). Histones of genes that are 
transcriptionally active are highly acetylated in comparison to histones of genes that 
are silent. Histone acetylation destabilizes chromatin structure by disrupting 
internucleosome associations as well as histone tail interactions with linker DNA 
(Sims et al., 2004a). Therefore, acetylation of histones is important for productive 
transcription (Saunders et al., 2006). Histone lysine methylation at specific lysines 
appears to play a role in establishing both short-and long-term transcriptional 
regulation (Sims et al., 2004a). Silent or repressed regions co-map with methylation at 
histone lysine residues H3-K9, H3-K27 and H4-K20 (Sims et al., 2004a). In contrast, 
transcriptionally active domains are typically associated with methylation at H3-K4, 
H3-K36 and H3-K79 (Lachner et al., 2003; Sims et al., 2003). These lysines are 
methylated by specific methyl transferases called Set1p and Set2p. 
 Set1p is a specific histone H3-H4 methyltransferase in yeast. It associates with 
RNAP II CTD and the PAF complex (Krogan et al., 2003a; Ng et al., 2003a) and most 
interestingly also with the CPF complex (Dichtl et al., 2004). Set1-mediated histone 
H3-H4 methylation occurs at promoters and within the coding region of active genes 
in yeast (Ng et al., 2003b). 
 Yeast Set2p is an H3-K36-specific histone methyltransferase. Set2 associates 
with the hyperphosphorylated form of RNAP II CTD (Krogan et al., 2003b). It was 
further demonstrated that association of Set2 and H3-K36 methylation within coding 
regions is dependent on the PAF complex (Krogan et al., 2003b).  
 The PAF complex consist of five subunits, Paf1, Ctr9, Cdc73, Rtf1 and Leo1 
and is conserved from yeast to humans (Krogan et al., 2002; Mueller and Jaehning, 
2002; Squazzo et al., 2002). Paf1 was originally identified as a protein associated with 
RNAP II (Shi et al., 1996). The PAF complex has a crucial role in the regulation of 
histone monoubiquitylation and methylation of several histones. The PAF complex, in 
particular its Rtf1 component, is required for the recruitment of the H2B 
monoubiquitylation enzyme and therefore for monoubiquitylation of H2B (Wood et 
al., 2003). Histone H2B monoubiquitylation was shown to be a prerequisite for H3-
K4 and H3-K79 methylation (Ng et al., 2003a; Wood et al., 2003). Similarly, the PAF 
complex is required for recruitment of Set1 and Set2 in a manner dependent upon the 
phosphorylation state of the CTD of RNAP II and also for correct H3-K4, H3-K36 
and H3-K79 methylation (Krogan et al., 2003a; Krogan et al., 2003b; Ng et al., 
2003b; Wood et al., 2003). Apart from their many functions in histone modification, 
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the PAF complex subunits revealed a wide range of transcription elongation 
phenotypes, including sensitivity to 6AU. In addition, the PAF complex associates 
with transcription elongation factors, indicating that it is involved in transcription 
elongation, too (Costa and Arndt, 2000; Mueller and Jaehning, 2002; Rondon et al., 
2003; Squazzo et al., 2002). However, a recent study also found functions for the PAF 
complex which are independent of actively transcribing RNAP II (Mueller et al., 
2004). In addition, loss of the Paf1 factors causes a reduction of RNAP II CTD Ser2 
phosphorylation and also shortened poly(A) tails, suggesting that the complex 
facilitates linkage of transcriptional and posttranscriptional events (Mueller et al., 
2004). Yet an other function for the PAF complex has been reported recently. It was 
shown that the PAF complex is required for the 3’ end formation of snoRNAs, thus 
probably linking transcription elongation of snoRNAs to their 3’ end formation 
(Sheldon et al., 2005). 
 
1.8 Protein phosphatases 
 Reversible protein phosphorylation is involved in the regulation of cellular 
processes as diverse as glycogen metabolism, muscle contraction, ion channel 
regulation, transcription, translation and the cell cycle (Depaoli-Roach et al., 1994). 
Protein phosphatases are signal-transducing enzymes that dephosphorylate cellular 
phospho-proteins (Barford, 1995). The dephosphorylation of serine, threonine and 
tyrosine residues within proteins is catalyzed by three families of protein 
phosphatases including two families of Ser/Thr phosphatases and one protein tyrosine 
phosphatase family (Barford, 1996). Diversity of structure within a family is 
determined by targeting and regulatory subunits and domains. Structural studies of 
these enzymes have revealed that although the two families of protein Ser/Thr 
phosphatases are unrelated in sequence, the architecture of their catalytic domains is 
remarkably similar and distinct from the protein tyrosine phosphatases (Barford, 
1996).  
 Surprisingly, protein phosphatases are outnumbered by a large amount of 
protein kinases in the cell. Over the past decade an understanding has emerged of how 
such a small number of phosphatases is able to dephosphorylate thousands of proteins 
while allowing the level of phosphorylation of each of these proteins to be regulated 
independently. Many of these questions have been answered by studies of one of the 
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major eukaryotic protein phosphatases: protein phosphatase 1 (PP1). The PP1 
catalytic subunit can form complexes with > 50 regulatory subunits in a mutually 
exclusive manner. The formation of these complexes converts PP1 into many 
different forms, which have distinct substrate specificities, restricted subcellular 
locations and diverse regulation. This allows numerous cellular functions that rely on 
PP1 to be controlled by independent mechanisms (Cohen, 2002).  
 The  S. cerevisiae genome encodes ~32 protein phosphatases (Sakumoto et al., 
1999). Three of the 32 phosphatase are essential for cell viability (Sakumoto et al., 
1999). One of them is the serine/threonine-specific phosphatase Glc7p (Feng et al., 
1991).  
 
1.8.1 Glc7p 
 Glc7p is the only yeast homolog of the mammalian PP1 (Feng et al., 1991) 
and regulates both nuclear and cytoplasmic processes. The Glc7 protein has a 
sequence that is 81% identical with the rabbit protein phosphatase 1 catalytic subunit 
(Feng et al., 1991). The molecular weight of Glc7p is 36 kDa. It belongs to the few 
genes in S. cerevisiae that have an intron. Exon 1 of Glc7p spans nucleotides 1 – 177 
and Exon 2 nucleotides 703 – 1464 (Figure 1.6 a). Glc7p has been implicated in 
processes such as glycogen accumulation, carbohydrate metabolism, translation 
initiation (Ashe et al., 2000), transcription, mitosis, meiosis, vesicular trafficking, cell 
polarity, histone modification and ion homeostasis (Stark, 1996). Time-lapse 
fluorescence microscopy revealed that GFP-Glc7p localizes predominantly in the 
nucleus throughout the mitotic cell cycle, with the highest concentrations in the 
nucleolus (Bloecher and Tatchell, 2000). GFP-Glc7 was also observed in a ring at the 
bud neck, which was dependent on functional septins (Bloecher and Tatchell, 2000).  
 Originally, Glc7p has been identified as a gene that complements a defect in 
glycogen accumulation, hence its name: Glc7 for Glycogen-deficient (Feng et al., 
1991). Later, it was found that Glc7p regulates the phosphorylation of Gsy2, the 
major isoform of glycogen synthase (Anderson and Tatchell, 2001). Gac1p is the 
regulatory and targeting subunit of Glc7p in the dephosphorylation of Gsy2p (Wu et 
al., 2001). 
 Glc7p is involved in several different steps during mitosis. Distinct mutations 
in Glc7p lead to an arrest in the cell cycle (MacKelvie et al., 1995). It was proposed 
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that Sds22p is the regulatory subunit of Glc7p in this process and that Sds22p 
functions positively with Glc7p to promote dephosphorylation of nuclear substrates 
required for faithful transmission of chromosomes during mitosis (Peggie et al., 
2002). 
 Moreover, Glc7p regulates the mitotic phosphorylation of histone H3 at serine 
10 in S. cerevisiae (Hsu et al., 2000). The phosphatase activity of Glc7p is opposed by 
the kinase Ipl1p, which phosphorylates H3 S10 (Hsu et al., 2000). It is believed that 
phosphorylation of histone H3 is required for chromosome segregation (Hsu et al., 
2000). A function for Glc7p in meiosis was proposed, based on the fact that Glc7p 
counteracts Mek1p kinase activity, which is required for the pachytene checkpoint, 
and checkpoint-induced pachytene arrest (Bailis and Roeder, 2000).  
 Glc7p also has functions in glucose repression in S. cerevisiae (Tu and 
Carlson, 1994). Glucose repression is a signaling pathway that suppresses 
transcription of genes required under glucose starvation conditions. Reg1p was 
identified as the regulatory subunit of Glc7p in glucose repression (Tu and Carlson, 
1995). The Reg1p-Glc7p complex antagonizes the action of the protein kinase Snf1p 
in the transcription of genes required for non-carbon source utilization (Young et al., 
2002). Activation of Snf1p, when glucose is limiting, requires phosphorylation of  a 
threonine residue at the C-terminus of Snf1p. It was shown that Glc7p regulates the 
phosphorylation state of Snf1p . 
 Reg1p interacts with the 14-3-3 proteins Bmh1 and Bmh2. Together they 
regulate the glucose-induced degradation of maltose permease (Mayordomo et al., 
2003) and also have roles in maintaining glucose repression (Dombek et al., 2004). 
Reg1p-Glc7p is required for the glucose-induced degradation of fructose-1,6-
bisphosphatase in the vacuole (Cui et al., 2004).  
 Interestingly, a defect in processing of rRNA was also reported for a 
conditional Glc7p deletion strain (Peng et al., 2003). Deletion of Glc7p results in the 
accumulation of 35S pre-RNA, indicating a defect in A2 cleavage of the pre-rRNA 
(Peng et al., 2003). The delay in A2 cleavage may be a consequence of either altered 
snoRNA processing and/or a reduction in the abundance of ribosomal proteins (Peng 
et al., 2003).  
 Two regulatory proteins of Glc7p have been described (Garcia-Gimeno et al., 
2003; Nigavekar et al., 2002). One of them, Glc8p, is an activator of Glc7p 
(Nigavekar et al., 2002). However, Glc8p induces the activity of Glc7p only during 
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stationary phase, because the expression of Glc8p is repressed by glucose (Nigavekar 
et al., 2002). The other regulatory protein, Ypi1p, is an inhibitor of the phosphatase 
activity of Glc7p (Garcia-Gimeno et al., 2003). 
1.8.2 Description of temperature-sensitive glc7 mutant alleles used for this thesis 
 During the course of this thesis we worked with four temperature-sensitive 
(ts) glc7 mutant alleles: glc7-10, glc7-12, glc7-13 and glc7-5 and the corresponding 
isogenic W303 WT strain (Figure 1.6 b). These strains were all generated in the 
laboratory of Prof. Mike Stark, University of Dundee. The isogenic WT background 
is MATa his3 leu2 uro3 ade2 glc7::LEU2 trp1::GLC7::TRP1. The reported 
phenotypes of these glc7 mutant alleles will be discussed in the following paragraphs.  
 
1.8.2.1 glc7-10 
 The temperature-sensitive glc7-10 allele displays aberrant bud morphology 
and an abnormal actin cytoskeleton at the restrictive temperature (Andrews and Stark, 
2000). At 37ºC, glc7-10 strains accumulate a high proportion of budded cells with an 
unmigrated nucleus, duplicated spindle pole bodies, a short spindle, delocalized 
cortical actin and 2C DNA content indicating a cell cycle block prior to the metaphase 
to anaphase transition (Andrews and Stark, 2000). Pkc1p, the yeast protein kinase C 
homolog, which is thought to regulate the Mpk1p MAP kinase pathway involved in 
cell wall remodeling and polarized cell growth, was found to act as a dosage 
suppressor of glc7-10. Therefore, Glc7p is required for normal cell wall integrity, bud 
development and cell cycle progression. In addition, glc7-10 cells require higher 
levels of Pkc1p activity to sustain these functions (Andrews and Stark, 2000).  
 Sequencing of the coding region of glc7-10 revealed one point mutation at 
position +928, causing an F135L substitution, a residue that is conserved in all 
members of the PPP family of protein phosphatases (Andrews and Stark, 2000). The 
minimum restrictive temperature of glc7-10 is ~37ºC. 
 
1.8.2.2 glc7-12 
 The temperature-sensitive Glc7p allele, glc7-12, causes a block to the 
completion of mitosis at the restrictive temperature (MacKelvie et al., 1995). At 37ºC, 
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around 35% of glc7-12 cells arrest with a nucleus stretched across the neck of the bud 
and a short mitotic spindle. Additional copies of SDS22, a known regulator of the 
mitotic function of PP1 in Schizosaccharomyces pombe (Ohkura et al., 1989) lead to 
the suppression of the glc7-12 mutant (MacKelvie et al., 1995). This suggests that the 
interaction of the two proteins is of functional significance and indicates that Sds22p 
is a regulatory subunit of Glc7p during mitosis. However, even at high copy number, 
SDS22 was unable to rescue growth of either glc7-10 or glc7-13. This allele-specific 
effect of Sds22p indicates that the function of Sds22p is related to the role of PP1 
during mitosis.  
 Sequencing of the coding region of glc7-12 revealed three separate point 
mutations at positions +93, +734 and +1261. However, since the mutation +734 is 
silent, glc7-12 encodes a product with two predicted amino acid changes: N32Y and 
G227D. The N32Y substitution is not highly conserved but it lies immediately 
adjacent to the motif [-E(I/V)R-] conserved in PP1. The central G227D substitution 
alters a residue highly conserved in PP1 which marks the boundary of a predicted α-
helical region (MacKelvie et al., 1995). The minimum restrictive temperature of glc7-
12 is ~33-34ºC. 
 
1.8.2.3 glc7-13 
 The temperature-sensitive glc7-13 mutant strain exhibits a random arrest with 
respect to the cell cycle suggesting that glc7-13 is not involved in cell cycle 
progression (Mike Stark, personal communication). In addition, the cell size of glc7-
13 mutant cells is reduced at the restrictive temperature compared to WT (Mike Stark, 
personal communication). Sequence analysis of the glc7-13 coding region revealed 
two point mutations at positions +143 and at +1049. Therefore, glc7-13 has two 
amino acid substitutions: Q48R and L175P (Andrews and Stark, 2000). The minimum 
restrictive temperature of glc7-13 is ~32ºC. 
 
1.8.2.4 glc7-5 
 Glc7p promotes mRNA export by facilitating association of Mex67p, a 
conserved heterodimeric export receptor, with mRNA (Gilbert and Guthrie, 2004). 
Npl3p is required for mRNA export in S. cerevisiae probably by acting as an adaptor 
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for Mex67p. Gilbert and co-workers could show that nuclear dephosphorylation of 
Npl3p in vivo is promoted by Glc7p and that this is required for mRNA export 
(Gilbert and Guthrie, 2004). The authors proposed that Mex67p-dependent mRNA 
export is regulated by Glc7 dependent dephosphorylation of Npl3p (Gilbert and 
Guthrie, 2004). For their studies Gilbert and co-workers used the glc7-5 ts allele. This 
implicates that glc7-5 mutant strains accumulate mRNAs in the nucleus and also that 
phosphorylated Npl3p accumulates in these mutants. 
 glc7-5 was also shown to arrest in the G1 phase of the cell cycle (M. Stark, 
personal communication). glc7-5 has a single point mutation at position 1252, which 
changes a threonine to an alanine at position 224. The minimum restrictive 
temperature of glc7-5 is ~32ºC. 
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Fig. 1.6. Location of point mutations in glc7 mutant alleles. 
A) Schematic representation of the genomic organization of Glc7p. 
B) Schematic representation of glc7 mutants used in this study. Stars indicate the nucleotide positions 
of the point mutations that change the amino acid sequence.  
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2 Glc7p regulates polyadenylation but not cleavage of pre-mRNAs 
2.1 Summary 
Pre-mRNAs are cleaved and the upstream fragments are subsequently polyadenylated 
at their 3’ end. Cleavage and polyadenylation factor (CPF) is a multiprotein complex 
conducting these two reactions in cooperation with cleavage factor IA (CF IA) and 
cleavage factor IB (CF IB). Here, we show that the protein phosphatase Glc7p, a 
component of CPF, is required for the polyadenylation step however not for the 
cleavage step of pre-mRNAs. We found that loss of Glc7p activity causes the 
accumulation of shortened poly(A) tails in vivo. GST-pulldown experiments revealed 
interactions with several subunits of CPF and CF IA. Moreover, the protein levels of 
several subunits of CPF are reduced in a glc7 mutant strain, suggesting that CPF 
complex formation is compromised. Finally, we observe a poly(A) site selection 
defect in a glc7 mutant strain.  
These results indicate that Glc7p is essential for polyadenylation and poly(A) site 
selection of pre-mRNAs may be regulated via CPF complex assembly. 
 
2.2 Introduction  
pre-mRNAs of eukaryotes have to undergo extensive processing including addition of 
a 5’ cap, splicing of introns and 3’ end processing, to become mature, functional 
mRNAs. These processes all occur co-transcriptionally and are coupled to 
transcription via the CTD of RNAP II, which acts as a landing platform for processing 
factors (Proudfoot, 2000a). 
3’ end processing of pre-mRNAs consists of two steps: endonucleolytic cleavage at 
the poly(A) site followed by the addition of a poly(A) tail to the upstream cleavage 
product. Poly(A) tails are important for the stabilization, export and also for 
translation of mRNAs. Loss of the poly(A) tails leads to a rapid degradation of 
mRNAs. In S. cerevisiae the average poly(A) tail has a length of around 70 
nucleotides. Cis-acting sequences in the 3’ untranslated regions (3’UTRs) guide the 
trans-acting cleavage and polyadenylation factors to the correct cleavage and 
polyadenylation site. In S. cerevisiae the CPF, CF IA, CF IB and the poly(A) binding 
protein (Pab1p) are required for the cleavage and polyadenylation reactions in vitro 
(Chen and Moore, 1992; Ohnacker et al., 2000). CPF has been affinity purified from 
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yeast extracts (Ohnacker et al., 2000). Mass spectrometry of this purified CPF led to 
the identification of Ref2p, Pti1p, Swd2p, Ssu72p and Glc7p, formerly unknown 
subunits of CPF (Dichtl et al., 2002a). In addition, CPF contains the putative 
endonuclease Ysh1p, the poly(A) polymerase Pap1p and the subunits Yhh1p, Ydh1p, 
Yth1p, Pfs2p, Pta1p, Mpe1p (Ohnacker et al., 2000). Several other groups also found 
these subunits to be part of CPF (Gavin et al., 2002; Walsh et al., 2002). CF IA was 
shown to comprise the subunits Rna14p, Rna15p, Pcf11p and Clp1p (Kessler et al., 
1996). CF IB consist of a single subunit Nab4p/Hrp1p (Kessler et al., 1996). Several 
subunits of CPF have been shown to be involved in recognition of the poly(A) site 
including Yhh1p, Ydh1p and Yth1p (Barabino et al., 2000; Dichtl et al., 2002b; Dichtl 
and Keller, 2001; Kyburz et al., 2003). These factors bind to sequences surrounding 
the poly(A) site, which specify the actual cleavage site in vivo (Dichtl and Keller, 
2001). 
Phosphorylation of proteins is a major control mechanism in the cell. It was proposed 
that 3’ end formation is also regulated via phosphorylation events, since the 
polyadenylation activity of Pap1p is downregulated by phosphorylation in vitro 
(Mizrahi and Moore, 2000). However, this type of regulation seems to be restricted to 
the S/G2 transition stage of the cell cycle (Mizrahi and Moore, 2000). Therefore, 
Pap1p might not be the target of regulating polyadenylation at each round of 
transcription of a gene. 
Glc7p is a serine/threonine phosphatase that has been implicated in many cellular 
processes in the nucleus and the cytoplasm. These include glycogen accumulation, 
carbohydrate metabolism, translation initiation, transcription, mitosis, meiosis, 
vesicular trafficking, cell polarity, histone modification and ion homeostasis (Stark, 
1996). Glc7p is the only yeast homolog of the mammalian protein phosphatase 1 
(PP1) and their protein sequences are 81% identical (Feng et al., 1991). To achieve 
specificity for different substrates Glc7p associates with targeting or regulatory 
subunits that direct it to the substrate and/or regulate its activity. Thus, it is possible 
that a single phosphatase carries out many distinct reactions. The association of Glc7p 
with CPF suggests that a targeting and/or regulatory subunit may recruit Glc7p to the 
complex. This could also imply that Glc7p is involved in the regulation of cleavage or 
polyadenylation by phosphorylation. While our studies on the function of Glc7p in 3’ 
end processing were ongoing, He and co-workers reported that Glc7p is required for 
polyadenylation of pre-mRNAs (He and Moore, 2005). The authors demonstrated that 
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the phosphorylation state of Pta1p is regulated by Glc7p and that dephosphorylation 
of Pta1p is necessary to switch CPF to a poly(A) adding-competent complex.  
Here, we show that glc7-13 mutants are defective for polyadenylation but not for 
cleavage of pre-mRNAs in vitro and in vivo. In addition, the glc7-12 mutant strain 
displays a poly(A) site selection defect. Loss of Glc7p activity leads to reductions in 
protein levels of several subunits of CPF.  
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2.3 Results 
2.3.1 GST-pulldown experiments reveal physical interactions between CPF subunits 
and Glc7p 
The S. cerevisiae protein phosphatase Glc7p co-purified with CPF (Dichtl et al., 
2002b; Walsh et al., 2002). We therefore decided to identify interaction partners of 
Glc7p within CPF. To this end we performed GST-pulldown experiments. Glc7p was 
expressed as a fusion protein with glutathione-S transferase (GST) and incubated with 
in vitro translated subunits of CPF and CF IA. As a control GST alone was incubated 
with the in vitro translated proteins to test for background binding of GST to these 
proteins. We observed strong interactions of Glc7p with Pfs2p, Ysh1, Pta1p, Pap1p, 
Pcf11p and Ssu72p. Intermediate interactions are observed for Yhh1p, Ydh1p, 
YDL094c, Clp1p and Glc7p itself. Weak GST-pulldown interactions were detected 
for Rna14p. No GST-pulldown interactions with Glc7p were observed for Pti1p, 
Ref2p, Mpe1p, Fip1p, Pab1p, Rna15 and Nab4p (Fig. 2.1 a; Table 2.1). All these 
numerous interactions of Glc7p with CPF indicate that Glc7p is an integral part of 
CPF. Moreover, interactions designated as “strong” could have identified Ysh1p, 
Pap1p, Pta1p, Pfs2p, Ssu72p and Pcf11p as the minimum core interaction partners of 
Glc7p within CPF and CF IA.  
It is striking that these core interactions include the putative endonuclease Ysh1p and 
the poly(A) polymerase Pap1p, as this may indicate an important function for Glc7p 
in the regulation of 3’ end formation.  
Correlating with our results, it was reported recently that Pta1p is a phosphoprotein 
that is targeted by Glc7p to regulate polyadenylation of pre-mRNAs (He and Moore, 
2005). These data also strengthen the idea that the core interactions we observed in 
our in vitro GST- pulldown assays reflect the situation in vivo.   
We do not observe an interaction of Glc7p with Ref2p in our pulldown experiment. 
Contrary to our observation, an interaction between the two proteins was 
demonstrated by yeast two hybrid experiments and by affinity purification (Nedea et 
al., 2003; Uetz et al., 2000).  
We also tested whether GST-Glc7p interacts with proteins involved in transcription or 
processing of pre-mRNAs. Those included Rpb2 (second largest subunit of RNAP II), 
Sua7p, a general transcription factor required for transcription initiation and start site 
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selection by RNAP II, which interacts with Ssu72, Upf1p, an ATP-dependent RNA 
helicase of the SFI superfamily, required for nonsense mediated mRNA decay and for 
efficient translation termination at nonsense codons and Nrd1p, an RNA-binding 
protein that interacts with the C-terminal domain of the RNAP II large subunit and is 
required for transcription termination and 3' end maturation of non- polyadenylated 
RNAs. GST-Glc7p showed strong interaction with Rpb2p, Sua7p and Upf1p and 
moderate binding with Nrd1p (Fig. 2.1 b, Table 2.1), suggesting further functions of 
Glc7p in the transcription process. 
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Figure 2.1. Glc7p interacts directly with subunits of CPF and CFIA 
(A) GST (lane 2) and GST-Glc7p (lane 1) bound to Glutathione Sepharose 4B were incubated with in 
vitro translated 35S-labeled subunits of CPF and CFIA as indicated on the left of the panel. Bound 
proteins were separated by SDS-PAGE and visualized by autoradiography. Input (lane 3) shows 10% 
of the in vitro translation reaction included into the binding reaction. 
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Table 2.1 
 
strong interaction medium 
interaction 
weak interaction no interaction 
Pfs2 Yhh1 Rna14 Pti1 
Pta1 Ydh1 Nrd1 Ref2 
Ysh1 Glc7  Mpe1 
Pap1 Ydl094c  Fip1 
Pcf11 Clp1  Pab1 
Rpb2   Rna15 
Upf1   Nab4 
Sua7    
Ssu72    
 
 
2.3.2 The glc7-13 mutant strain shows a defect in polyadenylation but not cleavage 
of pre-mRNAs in vitro 
3’ end processing of pre-mRNAs is a two step reaction: endonucleolytic cleavage 
followed by polyadenylation of the upstream cleavage product (Zhao et al., 1999a). 
Subunits of CPF are either involved in the cleavage or the polyadenylation reaction or 
in both. Since Glc7p co-purified with CPF and physically interacts with several 
subunits of CPF in GST-pulldown experiments, we wanted to gain more insight into 
the role of Glc7p in 3’ end processing of pre-mRNAs. Therefore, we carried out in 
vitro cleavage and polyadenylation assays with protein extracts from WT and Glc7p 
mutant strains to asses whether Glc7p could have a function in one of these reactions.   
To this end, we prepared protein extracts of WT, glc7-5, glc7-12, glc7-13 and glc7-10 
mutant strains. In order to find out whether cleavage is affected we tested these glc7 
mutants for their ability to cleave a CYC1 precursor RNA (CYC1 pre) in vitro at the 
permissive or non-permissive temperature. None of the glc7 alleles showed a defect in 
cleaving the CYC1 pre-mRNA substrate at the restrictive temperature of 37º C (Fig. 
2.2 a and b), indicating that Glc7p is not involved in the cleavage reaction of pre-
mRNAs. However, in the polyadenylation assay, extracts prepared from glc7-13 cells 
were not capable to polyadenylate a pre-cleaved CYC1 precursor RNA at 37º C (Fig. 
2.2 a, Monika Garras, unpublished). In contrast, glc7-12 and glc7-5 mutant extracts 
showed no defect in polyadenylation, suggesting that the defect in polyadenylation is 
allele-specific. 
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We conclude that Glc7p is needed for the polyadenylation step of 3’ end processing 
but not for the cleavage step.  
This result is in agreement with recent data published by He and co-workers showing 
that a conditional null allele of Glc7p no longer polyadenylates an in vitro transcribed 
precursor RNA (He and Moore, 2005). 
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Figure 2.2. glc7-13 is deficient in polyadenylation but not in cleavage of pre-mRNAs. 
In vitro analysis of cleavage  and polyadenylation activities of glc7 mutant extracts (A and B). Input 
lanes represent mock-treated reactions. The migration positions of the CYC1 and CYC1-precleaved 
(CYC1-pre) RNA substrate, specific cleavage products (5’ and 3’) and the polyadenylation products 
(poly(A) are indicated on the right of each panel (A and B). Extracts prepared from yeast strains as 
indicated on top were monitored for their ability to cleave internally 32P-labeled CYC1 RNA substrate 
at 30º C and 37º C. Specific polyadenylation was analysed at 30º C and 37º C with internally 32P-
labeled precleaved CYC1 RNA substrate that ends at the natural poly(A) site. 
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2.3.3 Poly(A) tails are shorter in glc7 mutants in vivo  
To further substantiate the function of Glc7p in the polyadenylation reaction we were 
interested whether Glc7p was also important for poly(A) tail synthesis in vivo. 
Analysis of the global poly(A) tail length distribution of a cell’s mRNA is helpful to 
identify a defect in polyadenylation in vivo and to get a general overview if gene 
expression might be altered in a given strain. 
To investigate the global poly(A) tail length distribution in vivo, total RNA was 
extracted from WT or glc7-10, glc7-12, glc7-13 and glc7-5 mutant strains grown at 
RT or shifted to 37ºC for one or two hours. Tail lengths were determined by labeling 
the RNAs at their 3’ ends, followed by RNase A treatment that leaves only the 
poly(A) tails intact. In this assay, we observed that poly(A) tails were significantly 
shorter in glc7-12 and to a lesser extent also in glc7-13 and glc7-5 mutant strains 
compared to the WT, suggesting a function for Glc7p in polyadenylation of pre-
mRNAs (Fig. 2.3). In contrast, poly(A) tails in the glc7-10 mutant strain were not 
affected. We conclude from these findings that Glc7p is necessary for poly(A) 
addition not only in vitro but also in vivo. In addition we propose that gene expression 
is partially compromised in glc7-12 mutants.  
After we have performed this experiment it was reported that a conditional null allele 
of Glc7p showed a marked decrease in the length of poly(A) tails in vivo (He and 
Moore, 2005), confirming our result.  
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Figure 2.3. Poly(A) tail length distribution is affected in glc7-12 mutant strains 
Poly(A) tail length analysis of total RNA extracted from WT, glc7-10, glc7-12, glc7-13 and glc7-5 
mutant strains after growth at 25º C and 37º C for various time points as indicated at the bottom of the 
panel. The position and size (in number of nucleotides) of the marker bands are indicated on the left. 
 
 
2.3.4 glc7-13 mutant cells show a poly(A) site selection defect 
To complete our study on the function of Glc7p in polyadenylation, we were 
interested if Glc7p might also be involved in selection of the poly(A) site. 3’ 
untranslated regions (UTRs) of mRNAs can contain several poly(A) sites. In most 
cases, however, the most proximal site is the main poly(A) site which is 
predominantly used. A well known example of a gene that encodes multiple poly(A) 
sites is ACT1 (Mandart and Parker, 1995). The ACT1 3’ UTR contains at least four 
potential polyadenylation sites. WT cells mainly use the most proximal poly(A) site 
and to a lesser extent downstream sites.  
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To test for poly(A) site selection, we carried out Northern analysis of WT and glc7-
10, glc7-12, glc7-13 and glc7-5 mutant strains with a probe directed against the ACT1 
mRNA. This analysis allows detection of the most proximal poly(A) site (site I) and 
the most distal poly(A) site (site IV) of ACT1. When cells were shifted to the 
restrictive temperature of 37˚ C for two hours, an increased signal for poly(A) site IV 
can be observed in glc7-13 mutants, indicating that site IV is now as frequently used 
as site I in this mutant (Fig. 2.4). The other glc7 mutants did not show an alteration in 
the selection of the poly(A) site suggesting that this phenotype is allele-specific.  
We therefore propose that Glc7p is involved in poly(A) site selection of ACT1 pre-
mRNA.  
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Figure 2.4. glc7-13 mutant strains are deficient in recognition of the ACT1 poly(A) site in vivo 
The drawing below the figure shows the relative positions of the different poly(A) sites. Northern 
analysis of total RNA extracted from WT and glc7-10, glc7-12, glc7-13 and glc7-5 mutant strains 
grown at 25º C or after shift to 37º C for 0.5, 1 and 2 hours as indicated at the top. Bands corresponding 
to site I or IV as indicated on the right. Blot was proped against Act1 and 18S, which served as a 
loading control.  
 
 
2.3.5 The protein levels of several CPF subunits are altered in glc7 mutants 
One possible explanation for the defects observed with some glc7 mutants in the 
previous chapters is that CPF did not assemble correctly. The fact that Glc7p is part of 
the CPF complex rises the question whether mutations in Glc7p could destroy the 
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complex and consequently its function in cleavage and polyadenylation. Reduced 
activity of the phosphatase Glc7p might lead to a destabilization of the interactions 
between subunits of CPF since modifications of these subunits could be important for 
the association with the complex or for their function. Therefore the observed defects 
in polyadenylation in glc7 mutants could be the result of a loss of CPF subunits from 
the complex that have important functions in polyadenylation.  
To assess protein levels of distinct subunits of CPF in glc7 mutant strains, we 
performed Western analysis on protein extracts derived from WT, glc7-10, glc7-12, 
glc7-13 and glc7-5 mutant cells before and after a one hour shift to the restrictive 
temperature (37˚ C) using antibodies against several subunits of CPF and CF IA (Fig. 
2.5). 
Results of the Western analysis showed a significant decrease of protein levels in the 
CPF subunits Fip1p, Pfs2p, Ysh1p, Pti1p, Pta1p and a modest decrease of Pap1p 
levels in the mutant strain glc7-12 at the restrictive temperature. All of the CF IA 
subunits tested (Rna15p, Rna14p, Pcf11p) only showed a slight decrease in protein 
levels in glc7-12 mutants. In contrast, none of the other glc7 mutants resulted in a 
reduction in protein levels within these subunits. These data again suggests that there 
seems to be an allele-specific separation of phenotypes. Our results are only in part in 
accordance with those of He and co-workers (He and Moore, 2005). These authors 
also observed a decrease in protein levels of Pta1p and Fip1p, however not for 
Rna15p and Pap1p. This difference could be a result of the different strains used in 
these two studies. We were working with temperature-sensitive (ts) alleles whereas 
He and co-workers used a conditional null allele of Glc7p. 
In conclusion, mutations in Glc7p seem to destabilize subunits of CPF and CF IA. 
This destabilization could contribute to the defects observed for polyadenylation in 
glc7-12 in vivo. 
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Figure 2.5. The amount of CPF subunits is reduced in glc7-12 mutant strains 
Western analysis of WT and glc7 mutant extracts prepared from cells grown at 25º C, or after shift to 
37º C for 1 hour as indicated on top of the panel. Equal amounts of total protein were loaded in each 
lane. Lane 11 shows purified CPF. Lane 12 shows purified CF IA. The filters were treated with 
antibodies directed against the proteins indicated at the left. 
 
 61
2.4 Discussion 
 
Phosphorylation of proteins regulates many cellular processes. The essential protein 
phosphatase Glc7p, the yeast homolog of mammalian PP1, has been affinity purified 
together with CPF (Dichtl et al., 2002a; Walsh et al., 2002). This suggested to us that 
Glc7p could have a function in 3’ end processing of pre-mRNAs. Here, we show that 
polyadenylation of a pre-cleaved RNA substrate is impaired in an in vitro cleavage 
and polyadenylation assays with whole cell extracts prepared from several glc7 
mutant strains. The involvement of Glc7p in the polyadenylation reaction was further 
supported by the fact that Glc7p also regulates poly(A) tail synthesis in vivo as 
poly(A) tails in several glc7 mutant strains were shorter than poly(A) tails in WT 
cells. In addition, in glc7-13 mutants the poly(A) site selected for 3’ end processing 
shifted from the predominant WT poly(A) site towards a more distant cryptic poly(A) 
site. Western analysis of CPF subunits suggested that Glc7p phosphatase activity 
might regulate the assembly and therefore the stability of the CPF complex.  
 
How could phosphorylation regulate CPF activity 
One way to control the polyadenylation step of pre-mRNAs would be to directly 
regulate the activity of Pap1p by phosphorylation. Several reports indicate that Pap1 
indeed can be phosphorylated and that this phosphorylation inhibits the enzyme 
resulting in the lack of poly(A) tails (Colgan et al., 1998; Mizrahi and Moore, 2000). 
However, phosphorylated forms of Pap1 have only be found in specific phases during 
the cell cycle: the late S/G(2) phase in yeast and the M phase in vertebrates (Colgan et 
al., 1998; Mizrahi and Moore, 2000). Therefore, this form of regulation does not seem 
to be involved in controlling the activity of Pap1 in each round of transcription. 
Moreover, in Xenopus and Hela cells it was demonstrated that Pap1 is heavily 
phosphorylated in a C-terminal region not conserved in the yeast enzyme (Colgan et 
al., 1998) suggesting that the mechanism of regulation by phosphorylation is quite 
diverse among species. Also, He and co-workers could show that in Glc7p depleted 
extracts Pap1p does not accumulate in a phosphorylated and therefore inactive form, 
indicating that Glc7p is not involved in the dephosphorylation of Pap1p (He and 
Moore, 2005). 
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In addition, these authors reported that Glc7p influences polyadenylation of pre-
mRNAs by regulating the phosphorylation state of the CPF subunit Pta1p (He and 
Moore, 2005), which is phosphorylated by a unknown kinase. The phosphorylated 
state of Pta1p inhibits poly(A) tail synthesis. Glc7p dephosphorylates Pta1p at the end 
of each round of transcription leading to efficient polyadenylation of pre-mRNAs (He 
and Moore, 2005). However, it remains unclear how phosphorylated Pta1p inhibits 
Pap1p activity or how dephosphorylated Pta1p stimulates Pap1p activity. 
Phosphorylated Pta1p might destabilize CPF such that not all subunits required for 
polyadenylation are present during the elongation step of transcription. This could 
also be an efficient mechanism to prevent 3’ end processing at cryptic poly(A) sites. 
Dephosphorylation of Pta1p during 3’ end formation could also stimulate contacts to 
the missing subunits. This would lead to the formation of a stable CPF complex which 
can then efficiently polyadenylate the pre-mRNA. This effect of Pta1p might be 
mediated via the CPF subunit Fip1p, which helps to recruit Pap1p to CPF by 
interactions with another CPF subunit, Yth1p (Barabino et al., 2000; Zhelkovsky et 
al., 1998). Fip1p also regulates the processive activity of Pap1p (Preker et al., 1995). 
Pta1p could also be indirectly linked to Fip1p via interactions with subunits like 
Yth1p. Disturbing this interaction network could then exclude Fip1p from CPF and 
consequently Pap1p. 
 
How is Glc7p recruited to CPF 
Because Glc7p has many different functions at diverse locations in the cell, a specific 
targeting subunit has to recruit Glc7p to the CPF complex. It has been proposed that 
Ref2p is the CPF subunit that achieves the recruitment of Glc7p (Nedea et al., 2003). 
Nedea and co-workers demonstrated that when a specific region of Ref2p is deleted, 
Glc7p no longer co-purifies with the CPF complex (Nedea et al., 2003). This specific 
region of Ref2p contains a putative type I protein phosphatase binding site (amino 
acids 368-376), the canonical RVXF motif found in the majority of PP1/Glc7p 
interacting proteins (Walsh et al., 2002). Our pulldown experiments suggest that 
Glc7p interacts not only with Ref2p but with several subunits of CPF. These 
interactions on one hand seem to facilitate the recruitment and stabilize the interaction 
of Glc7p with CPF. On the other hand these interactions lead to an interaction of 
Glc7p with the substrate Pta1p.  
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3 Glc7p is involved in transcription termination of snoRNAs 
3.1 Summary 
The process that leads to the dissociation of RNA polymerase II (RNAPII) from the 
DNA template and the transcribed precursor RNA in the 3’ UTR of a gene is called 
transcription termination. Transcription termination of pre-mRNAs and snoRNAs 
requires a number of cis- and trans-acting factors. Known components of snoRNA 
transcription termination are the Nrd1 complex and subunits of the CPF subcomplex 
APT. Here, we show that the protein phosphatase Glc7p is involved in transcription 
termination of snoRNAs but not of pre-mRNAs. Our data suggest that Glc7p 
functions in the Nrd1 complex-dependent pathway of snoRNA transcription 
termination. However, Glc7p does not regulate the phosphorylation status of any of 
the Nrd1 complex subunits. Also, phosphorylation of the APT subunit Pti1p and the 
CPF subunit Pta1p is unaltered in glc7 mutant strains. Therefore it remains to be 
elucidated how Glc7p regulates snoRNA transcription termination. 
 
3.2 Introduction 
Two major classes of genes are transcribed by RNAP II: protein encoding genes and 
small nucleolar RNA (snoRNA) genes (Kiss, 2002). snoRNAs are non-coding RNAs 
that associate with a number of proteins to form small nucleolar RNPs (snoRNPs; 
(Kiss, 2002). The majority of snoRNAs functions as guide RNAs in the post-
transcriptional synthesis of 2’-O-methylated nucleotides and pseudouridines in 
rRNAs, tRNAs and snRNAs and most likely other cellular RNAs (Kiss, 2002). 
Transcripts of both RNA classes have to be processed in order to become mature, 
functional RNAs. pre-mRNAs, which are the primary transcripts of protein encoding 
genes, are capped at the 5’ end, spliced and 3’ end processed. In contrast, the majority 
of snoRNA transcripts only undergo 3’ end processing.  
3’ end processing of pre-mRNAs comprises two steps: endonucleolytic cleavage 
followed by the addition of a poly(A) tail to the upstream cleavage product. In yeast, 
this reaction requires the cleavage and polyadenylation factor (CPF), cleavage factor 
IA (CF IA) and cleavage factor IB (CF IB) (Chen and Moore, 1992; Ohnacker et al., 
2000). CPF appears to form two distinct subcomplexes, the core-CPF subcomplex and 
the APT subcomplex (APT for associated with Pta1p). The core-CPF contains the 
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poly(A) polymerase Pap1p, the putative endonuclease Ysh1p, the subunits Ydh1p, 
Yth1p, Yhh1p, Fip1p, Mpe1p, Pfs2p and Pta1p. The APT subcomplex includes the 
six CPF subunits Ref2p, Pti1p, Swd2p, Ssu72p, Syc1p and Glc7p (Nedea et al., 2003). 
It has been shown that several of the APT subunits are involved in transcription 
termination of snoRNAs (Cheng et al., 2004; Dheur et al., 2003; Dichtl et al., 2004; 
Ganem et al., 2003; Steinmetz and Brow, 2003). In contrast, core-CPF subunits 
participate predominantly in processing of pre-mRNAs and not of snoRNAs. 
Processing of snoRNAs can occur in several different ways. They all have in common 
that the snoRNA is cleaved within the 3’ UTR and subsequently trimmed by the 
nuclear exosome to form the mature snoRNA (van Hoof et al., 2000). The nuclear 
exosome is a protein complex consisting of at least 10 different 3’ to 5’ exonucleases. 
Processing of snoRNA transcripts often depends on the endonuclease Rnt1p, which 
recognizes and cleaves specific hairpin structures in the 3’ UTR thereby generating 
entry sites for the nuclear exosome (Chanfreau et al., 1997). However, Rnt1p cleavage 
sites are not present in all snoRNA precursors. Several snoRNAs contain sequences in 
their 3’ region, which direct cleavage of the primary transcript by CF IA to generate 
the entry site for the nuclear exosome (Morlando et al., 2002). 
Transcription termination is defined as the process of RNAP II dissociating from the 
DNA template and the nascent RNA. Transcription termination of protein coding 
genes is dependent on the 3’ end processing signal, also termed poly(A) signal 
(Proudfoot, 2000a). Several factors of CF IA, including Pcf11p, Rna14p, Rna15p and 
the CPF subunits Ssu72p, Yhh1p, Swd2p and Ysh1p have been shown to be required 
for transcription termination of pre-mRNAs (Birse et al., 1998b; Dichtl et al., 2004; 
Dichtl et al., 2002b; Gross and Moore, 2001b; Minvielle-Sebastia et al., 1997; 
Steinmetz and Brow, 2003 ; M. Garras, personal communication). Similarly, 
transcription termination of snoRNAs requires cis- and trans-acting factors. The 
RNA-binding proteins Nrd1p and Nab3p and the putative RNA helicase Sen1p, all 
components of the Nrd1 complex have been implicated in transcription termination of 
snoRNAs (Steinmetz et al., 2001). A number of Nrd1 and Nab3 binding sites have 
been identified in snoRNA 3’UTRs and also in the Nrd1 ORF and 5’ and 3’ flanking 
regions (Carroll et al., 2004; Steinmetz et al., 2001; Steinmetz et al., 2006). They 
direct the termination of snoRNA transcription and also the autoregulation of the 
Nrd1 transcript itself (Arigo et al., 2006a; Vasiljeva and Buratowski, 2006). Nrd1p 
binds to the consensus sequence GUA[AG] whereas Nab3p binds to UCUU. The 
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arrangement of these motifs varies considerably at different snoRNA terminators, 
indicating a certain redundancy. In some snoRNAs, such as snR13, snR47 and snR65, 
the terminator region is arranged in a bipartite fashion (Steinmetz et al., 2006). Region 
I of these terminators contains the Nrd1p and Nab3p binding sites and shows some 
sequence similarity with the Nrd1 autoregulatory element. Interestingly, region II has 
sequence similarities with the cleavage and polyadenylation sites of pre-mRNAs and 
can direct polyadenylation, indicating that protein-coding and non-coding RNAP II 
transcribed genes might use similar mechanisms to direct transcription termination 
(Steinmetz et al., 2006). Previous studies have also described a requirement of the 
CTD kinase Ctk1p and the CTD of RNAP II itself for snoRNA transcription 
termination (Conrad et al., 2000; Steinmetz et al., 2001). Several studies suggest that 
the APT subunits Pti1p, Ref2p, Ssu72p, and Pta1p are participating in the Nrd1p-
dependent pathway of snoRNA transcription termination (Dheur et al., 2003; Nedea et 
al., 2003). Recently, also the Paf1 complex which is involved in transcription 
elongation and histone modification, has been shown to take part in 3’ end formation 
of snoRNAs (Sheldon et al., 2005). Furthermore, physical interactions of Nrd1p with 
the nuclear exosome have been reported, implicating the assembly of a 3’ end 
processing/termination complex that couples transcription termination to processing 
of snoRNAs (Vasiljeva and Buratowski, 2006). However, the exact molecular 
mechanism of snoRNA transcription termination remains to be elucidated. 
In this work we have analyzed the function of Glc7p in transcription termination of 
pre-mRNAs and snoRNAs. We show that Glc7p is essential for snoRNA but not for 
pre-mRNA transcription termination. Finally, we present data that Glc7p is not 
involved in the regulation of the phosphorylation status of Nrd1p, Sen1p and Nab3p, 
indicating that Glc7p does not influence snoRNA transcription termination via 
regulation of the Nrd1 complex.  
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3.3 Results 
3.3.1 Expression profiling of glc7-12 reveals defects in snoRNA transcription 
termination 
The CPF subunits Ssu72p, Pti1p, Ref2p and Swd2p (Dheur et al., 2003; Dichtl et al., 
2004; Ganem et al., 2003; Steinmetz and Brow, 2003) have been shown to function in 
transcription termination of some snoRNAs. We therefore wondered whether Glc7p 
could also influence the transcription termination of these RNAs. To approach this 
question we performed an Affimetrix microarray analysis of poly(A)+ RNA derived 
from glc7-12, a temperature sensitive Glc7p mutant, and the wild type strain at RT 
and 37º C to see if aberrant termination of snoRNAs affects the expression of 
downstream coding genes (for more detailed information concerning the microarray 
set up see Chapter 5 and Materials and Methods). A defect in transcription 
termination of snoRNAs can either lead to an increase in the RNA level of the 
downstream gene due to read-through or to a decrease resulting from interference 
with the downstream gene promoter. In several mutant strains (ssu72-ts69, nrd1-5), 
this approach has led to the identification of snoRNA transcription termination defects 
(Ganem et al., 2003; Steinmetz et al., 2001).  
Results of our microarray analysis of glc7-12 indicate nine mRNA genes with altered 
expression patterns that have a snoRNA located upstream (Table 3.1). The expression 
levels of Hem4, Trs31, Rim20, Rec104 and Yjl149w increased in glc7-12 and are 
located downstream of the snoRNA genes snR5, snR13, snR31, snR71 and snR190-
snR128, respectively. Steinmetz and co-workers (Steinmetz et al., 2001) found six 
instances in their microarray analysis of nrd1-5 in which the mRNA levels 
downstream of snR3, snR13, snR47, snR71 and snR190-snR128 were increased. In 
addition, we found four mRNAs (Ytm1, Rpl7a, Ypl144w, Ckb2) with decreased 
expression levels. These mRNAs are located downstream of snR8, snR39b, snR17b 
and snR9, respectively. These results suggest an involvement of Glc7p in 
transcription termination of snoRNAs.  
Interestingly, we also found downregulation of six mRNA genes encoding a snoRNA 
in their intron (Table 3.1). There are only seven protein coding genes in yeast that 
have a snoRNA in their intron. However, we did not further investigate these results. 
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Table 3.1.  
downregulated
downregulated
downregulated
downregulated
downregulated
downregulated
downregulated
downregulated
downregulated
downregulated
upregulated
upregulated
upregulated
upregulated
upregulated
expression alteration
a ORF is followed by a snoRNA transcribed conversely
b snoRNA encoded in Intron of ORF
snR59b Rpl17b
snR54b Imd4
snR44b  Rps22b
snR39b Rpl17a
snR38bTef4
snR24b Asc1
snR39bRpl7a
snR17ba Ypl144w
snR9aCkb2
snR8Ytm1
snR190, snR128a  Yjl149w
snR71  Rec104
snR31  Rim20
snR13 Trs31
snR5  Hem4
upstream snoRNAORF
 
 
 
3.3.2 snoRNA read-through transcripts accumulate in glc7 mutants 
Our microarray analysis of the glc7-12 mutant strain suggested that a deficiency in 
snoRNA transcription termination is the cause for the up- or downregulation of genes 
downstream of a snoRNA. To test this we performed Northern analysis of total RNA 
extracted from WT, glc7-10, glc7-12, glc7-13 and glc7-5 strains grown at 25° C or 
after shift to the non-permissive temperature 37° C. In case of a failure to terminate 
transcription of a snoRNA, probes for a given mRNA that derived from the snoRNA 
downstream gene, should not only detect the respective mRNA but in addition a 
tandem transcript consisting of the snoRNA, the intergenic region and the 
downstream mRNA. 
For this purpose probes directed against mRNAs (Trs31, Asn1, Rec104) that are 
located immediately downstream of snoRNAs (snR13, snR45, snR71) were used. 
Results for all probes showed the accumulation of extended RNAs (Fig. 3.1 a). The 
lengths of the extended RNA products correlated with RNA molecules that have been 
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demonstrated to consist of a snoRNA sequence followed by the 3’ intergenic region 
and the sequence of the adjacent protein coding gene (Dichtl et al., 2002a; Ganem et 
al., 2003; Steinmetz et al., 2001). The amount of the read-through product varied 
significantly between the different glc7 mutant alleles. glc7-12 and glc7-5 mutant 
strains displayed strong defects in terminating transcription at the snR13, snR45 and 
snR71 terminators. In contrast, glc7-10 and glc7-13 accumulated only very little read-
through products within the same time interval at the restrictive temperature. 
Interestingly, in case of Trs31, only the read-through product is observed in the 
mutant strains. This indicates that ongoing transcription initiated from the snoRNA 
gene interfered with transcription initiation from the Trs31 promoter, leading to the 
downregulation of the Trs31 message itself. 
If the read-through products we observed with the probe against the mRNA are 
indeed tandem transcripts, we can expect a probe against the upstream snoRNA to 
hybridize to the same read-through product. For technical reasons, attempts to obtain 
the same read-through products with probes directed against the snoRNA failed. We 
therefore used the method of primer extension on total RNA to demonstrate that 
transcription of this tandem transcript indeed started at the snoRNA transcription start 
site and fails to terminate at the snoRNA termination site. The method of primer 
extension allows to detect extended RNAs with oligonucleotide primers that are 
complementary to sequences in the intergenic region downstream of the termination 
site of snR13. In WT, the transcript does not contain the sequence complementary to 
this primer because transcription termination occurred upstream of the primer 
annealing site. Indeed, no reverse transcription product was observed in the WT strain 
(Fig. 3.1 b). In contrast, we observe a reverse transcription product in glc7-5 mutant 
strains after shift to the non-permissive temperature (Fig. 3.1 b). This indicates that 
transcription did not terminate but continued at the snR13 termination site. 
Furthermore, the 5’ end of this product coincides with the snR13 RNA 5’ end. This 
result confirms that the read-through product, which we detected in the Northern 
analysis with the probe directed against the Trs31 mRNA was initiated from the 
snR13 transcription start site and eliminates the possibility that it initiated further 3’ 
of the snoRNA transcription start site. Therefore, the read-through product we see in 
the Northern analysis is a tandem transcript consisting of the snoRNA, the intergenic 
region and the downstream mRNA. However, we did not observe a read-through 
product in glc7-12 mutant strains, which was rather unexpected.  
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In conclusion, transcription termination at the snoRNA terminator did not occur but 
transcription continued into the downstream protein coding gene. This could suggests 
that glc7 mutants have a defect in snoRNA transcription termination. 
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Figure 3.1. glc7 mutant strains accumulate snoRNA-mRNA tandem transcripts. 
The drawing on top illustrates the genomic arrangement of the analysed genes and the relative direction 
of transcription. A) Northern analysis (panel I – IV) of 20µg total RNA extracted from WT, glc7-10, 
glc7-12, glc7-13 and glc7-5 cells following growth in YPD medium at 25º C or after shift to 37º C for 
the indicated times. Blots were probed against Trs31 (panel I), Asn1 (panel II), Rec104 (panel III) and 
18S (panel IV; loading control). Migration of RNAs is indicated on the left. B) Primer extension 
analysis of 6µg of total RNA extracted from WT, glc7-12 and glc7-5 cells following growth at 25º C or 
after shift to 37º C for 2 hours.  
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3.3.3 glc7-12 is defective in snoRNA transcription termination  
A defect in transcription termination is not the only explanation for the accumulation 
of read-through products. Instead, it is possible that the accumulation of read-through 
products results from a stabilization of elongated transcripts that occurs exclusively in 
the mutants and not in the WT. 
To discriminate between these possibilities and to establish a function of Glc7p in 
snoRNA transcription termination we performed transcriptional run-on analysis 
(TRO; see Materials and Methods). TRO monitors the distribution of actively 
transcribing RNAP II complexes over the genomic region of interest. 
We tracked the density of RNAP II over the endogenous snR3 and the adjacent gene 
locus in the WT and glc7-12 mutant strain in vivo as described by Steinmetz and co-
workers (Steinmetz et al., 2001). The two single-stranded DNA probes A and B we 
used in the experiment, cover the genomic region over the snoRNA and the adjacent 
5’ end of gene YJR129c (see scheme in Fig. 3.2 a). These probes are complementary 
to transcripts initiated from the snR3 promoter. In WT, efficient transcription 
termination would result in run-on signals exclusively over probe A, since probe B is 
already complementary to regions past the snR3 termination site. Therefore, a signal 
over probe B indicates that correct transcription termination failed and transcription 
continued to the adjacent gene YJR129c. The gene YJR129c is transcribed in reverse 
orientation to snR3. As a result, mRNAs of YJR129c are not complementary to probe 
B and therefore cannot hybridize to probe B. Consequently, a run-on signal over 
probe B truly indicates that snR3 transcription termination has not occurred. 
When testing the WT and the glc7-12 mutant in this assay, we observed that glc7-12 
displayed an ~3 fold stronger run-on signal with probe B compared to the WT 45 min 
after shift to the non-permissive temperature, indicating that transcription termination 
was severely compromised in this mutant (Fig. 3.2 b and c). In addition, this result 
clearly shows that the read-through products detected in our northern analysis do not 
merely accumulate because trimming to the mature form failed. If RNAP II would 
read over the termination signal and consecutive degradation would lead to the 
formation of mature snoRNAs, we would expect a run-on signal over probe B for the 
WT as well. However, this is not the case. 
In summary, these results again indicate that Glc7p is involved in transcription 
termination of snoRNAs.  
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Figure 3.2. Glc7 is required for transcription termination of snoRNAs. 
A) Arrangement of the SNR3 –YJR129C genomic locus. Probes (~360 nt each) are shown below their 
locations. Note the SNR3 and YJR129C are transcribed from opposite strands of the DNA, as indicated 
by the arrows. B) Representative slot blot from transcription run-on analysis from WT and glc7-12 
mutant cells before and after shift to 37º C. M13 slots are single-stranded phagemids with no insert and 
serve as a control for background hybridization. Transcription of Actin (Act1) serves as positive 
control. C) Quantification of the transcript by phosphorimager analysis. Background (M13) was 
substracted from each value and corrected counts were normalized to the A probe. Error bars represent 
standard deviation (n=3).  
 
 
3.3.4 glc7 mutants accumulate Nrd1 and read-through transcripts at the Nrd1 
transcription site 
The yeast Nrd1 complex is required for transcription termination of RNAP II- 
transcribed snRNA and snoRNA genes (Steinmetz et al., 2001). In addition, two 
further phenotypes characterize mutations in the Nrd1 complex subunits Nrd1, Nab3 
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and Sen1. First of all, they lead to the accumulation of a tandem transcript (Nrd1-
Mrpl17) composed of Nrd1, the intergenic region and the downstream mRNA 
Mrpl17, indicating that transcription termination at the Nrd1 terminator was 
inefficient. The reason for this is most likely the presence of Nrd1 and Nab3 binding 
sites in the 3’ UTR of Nrd1, because these binding sites are also required for snoRNA 
transcription termination (Carroll et al., 2004). Second, the Nrd1 message itself 
accumulates in these mutants. It has been proposed that this phenotype is due to an 
auto-regulatory property of the Nrd1 complex that regulates the expression of the 
Nrd1 mRNA by premature transcription termination, a process that again involves 
Nrd1 and Nab3 binding sites, however in the 5’UTR and ORF of Nrd1 (Arigo et al., 
2006a). 
Considering these facts, we were interested if Glc7p is involved in the Nrd1-
dependent pathway of transcription termination. If this was the case, glc7 mutants 
should show the additional phenotypes of the Nrd1 complex mutants, such as 
accumulation of Nrd1 mRNA and the read-through product Nrd1-Mrpl17. 
To this end, we performed northern analysis on total RNA extracted from WT, glc7-
10, glc7-12, glc7-13 and glc7-5 mutant strains before and after shift to the non-
permissive temperature. With probes directed against Nrd1 or Mrpl17, accumulation 
of the read-through product Nrd1-MRPL17 was detected for glc7-12, glc7-13 and also 
to a lesser extent for glc7-5 (Fig. 3.3). In contrast, strain glc7-10 did not accumulate 
such a read-through product. In addition, all mutant strains showed an accumulation 
of the Nrd1 mRNA, which was most pronounced in glc7-12 and glc7-5. An increase 
in the Nrd1 mRNA level at the restrictive temperature was also observed in glc7-12 
by microarray analysis. This implies that Glc7p also functions in regulation of the 
Nrd1 mRNA levels. Interestingly, glc7-5 showed strong accumulation of Nrd1, 
similar to glc7-12, but did not accumulate the read-through product as efficiently as 
glc7-12. Therefore, these two phenotypes seem to be partly uncoupled in the glc7-5 
mutant. 
We conclude that Glc7p is part of the Nrd1-dependent snoRNA transcription 
termination pathway.  
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Figure 3.3. glc7 mutant strains accumulate Nrd1-Mrpl17 tandem transcripts 
The drawing on top illustrates the genomic arrangement of the NRD1-MRPL17 locus and the relative 
direction of transcription. Northern analysis (panel I – III) of 20µg total RNA extracted from WT, glc7-
10, glc7-12, glc7-13 and glc7-5 cells following growth in YPD medium at 25º C or after shift to 37º C 
for the indicated times. Blots were probed against Nrd1 (panel I), Mrpl17 (panel II) and 18S (panel III; 
loading control). Migration of RNAs is indicated on the left. 
 
 
3.3.5 glc7-12 does not show a transcription termination defect at the Cyc1 
terminator 
Read-through of the Nrd1 terminator as it appears in glc7 and Nrd1 complex mutants, 
is a special case of transcription termination failure. Nrd1 is a protein-coding gene and 
its mRNA therefore is polyadenylated. The poly(A) signal in the 3’ UTR is required 
for transcription termination of polyadenylated messages. However, Nrd1 has Nrd1 
and Nab3 binding sites in addition to the poly(A) signal in the 3’ UTR that are 
required for snoRNA transcription termination. We wondered whether the termination 
defect observed for the Nrd1 terminator in the glc7 mutants was general, applying to 
all protein coding genes or whether it was due to the function of Glc7p in the Nrd1-
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dependent pathway of snoRNA transcription termination. To answer this question we 
performed TRO analysis in glc7-12, monitoring the distribution of RNAP II with 
probes P1 to P6 that hybridize to the 3’ end of the ORF and the following 3’ UTR of 
the protein encoding gene Cyc1 in vivo (see scheme in Fig 3.4). The plasmid borne 
Cyc1 construct is a well documented substrate for TRO analysis of protein encoding 
genes (Dichtl et al., 2002a; Sadowski, 2003). In the WT, where transcription 
termination occurs shortly after the poly(A) site, run-on signals should be visible only 
over probe P1 to P3 but not over the probes located more downstream. A mutant 
strain defective for transcription termination would show additional run-on signals at 
probes P4 to P6.  
We observed that compared to the WT, glc7-12 did not show higher levels of actively 
transcribing RNAP II after the poly(A) site at the non-permissive temperature (Fig. 
3.4). Therefore, transcription termination of Cyc1 is not affected in glc7-12, 
suggesting that read-through of the Nrd1 terminator in glc7 mutant strains is 
associated with the functions of the Nrd1 complex and not with transcription 
termination defect of protein coding genes in general. However, the observation that 
glc7-12 shows no transcription termination defect on the Cyc1 terminator could be 
allele- specific. 
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Figure 3.4. Glc7 is not required for transcription termination of CYC1. 
A) Schematic diagram of plasmid pUGCYC1 showing the arrangement of M13 probes (P1 – P6) 
relative to the CYC1 poly(A) site (position 506). B) Representative slot blot from transcription run-on 
analysis from WT and glc7-12 mutant cells before and after shift to 37º C for 45 minutes as indicated. 
M13 slots are single-stranded phagemids with no insert and serve as a control for background 
hybridization. Transcription of Actin (Act1) serves as positive control. C) Quantification of the 
transcript by phosphorimager analysis. Background (M13) was substracted from each value and 
corrected counts were normalized to the P1 probe. Error bars represent standard deviation (n=3). 
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3.3.6 glc7 mutants do not show a general transcription termination defect for 
protein encoding genes 
To exclude the possibility that the terminating activity of Glc7p is restricted to the 
Cyc1 terminator and to a specific glc7 allele we carried out a transcriptional 
interference assay established by Morillon and co-workers (Morillon et al., 2003b). 
This assay allowed it to test a different mRNA terminator region, the Gal 10 
terminator. Deficiencies in transcription termination could be recorded as follows (see 
Materials and Methods): transcription from the upstream pTEF:KanR fusion gene, if 
not terminated, will interfere with transcription initiation from the downstream Gal7 
promoter (see scheme in Fig. 3.5 a). Because the Gal7 promoter drives expression of 
the GFP gene, interference with transcription from the Gal7 promoter will lead to a 
reduction in GFP signal, thus indicating a defect in transcription termination of a 
mutant strain.  
As a positive control, we used the yhh1-6 mutant strain. This strain was shown to 
have a transcription termination defect in a TRO experiment at the Cyc1 terminator 
(Dichtl et al., 2002b). yhh1-6 exhibits a strong transcription termination defect in the 
transcriptional interference assay, confirming that our system is indeed functioning 
(Fig. 3.5 b). In contrast, glc7-10, glc7-12 and glc7-13 did not show a dramatic 
decrease of the GFP signal, indicating that transcription initiation from the Gal7 
promoter is not disturbed by non-terminating polymerases coming from the TEF 
promoter. We observed a very low GFP signal in glc7-5, which probably does not 
correlate with a defect in transcription termination. We conclude this because the GFP 
signal is also very low in glc7-5 mutants that bear a different construct from which 
transcription is only possible from the Gal7 promoter simply because the TEF 
promoter is deleted (delta Tef induced; see scheme in Fig. 3.5 a). With the help of this 
construct the transcriptional efficiency of GFP of a strain can be monitored. Because 
the GFP levels in glc7-5 with the delta TEF construct were very low, we conclude that 
glc7-5 has a deficiency in initiating or elongating transcription by RNAP II but not a 
transcription termination defect.  
These results suggest that there is no transcription termination defect in glc7 mutants 
for protein coding genes. In addition, we see that this effect is not allele-specific. 
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Figure 3.5. Glc7 is not required for transcription termination of GAL10. 
A) Schematic of the transcription interference assay constructs. In yeast the GAL10-7 genes are 
expressed in tandem following GAL induction. Expression from the GAL7 promoter is very sensitive 
to transcriptional interference that occurs when transcription of the upstream GAL10 gene fails to 
terminate efficiently. A pTEF:KanR fusion gene is positioned upstream of the GAL10-7 intergenic 
region containing the GAL10 terminator and the galactose inducible GAL7 promoter driving 
expression of the GFP gene. Interference can be assessed by a reduction in GFP expression when the 
upstream pTEF:KanR fusion gene is expressed (pKGGURA). In order to control for transcriptional 
efficiency affecting the levels of GFP, a second version of the construct that lacks the TEF promoter, 
abolishing expression from KanR was transformed into strains (pKGGΔTEF). B) Plasmids pKGGURA 
and pKGGΔTEF were transformed into the strains indicated and assayed for GFP expression in 
synthetic medium containing glucose (represses expression from GAL7) or galactose (induced 
expression from GAL7) after shift to 37º C for 1 hour relative to WT. pTEF is expressed in both 
growth conditions. Expression of GFP (ΔTEF induced) serves as a control for transcription efficiency 
of the system.  
 
 
3.3.7 Glc7p genetically interacts with subunits of CPF 
It has been proposed that CPF can be subdivided into core-CPF and the APT sub 
complex, which stands for “associated with Pta1” (Nedea et al., 2003). The APT sub 
complex is composed of the subunits Pti1p, Ssu72p, Ref2p, Swd2p, Syc1p and Glc7p. 
 78 
For all of these subunits, except for Syc1p, it was shown (including this work) that 
mutations in these protein factors lead to a snoRNA transcription termination defect 
(Dheur et al., 2003; Dichtl et al., 2004). The only exception is Ssu72p, which in 
addition shows a transcription termination defect for protein coding genes (Ganem et 
al., 2003; Steinmetz and Brow, 2003). Therefore, the APT subcomplex of CPF seems 
to be predominantly dedicated to the processing of snoRNAs.  
To investigate a functional relationship between components of APT and Glc7p, we 
overexpressed several subunits in a 2µ vector in WT and glc7-10, glc7-12, glc7-13 
and glc7-5 ts mutant strains. Overexpression of Pta1p, Pti1p and Syc1p dramatically 
inhibited growth of glc7-12 at 33° C whereas growth of WT or glc7-10 was not 
affected at 37° C (Fig. 3.6). Moreover, no effect was observed for glc7-13 and glc7-5 
at any temperature. Overexpression of Ssu72p had no influence on growth of any of 
the glc7 mutants. The only effect was seen on glc7-12 with overexpressed Pta1p, 
Pti1p and Syc1p but not with Ssu72p. The other glc7 mutant strains were not affected, 
indicating that this effect is allele-specific. Physical interactions between Glc7p, Pta1p 
and Pti1p have been described previously (Gavin et al., 2006; He and Moore, 2005; 
Nedea et al., 2003; Walsh et al., 2002). Because Pta1p and Pti1p are both 
phosphoproteins they are potential substrates of Glc7p in the context of snoRNA 
transcription termination.  
Taken together, these experiments suggest that accumulation of Pta1p, Pti1 and Syc1p 
severely restricts growth in glc7-12 cells at a semi-permissive temperature, illustrating 
that Glc7p regulates some aspects of the function of these proteins. 
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Figure 3.6. Overexpression of several APT subunits affects growth of glc7-12 mutant cells. 
A) Schematic representation of growth plate. B) WT and glc7 mutant strains were transformed with 2µ 
overexpression vectors containing ORF of genes indicated on the left of each panel. Growth of strains 
was tested on synthetic medium at RT, 33º C and 37º C as indicated.  
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3.3.8 Pta1p is not the target of Glc7p in the process of snoRNA transcription 
termination 
Recently, it was shown by He and co-workers (He and Moore, 2005), that 
phosphorylation of Pta1p is indeed regulated by Glc7p. These authors depleted Glc7p 
in vivo and observed that, in contrast to the WT, phosphorylated Pta1p accumulated in 
a Western analysis with an anti-phosphoserine antibody. Furthermore, it has been 
shown that phosphorylated Pta1p inhibits polyadenylation of pre-mRNAs, indicating 
that Glc7p regulates the polyadenylation activity of CPF via Pta1p. To test if Pta1p is 
also the target of Glc7p in the regulation of snoRNA transcription termination, we 
performed in vitro cleavage and polyadenylation assays with extracts purified from 
glc7 mutants that showed snoRNA transcription termination defects. As depicted in 
Fig. 2.2 we found that the only glc7 mutant allele to have a polyadenylation defect 
was glc7-13. Since glc7-12 does not display an mRNA polyadenylation defect but is 
deficient in snoRNA transcription termination, we assume that regulation of snoRNA 
transcription termination does not involve regulation of Pta1p’s phosphorylation 
status by Glc7p.  
To confirm this, we tested if the phosphorylation level of Pta1p is affected in the glc7-
12 and glc7-13 mutants compared to the WT. Therefore we affinity-purified TAP-
tagged Pta1p from these mutants and the WT after shift to the restrictive temperature. 
We did not observe an alteration in the phosphorylation status of Pta1p in glc7-12 
mutants compared to the WT (data not shown). Unexpectedly, the phosphorylation 
state of Pta1p was not altered in glc7-13 mutants as well.  
We conclude that regulation of snoRNA transcription termination by Glc7p is not 
mediated by Pta1p. 
 
 
3.3.9 Glc7p physically interacts with components of CF IA 
3’ end processing of pre-mRNAs is coupled to transcription termination (Birse et al., 
1998b; Buratowski, 2005). The coupling is mediated by the poly(A) signal and the 
CTD (Fong and Bentley, 2001; Hirose and Manley, 1998; Howe, 2002; Zhang et al., 
2005). Cleavage of the pre-mRNA is required but not sufficient for transcription 
termination to occur (Birse et al., 1998a; Kim et al., 2004b; Luo et al., 2006; 
Sadowski, 2003). Interestingly, CF IA, a complex required for the cleavage step in 3’ 
 81
end processing of pre-mRNAs, has been shown to be involved in 3’ end processing of 
snoRNAs (Morlando et al., 2002). Also, the CTD is necessary for 3’ end 
processing/termination of snoRNAs. Consequently, there seems to be a certain 
similarity concerning the mechanisms of transcription termination for mRNAs and 
snoRNAs. We were interested, if Glc7p physically interacts with subunits of CF IA to 
answer the question whether Glc7p might influence snoRNA transcription termination 
via one of these factors. To this end, we carried out GST- pulldowns with GST-tagged 
Glc7p and in vitro translated subunits of CF IA. As shown in Fig. 3.7, Pcf11p has a 
strong affinity for Glc7p. Pcf11p is a protein that can bind to the CTD and was 
previously shown to dismantle the RNAP II elongation complex to support 
transcription termination of pre-mRNAs (Zhang et al., 2005). Rna14p and Clp1p 
made weak interactions and Rna15p did not interact with Glc7p. 
In conclusion, Glc7p physically interacts with subunits of CF IA.  
Since CF IA is not sufficient to carry out 3’ end processing of snoRNAs on its own, 
but might interact with the Nrd1 complex, it is tempting to speculate that Glc7p might 
be involved in regulating this interaction.  
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Figure 3.7. Glc7p interacts directly with subunits of CFIA (see also Fig. 2.1) 
GST (lane 2) and GST-Glc7p (lane 1) bound to Glutathione Sepharose 4B were incubated with in vitro 
translated 35S-labeled subunits of CPF and CFIA as indicated on the left of the panel. Bound proteins 
were separated by SDS-PAGE and visualized by autoradiography. Input (lane 3) shows 10% of the in 
vitro translation reaction included into the binding reaction. 
 
 
3.3.10 Phosphorylation levels of the CTD are not altered in glc7 mutants 
The CTD of RNAP II is required for transcription termination of snoRNAs. In yeast, 
the CTD consists of 26 repeats of the heptapeptide YSPTSPT, which can be 
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phosphorylated at serines 2 and 5. The dynamic pattern of phosphorylation of the 
CTD is important for binding of RNA processing factors including factors necessary 
for transcription termination. Considering the CTD binding property of Pcf11p and its 
strong interaction with Glc7p, we asked whether Glc7p might regulate the 
phosphorylation status of the CTD. Misregulation of the phosphorylation status could 
explain the transcription termination defects on snoRNAs observed in glc7 mutant 
strains. 
Total protein extracts prepared from the WT, glc7-5, glc7-10, glc7-12, and glc7-13 
mutants before and after shift to the non-permissive temperature were analyzed by 
Western analysis with antibodies directed against the unphosphorylated CTD 
(8WG16), against the CTD phosphorylated at Ser2 (H5) and against phosphorylation 
at Ser5 (H14). As shown in Fig. 3.8 we could not detect a change in the level of 
phosphorylation in these mutants compared to the WT. Therefore it is unlikely that 
the phosphorylation status of the CTD of RNAP II is regulated by Glc7p. 
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Figure 3.8. The phosphorylation level of the CTD is not altered in glc7 mutant strains. 
Western analysis of WT and glc7 mutant extracts prepared from cells grown at 25º C, or after shift to 
33º C for 1 and 2 hours as indicated on top of the panel. Equal amounts of total protein were loaded in 
each lane. The filters were treated with antibodies directed against the unphosphorylated CTD 
(8WG16), the CTD phosphorylated at Ser5 (H14) and the CTD phosphorylated at Ser2 (H5) as 
indicated at the left. 
 
 
3.3.11 Glc7p does not dephosphorylate any subunit of the Nrd1 complex in vivo 
The Nrd1 complex subunits Nrd1p, Nab3p and Sen1p are all phospho-proteins. 
Because Glc7p is involved in the Nrd1-dependent pathway of snoRNA transcription 
termination it could be possible that Glc7p targets one of these proteins. We therefore 
decided to test whether phosphorylation of any of these proteins was regulated by the 
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phosphatase Glc7p. To this end, we performed Western analysis on protein extracts 
derived from WT, glc7-12 and glc7-13 mutant strains before and after shift to the 
non-permissive temperature. To detect phosphorylated forms of these proteins we 
used antibodies directed against phosphoserine and phosphothreonine residues. None 
of the Nrd1 complex subunits showed increased phosphorylation in the glc7 mutant 
strains at the restrictive temperature (B. Paguet, data not shown). This indicates that 
Glc7p is not involved in the regulation of phosphorylation of these proteins.  
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3.4 Discussion 
 
Transcription termination is an important mechanism releasing the transcription 
machinery from the DNA template. Thereby RNAP II molecules are recycled for new 
rounds of transcription. In addition, transcription termination prevents transcription of 
downstream genes, whereas a failure to terminate transcription interferes with the 
proper expression of downstream genes. We report here that Glc7p, the yeast 
homolog of the mammalian protein phosphatase 1 (PP1) is required for transcription 
termination of snoRNAs, however not for transcription termination of pre-mRNAs. 
Transcriptional run on analysis revealed that snoRNA termination is deficient in a 
glc7 mutant strain. This indicates that the cause for the accumulation of 3’ extended 
snoRNAs is not a processing defect but a transcription termination defect. 
Furthermore, Glc7p showed all mutant phenotypes characteristic of mutations in 
factors of the Nrd1-dependent transcription termination pathway of snoRNAs, 
indicating that Glc7p has a function in this pathway. However, none of the Nrd1 
complex subunits was found to be an in vivo substrate for Glc7p. Assaying the 
phosphorylation status of these proteins in several glc7 mutant strains by Western 
analysis showed no Glc7 dependent change of phosphorylation. 
 
Is it CPF-associated Glc7p that is involved in snoRNA transcription termination? 
Glc7p has numerous functions in the nucleus as well as in the cytoplasm. Different 
targeting subunits that associate with Glc7p assure specificity for the reactions Glc7p 
is involved in by localizing or regulating the activity of Glc7p. It is difficult to prove 
whether Glc7p is involved in snoRNA transcription termination as part of CPF or as 
an independent unit. The problem is that the specific targeting subunit of Glc7 for this 
process is not known and in addition it is unclear whether the activity of Glc7p in this 
specific reaction depends on interactions with CPF. However, we assume that Glc7p 
as a subunit of CPF influences snoRNA transcription termination based on the 
following findings: Glc7p was found to be part of the CPF subcomplex APT. Five of 
the six APT subunits (including data of this work) have been shown to be required for 
transcription termination of snoRNAs (Dheur et al., 2003; Dichtl et al., 2002a; Nedea 
et al., 2003; Steinmetz and Brow, 2003). This indicates that the APT subcomplex is a 
specific snoRNA transcription termination complex. In addition, the APT subunit 
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Ref2p has been described as the recruiting factor for Glc7p to CPF (Nedea et al., 
2003) and Ref2p is also a factor required for snoRNA transcription termination 
(Dheur et al., 2003). Therefore, we consider it likely that Glc7p as part of the 
subcomplex APT is involved in snoRNA transcription termination. It remains to be 
clarified if the APT subcomplex functions independently of the core-CPF in this 
process or whether the complete CPF complex is assembled on snoRNA terminators. 
 
What could be the substrates for Glc7 in the process of snoRNA transcription 
termination? 
The fact that Glc7p interacts with the APT subcomplex and is involved in the Nrd1-
dependent snoRNA transcription termination pathway inspired us to test subunits of 
the APT and the Nrd1 complex as candidate substrates for the phosphatase Glc7p. 
Western analysis proved that neither Nrd1, Nab3, Sen1 nor Pti1p were substrates of 
Glc7p. In addition, Pta1p, the subunit of CPF that links the APT subcomplex to core-
CPF, did not show an altered phosphorylation pattern in glc7 mutants either. This is 
remarkable, since Pta1p is a designated substrate of Glc7p in the process of 
polyadenylation (He and Moore, 2005), indicating that Glc7p must regulate the 
phosphorylation of a protein distinct from Pta1p in the process of snoRNA 
transcription termination. 
Pcf11p, a subunit of CF IA, has been shown to be required in transcription 
termination of pre-mRNAs (Sadowski, 2003). Interestingly, it has a CTD interaction 
domain highly similar to the one of Nrd1p and was shown to bind preferentially to the 
phosphorylated CTD (Sadowski, 2003). The involvement of Pcf11p in snoRNA 
transcription termination was never tested, although two subunits of CF IA, Rna14p 
and Rna15p, have been reported to play a role in 3’ end formation of snoRNAs 
(Morlando et al., 2002). The snoRNP core protein Nop1p interacts with all four CF IA 
subunits Pcf11p, Rna14p, Rna15p and Clp1p and the APT subunits Ssu72p, Ref2p, 
Pti1p and Swd2 (Morlando et al., 2004). In addition, Nop1p is required for 3’ end 
formation of snoRNAs, suggesting that the interacting proteins for which a function in 
this process has not been demonstrated, like Pcf11 and Clp1p, might be involved 
(Morlando et al., 2004). Since we observed a strong GST-pulldown interaction of 
Glc7p with Pcf11p it would be interesting to test whether Pcf11p is involved in 
snoRNA transcription termination and is regulated by Glc7p in this process. 
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How transcription termination is triggered 
Several cis- and trans-acting factors have been implicated in snoRNA and pre-mRNA 
transcription termination. However, the mechanism by which RNAP II is forced to 
dissociate from the DNA template and the nascent transcript remains elusive. Progress 
in understanding how RNAP II is triggered to release from the template has been 
made for transcription termination of pre-mRNAs. One quite mechanistical model 
implicates Pcf11p as a bridging factor between the nascent RNA and the CTD of 
RNAP II. Pcf11p dismantles RNAP II simply by restricting the distance RNAP II can 
transcribe further, away from the site where Pcf11p bound to the nascent RNA 
comparable to a dog on the leash. This ultimately causes RNAP II to dissociate from 
the template. As mentioned above Nrd1p and Pcf11p both have highly similar CTD 
interaction domains. Furthermore, Nrd1p, like Pcf11p is an RNA binding protein that 
binds to specific RNA motifs. It is tempting to speculate that Nrd1p might fill in the 
role of Pcf11p as a bridging factor in snoRNA transcription termination.  
Transcription termination of pre-mRNAs further requires Rat1p, a 5’to 3’ exonuclease 
that degrades the downstream cleavage product and is thought to torpedo RNAP II, 
facilitating its release (Kim et al., 2004b; Luo and Bentley, 2004). It is not known 
whether Rat1p is also required for snoRNA transcription termination.  
3’ end processing and transcription termination of pre-mRNAs are coupled. It has not 
been studied so far whether 3’ end formation and transcription termination of 
snoRNAs is also coupled.  
It is obvious that we still do not understand all aspects of transcription termination. It 
will be interesting to determine whether transcription termination of snoRNAs and of 
pre-mRNAs involve similar or even the same mechanisms to release RNAP II for new 
rounds of transcription.  
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4 Glc7p is involved in transcription elongation  
4.1 Summary 
During the transcription elongation phase RNAP II associates with a number of 
transcription elongation factors that regulate its processivity or remodel the chromatin 
structure. This actions are highly regulated to assure an efficient transcription of a 
gene. Here we report that the essential protein phosphatase Glc7p is required for 
poly(A)-dependent pausing. We show that several glc7 mutant alleles are sensitive to 
the drug 6-azauracil (6AU), which is a phenotypic feature of transcription elongation 
defects. In addition, Glc7p genetically interacts with factors implicated in 
transcription elongation. These include Spt4p, a subunit of DSIF, and the PAF 
complex subunits Leo1p and Rtf1p. Based on these findings, we propose that Glc7p 
regulates certain aspects of transcription elongation. Interestingly, the snoRNA 
transcription termination defect we observe in glc7 mutants is suppressed in glc7/spt4, 
glc7/leo1 or glc7/rtf1 double mutants. This could indicate a role for Spt4p, Leo1p and 
Rtf1p as antitermination factors in the process of snoRNA transcription and for Glc7p 
in coupling transcription elongation and termination of snoRNAs. 
 
4.2 Introduction 
Transcription of a gene by RNAP II can be divided into three main phases: initiation, 
elongation and termination (Saunders et al., 2006). The elongation phase of 
transcription by RNA polymerase II is highly regulated and tightly coupled to pre-
mRNA processing (Maniatis and Reed, 2002; Proudfoot et al., 2002). The key 
component in this coupling is the C-terminal domain (CTD) of the largest subunit of 
RNAP II. Each transcription phase has a characteristic CTD phosphorylation pattern 
in which a specific subset of processing factors and also elongation factors is attracted 
to the CTD. Traveling along with the elongating RNAP II enables these factors to 
process the transcript as soon as it emerges from the transcription machinery. Vice 
versa, the status of processing can alter the transcriptional activity of RNAP II 
(Manley, 2002). 
During elongation, RNAP II has to overcome nucleosome barriers or transient 
pausing caused by regulatory signals (Saunders et al., 2006). This is achieved with the 
help of positive and negative transcription elongation factors. Positive elongation 
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factors include TFIIS, TFIIF, FACT and the PAF complex (Belotserkovskaya and 
Reinberg, 2004; Conaway et al., 2003; Costa and Arndt, 2000; Mueller and Jaehning, 
2002; Rondon et al., 2004; Tan et al., 1994). A transcription elongation factor that 
acts both positively and negatively is DSIF (DRB-sensitivity-inducing factor; 
(Lindstrom et al., 2003; Rondon et al., 2003). DSIF is composed of the proteins Spt4p 
and Spt5p (Hartzog et al., 1998; Wada et al., 1998a). Studies with Spt5p revealed that 
it is inhibitory to transcription only during early stages of transcription. During 
promoter-proximal pausing Spt5p and the CTD are phosphorylated by Ctk1p. 
Phosphorylated Spt5p then stimulates the transcription process by preventing 
premature termination and pausing (Bourgeois et al., 2002; Wada et al., 1998a). In 
vitro transcription assays and genetic studies revealed Spt4p as a positive transcription 
elongation factor (Rondon et al., 2003). The PAF complex consists of five subunits, 
Paf1p, Ctr9p, Cdc73p, Rtf1p and Leo1p (Krogan et al., 2002; Mueller and Jaehning, 
2002; Squazzo et al., 2002). Originally, PAF was identified as a complex that 
associates with RNAP II (Shi et al., 1996). PAF is crucial in regulating 
monoubiquitylation and methylation of several histones (Wood et al., 2003) thus 
supports transcription elongation as a factor that remodels chromatin. 
Sensitivity to 6-azauracil is a phenotypic landmark of transcription elongation defects. 
The drug 6AU reduces intracellular levels of UTP and GTP thus depriving RNAP II 
of substrates for transcription. Mutations in many elongation factors cause 
hypersensitivity to 6AU, because the lack of their positive influence on transcription 
processivity renders RNAP II more vulnerable to nucleotide reduction. Subunits of 
the DSIF and the PAF complex show varying degrees of sensitivity to 6 AU (Hartzog 
et al., 1998; Squazzo et al., 2002).  
Different processing events can influence each other. For example, termination of pre-
mRNA transcription is coupled to 3’ end formation (Proudfoot, 2000a). Several recent 
reports present data that indicate a coupling of transcription elongation to 
transcription termination (Bucheli and Buratowski, 2005; Kaplan et al., 2005). It was 
found that Spt4p and some other elongation factors have properties of antitermination 
factors at the GAL10 – GAL7 locus (Kaplan et al., 2005). Kaplan and co-workers 
suggested that a reorganization of elongation factors associated with RNAP II past the 
polyadenylation signal would facilitate transcription termination (Kaplan et al., 2005). 
It was observed that the PAF complex crosslinks to genes throughout the transcribed 
regions of genes up to the polyadenylation site (Buratowski, 2005). While the 
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polymerase and several other elongation factors continue to transcribe, very little PAF 
cross-linking is seen 3’ to the poly(A) site (Ahn et al., 2004; Kim et al., 2004a). If the 
PAF complex acts as a positive elongation factor, polymerases downstream of the 
polyadenylation site that are no longer associated with PAF could become more 
competent for termination. This again suggests that a reorganization of the RNAP II 
transcription complex is required to allow transcription termination. 
Accumulating evidence suggests that transcription elongation factors are also required 
for 3’end formation of snoRNAs, a class of non-coding RNAP II transcripts. First, 
Sheldon and co-workers presented evidence that defects in the Paf1 complex lead to 
the accumulation of readthrough products at snoRNA loci (Sheldon et al., 2005). 
Second, Spt5p copurifies with the Nrd1 complex, a complex required for snoRNA 
transcription termination, suggesting tight coupling of elongation and termination of 
snoRNAs (Vasiljeva and Buratowski, 2006).  
In this work we analysed the function of Glc7p during transcription elongation and 
termination of pre-mRNAs and snoRNAs. We show that Glc7p is essential for 
snoRNA transcription termination. In addition our results show that Glc7 interacts 
genetically with the elongation factors Spt4p, Rtf1p and Leo1p and that the 
transcription termination defect of glc7 mutants can be suppressed by deletion of 
Spt4p, Rtf1p and Leo1p suggesting an antiterminator function of these elongation 
factors in the process of snoRNA termination. 
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4.3 Results 
4.3.1 Poly(A)-dependent pausing of RNAP II is reduced in glc7-12 mutants 
In mammals, the poly(A) signal drives transcription termination in two steps: 
poly(A)-dependent pausing of RNAP II followed by its poly(A)-dependent release. 
The CTD of RNAP II is required for poly(A)-dependent termination, but the body of 
the polymerase is sufficient for poly(A)-dependent pausing in the absence of the CTD 
(Park et al., 2004). While analyzing the results of our CYC1 TRO experiments we 
realized that WT cells consistently showed a very strong signal over probe P2 at 37ºC 
(Fig. 3.4 c). Probe P2 covers the poly(A) site of CYC1, indicating that a large amount 
of RNAP II molecules must have been stalled at this position. This enhanced pausing 
at the poly(A) signal seemed to be induced by the heat shock because at room 
temperature (RT) only moderate pausing is observed in the WT. Interestingly, pausing 
at the poly(A) site in glc7-12 mutants is reduced dramatically compared to the WT, 
indicating that RNAP II more often reads through the pause site without stalling. 
However, reduced stalling at the poly(A) site was not sufficient to interfere with 
transcription termination in glc7-12 mutants (Fig. 3.4).  
The poly(A) site is not the only transcriptional pause site during transcription of a 
gene. Another well known pause site is located at the 5’ end of genes at the transition 
of transcription initiation to transcription elongation. Transcription elongation factors 
modulate the processivity of RNAP II both negatively and positively at this pause site. 
This raised the question whether Glc7p might regulate transcription elongation factors 
to adapt RNAP II to cellular signals and is therefore involved in transcription 
elongation. Another possibility to explain the lack of stalling over the poly(A) site in 
glc7-12 mutants is that Glc7p directly modifies the body of RNAP II by 
dephosphorylation, since RNAP II without the CTD is sufficient for pausing. 
It is intriguing that ssu72-2 mutant cells also showed an abnormal density of RNAP II 
molecules at the poly(A) site (Dichtl et al., 2002a). In contrast to glc7-12 mutant cells 
however, ssu72-2 mutants display enhanced pausing of RNAP II at this site compared 
to the WT. Further investigation of this effect has lead to an implication of Ssu72p in 
transcription elongation. In addition, ssu72-2 mutants have a defect in snoRNA 
transcription termination (Dichtl et al., 2002a). Therefore it is likely that Ssu72 and 
Glc7p share similar functions in these processes. 
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4.3.2 Growth of glc7 mutant strains is affected by 6-azauracil 
To investigate whether Glc7p could be involved in regulating transcription elongation 
we applied a commonly used assay to test for growth of glc7 mutants on the drug 6-
azauracil (6AU). 6AU inhibits both the orotidylic acid decarboxylase and the IMP 
dehydrogenase (IMPDH), rate-limiting enzymes in the UTP and GTP biosynthetic 
pathways (Hampsey, 1997). 6AU diminishes the intracellular pools of UTP and GTP 
which is thought to affect the in vivo transcription elongation rate by depleting RNAP 
II for these nucleoside triphosphates. This is believed to reflect the need for an 
optimally functioning transcription machinery under conditions of lowered 
intracellular GTP and UTP levels. Whereas WT cells can tolerate 6AU up to a certain 
concentration, cells with mutations in transcription elongation factors react to the drug 
and either decrease or accelerate growth. This is because transcription elongation 
factors influence the transcription rate and the processivity of RNAP II either 
positively or negatively depending on the factor. For this reason, sensitivity of cells to 
6AU has been correlated with mutations in transcription elongation factors which 
influence transcription positively, whereas resistance to 6AU implies a repressive 
function of the respective transcription factor (Costa and Arndt, 2000; Nakanishi et 
al., 1995; Powell and Reines, 1996; Squazzo et al., 2002).  
We tested the WT, glc7-10, glc7-12, glc7-13 and glc7-5 strains for growth on medium 
containing different concentrations of 6AU (0, 10, 25, 50 and 100µg/ml) to see how 
strongly the mutants react to the drug (Fig. 4.1). In addition to growth at RT, cells 
were also incubated at semi-permissive and non-permissive temperatures. Because 
uracil in the growth medium can rescue the growth defects caused by 6AU, we grew 
the cells on synthetic medium lacking uracil. Growth defects become readily visible at 
higher dilutions, thus serial dilutions of cells spotted with highest concentrations on 
the left hand side of each column are depicted. 
Significant effects of 6AU on growth of all the mutants tested compared to the WT 
could be seen even at RT. glc7-10 and glc7-12 are resistant to 6AU, which becomes 
most apparent at high concentrations of the drug (50 and 100 µg/ml). In contrast, 
glc7-13 and glc7-5 are sensitive to 6AU, which is evident at 6AU concentrations of 
25 µg/ml and higher. These effects become even more obvious at 30º C, the semi-
permissive temperature for glc7-12, glc7-13 and glc7-5 and at 33º C, the semi-
permissive temperature for glc7-10. Because 33º C is the restrictive temperature for 
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glc7-12, glc7-13 and glc7-5, only glc7-10 was analyzed at higher temperatures. At 37º 
C, 6AU even rescues growth of glc7-10 which is unable to grow at this temperature 
without 6AU in this range of dilutions (a 10 fold higher concentration of cells is able 
to grow at this temperature, results not shown).  
In conclusion, we observe very strong effects of 6AU on the growth of all glc7 
mutants tested, suggesting an involvement of Glc7p in the regulation of transcription 
elongation. Our observation that distinct alleles are either sensitive or resistant to 6AU 
and therefore most likely influence transcription by RNAP II positively or negatively, 
lets us propose that Glc7p might regulate transcription elongation at several different 
steps.  
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4.3.3 Transcription of Pur5 is not altered by 6AU in glc7 mutant strains  
To further confirm that Glc7p is involved in transcription elongation as suggested by 
the growth effects caused by 6AU, we decided to test the induction of PUR5. In 
response to the application of IMPDH inhibitors such as 6AU, WT yeast strains 
induce transcription of PUR5, one of four genes encoding IMPDH-related enzymes 
(Shaw and Reines, 2000). Mutations that cause transcription elongation defects and 
6AU sensitivity also prevent the induction of PUR5 transcription in response to 6AU 
treatment. Thus, a 6AU-sensitive phenotype coupled with the inability to induce 
PUR5 in response to 6AU is suggestive of a defect in transcription elongation (Shaw 
and Reines, 2000).  
We investigated the induction of PUR5 before and after 6AU treatment by Northern 
analysis. To this end, we collected total RNA from WT, glc7-10, glc7-12, glc7-13 and 
glc7-5 after one or two hours of 6AU treatment. As a control, total RNA was also 
collected without 6AU treatment.  
As expected, WT cells showed a strong induction of PUR5 after treatment with 6AU 
(Howard et al., 2003; Shaw and Reines, 2000; Squazzo et al., 2002; Fig. 4.2). In 
contrast, induction of PUR5 was greatly attenuated in glc7-10 and glc7-12 cells and 
also to a lesser degree in glc7-13, indicating that the elongation machinery was 
impaired. This result, together with the 6AU phenotype, strongly suggests a function 
for Glc7p in transcription elongation. 
One of the glc7 mutants, glc7-5, was able to induce WT levels of PUR5 although 
growth of glc7-5 is very sensitive to 6AU. Interestingly, it was found that mutations in 
Spt4 and Spt5, which are well known transcription elongation factors, were able to 
induce PUR5 to levels that approached those seen in WT cells, although these mutants 
were sensitive to 6AU (Howard et al., 2003). This suggested the existence of two 
general classes of drug-sensitive elongation mutants: those that are defective in PUR5 
induction and those that are not. In conclusion, glc7-5 might belong to the latter class 
and therefore does not challenge the observations with the other glc7 mutants.  
Altogether, our results support the idea that Glc7p is involved in transcription 
elongation. Furthermore, these data suggest that not only mutants sensitive to 6AU 
exhibit reduced induction of PUR5, but also mutants that are insensitive to 6AU. The 
reason for this remains to be uncovered. 
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Figure 4.2. Induction of PUR5 is affected in glc7 mutant strains 
Northern analysis of 20µg total RNA extracted from WT, glc7-10, glc7-12, glc7-13 and glc7-5 cells 
following growth in synthetic medium (SD-ura; 0,67% yeast nitrogen base, 2% glucose, 1x complete 
drop out mix lacking uracil) with (+) or without (-) addition of 6AU (50µg/ml) at 30º C for the 
indicated times. 18S serves as loading control.  
 
 
4.3.4 Glc7p genetically interacts with transcription elongation factors 
To better understand the role of Glc7p in the process of transcription elongation, we 
decided to look for functional interactions of Glc7p with transcription elongation 
factors in vivo. For this, we generated a set of double mutants containing a glc7 
mutation and a deletion of either of the transcription elongation factors Spt4p, Rtf1p 
or Leo1p.  
 
4.3.4.1 Genetic interactions with Spt4p 
Spt4p is found together with Spt5p in a single, highly conserved complex, the Spt4/5 
complex (Hartzog et al., 1998). The human homologue of the Spt4/5 complex is DSIF 
(Wada et al., 1998a). One of the most interesting features of DSIF is that it appears to 
act as both a negative and positive regulator of RNAP II elongation (Renner et al., 
2001; Rondon et al., 2003; Yamaguchi et al., 1999). Since we found two different 
growth responses to 6AU when testing distinct glc7 mutant alleles, we suspected that 
Glc7p also can regulate transcription elongation both positively and negatively. In 
addition, in vitro studies indicate that DSIF increases the pausing of RNAP II (Renner 
et al., 2001; Yamaguchi et al., 1999). Our observations that glc7-12 decreases pausing 
 96 
at the poly(A) site suggest that Glc7p could function similar to DSIF in this respect. 
Thus, the Spt4/5 complex seemed a likely interaction partner for Glc7p. 
We found that both strains were sensitive to 6AU, however to varying degrees. spt4Δ 
was very sensitive to 6AU even at RT, whereas glc7-13 only showed a slight 
sensitivity to 6AU in this experiment. When we crossed a spt4 deletion strain with the 
glc7-13 mutant strain, the strong sensitivity of spt4Δ to 6AU could be partially 
rescued in the double mutant spt4 Δ /glc7-13 at RT and 30º C as indicated by the 
better growth of the double mutant compared to the single spt4Δ mutant (Fig. 4.4 a). 
This result suggests an interaction between these genes. However, growth was not 
rescued at higher temperatures, indicating that rescuing defects in transcription 
elongation might not be enough to restore growth since Glc7p is involved in many 
other processes.  
In the presence of 6AU growth of glc7-10 was enhanced compared to the WT. The 
glc7-10 allele was even able to suppress the 6AU sensitivity of spt4Δ at RT, 30º C and 
33° C in the glc7-10/spt4Δ double mutant (Fig. 4.4 b). However, suppression of the 
spt4Δ growth defect on 6AU was more reduced when the temperature conditions for 
glc7-10 became more stringent. Complete loss of growth was observed at 36º C, a 
temperature that still allowed growth of glc7-10. Therefore, deletion of spt4 in glc7-
10 strains is lethal under conditions that normally support growth of glc7-10, again 
indicating genetic interactions between Spt4p and Glc7p. 
Taken together, we observed opposite effects concerning growth in spt4Δ/glc7 double 
mutants, depending on the growth behavior of the single glc7 mutant on 6AU: the 
6AU sensitive glc7-13 allele improved growth of the double mutant, whereas the 6AU 
resistant glc-10 allele did not.  In other words, glc7-13 partially suppressed the growth 
defect of spt4, whereas spt4 suppressed growth of glc7-10. 
Therefore, we conclude that Glc7p genetically interacts with the Spt4/5 complex. 
These observations strongly suggest an in vivo role for Glc7p in transcription 
elongation. 
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Figure 4.3. Genetic interactions of Glc7 with Spt4 revealed by growth on 6AU. 
WT, glc7-10, glc7-13 and spt4Δ strains were transformed with pRS416 (URA3-CEN). Ten-fold serial 
dilutions of these strains grown at RT in synthetic medium (SD-ura; 0,67% yeast nitrogen base, 2% 
glucose, 1x complete drop out mix lacking uracil) were spotted on the same medium (plus 2% agar) 
with or without 6AU. The time of growth was 3 days for all panels at the respective temperatures 
indicated on the right. A) Summary of interactions between glc7-13 and spt4Δ. B) Summary of 
interactions between glc7-10 and spt4Δ. C) Complete experiment showing growth of strains indicated 
on the left also on synthetic medium without 6AU. 
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4.3.4.2 The phosphorylation state of Spt5 is not regulated by Glc7p 
Spt5p is a phosphoprotein (Ivanov et al., 2000). Regulation of the phosphorylation 
state of Spt5p is important for progression of the transcription cycle. It was shown 
that DSIF binds to RNAP II and effectively blocks transcription elongation in early 
stages of transcription (Wada et al., 1998a). This block is relieved by P-TEFb, the 
human homologue of the yeast CTD kinase Ctk1p. P-TEFb phosphorylates both the 
CTD and Spt5 (Ivanov et al., 2000; Kim and Sharp, 2001; Wada et al., 1998b). 
Following the pTEFb-mediated phosphorylation DSIF remains associated with the 
elongating polymerase and can apparently stimulate the elongation process (Ping and 
Rana, 2001).  
The genetic interactions we found between Glc7p and Spt4p could indicate that Glc7p 
might interfere with transcription elongation by regulating the phosphorylation state 
of Spt5p. To this end, we generated constructs with a ProteinA-tag at the C-terminus 
of Spt5p in WT, glc7-12 and glc7-13 mutant strains. This allowed us to affinity-purify 
Spt5p from these strains and subsequently investigate phosphorylation of Spt5p by 
Western analysis with antibodies directed against phospho-serine and threonine. The 
results showed no difference in the phosphorylation state of Spt5p between WT and 
the glc7 mutant strains after shift to the non-permissive temperature (B. Paguet, data 
not shown) indicating that Glc7p does not dephosphorylate Spt5p. 
In conclusion, Spt5 does not seem to be the target of Glc7p in transcription elongation 
and therefore Glc7p does not regulate pausing of RNAP II early in transcription. 
Nevertheless, the genetic interactions of Glc7p with Spt4 suggest that Glc7p could 
influence transcription elongation through elongation factors that associate with the 
Spt4/5 complex. 
 
4.3.4.3 Genetic interactions with subunits of the PAF1 complex 
Previous studies have shown that the Spt4-Spt5 complex co-immunopurifies and 
genetically interacts with the Paf1 complex (Mueller and Jaehning, 2002; Squazzo et 
al., 2002). The Paf1 complex consists of the subunits Paf1p, Ctr9p, Cdc73p, Rtf1p 
and Leo1p (Betz et al., 2002; Squazzo et al., 2002). It has been shown that mutations 
in Paf1p and Leo1p can suppress a cold-sensitive spt5 mutation (Squazzo et al., 2002) 
and a deletion of Rtf1p showed a range of synthetic phenotypes when combined with 
mutations in spt4 and spt5 (Costa and Arndt, 2000). In addition, members of the Paf 
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complex exhibit 6AU sensitivity and diminished PUR5 induction (Squazzo et al., 
2002). Finally, ChiP experiments demonstrated that the Paf complex is associated 
with RNAP II at promoters and coding regions of transcriptionally active genes (Kim 
et al., 2004a; Penheiter et al., 2005). For all of these reasons, the Paf complex has 
been implicated in transcription elongation.  
To find out whether Glc7p also genetically interacts with the Paf1 complex, we 
crossed the glc7-10, glc7-12, glc7-13 and glc7-5 mutant strains to deletion mutants of 
Paf1p, Ctr9p, Leo1p and Rtf1p in all combinations. This approach led to the recovery 
of three viable double mutants: glc7-12/leo1Δ, glc7-10/rtf1Δ and glc7-13/rtf1Δ. We 
verified that these were indeed double mutants by Southern analysis and PCR analysis 
of the genomic regions.  
When testing the glc7-12/leoΔ double mutant for growth at various temperatures, we 
observed that temperature sensitivity of glc7-12 at 33º C is slightly suppressed by 
leo1Δ, indicating genetic interactions between these genes (Fig. 4.4 a). This 
suppression is strongly enhanced when glc7-12/leo1Δ is grown on medium containing 
6AU, demonstrating that this genetic interaction is important for the process of 
transcription elongation. Interestingly, the glc7-12/leo1Δ double mutant is not viable 
at higher temperatures. This might be due to the fact that Glc7p is involved in many 
cellular processes which are not rescued by this interaction. Consequently, leo1Δ is 
able to partially suppress the temperature sensitivity of the glc7-12 mutation. 
Nevertheless, we clearly see genetic interactions between glc7-12 and leo1Δ that are 
amplified by 6AU, strongly suggesting that Glc7p regulates an aspect of transcription 
elongation.  
An even more remarkable suppression of temperature-sensitivity is observed in the 
glc7-13/rtf1Δ double mutant. rtf1Δ fully suppresses lethality of glc7-13 at 33° C 
independently of 6AU, because the glc7-13/rtf1Δ double mutant grows equally well 
on medium with or without 6AU (Fig. 4.4 b). Again, suppression of temperature-
sensitivity is limited to 33º C and glc7-13/rtf1Δ is not able to grow at higher 
temperatures. Therefore, we think that Rtf1p genetically interacts with Glc7p as well. 
Considering the 6AU independence of the temperature-sensitivity suppression this 
interaction might indicate an involvement of these factors not only in transcription 
elongation but in additional processes.  
In contrast to the glc7-13/rtf1Δ and glc7-12/leo1Δ double mutant, the glc7-10/rtfΔ 
double mutant is not able to grow at the restrictive temperature for glc7-10 in the 
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presence of 6AU (Fig. 4.4 c). The single mutants rtf1Δ and glc7-10 show varying 
degrees of 6AU resistance at this temperature compared to the WT. However, these 
effects are not sufficient to rescue growth under these conditions, whereas on medium 
without 6AU the glc7-10/rtfΔ double mutant is viable.  
In summary, the described double mutants reveal genetic interactions between 
different glc7 mutant alleles and the transcription elongation factors Rtf1p and Leo1p 
and imply a regulatory function for Glc7p in the process of transcription elongation. 
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Figure 4.4.  
For detailed information see page 104 
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Figure 4.4. Genetic interactions of Glc7 with the Paf complex subunits Leo1 and Rtf1. 
WT, glc7-10, glc7-12, glc7-13, leo1Δ and rtf1Δ strains were transformed with pRS416 (URA3-CEN). 
Ten-fold serial dilutions of these strains grown at RT in synthetic medium (SD-ura; 0,67% yeast 
nitrogen base, 2% glucose, 1x complete drop out mix lacking uracil) were spotted on the same medium 
(plus 2% agar) with or without 6AU. The time of growth was 3 days for all panels at the respective 
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temperatures indicated on the right. A) Summary of interactions between glc7-12 and leo1Δ. B) 
Summary of interactions between glc7-13 and rtf1Δ. C) Summary of interactions between glc7-10 and 
rtf1Δ D) Complete experiment showing growth of strains glc7-12, leo1Δ and the double mutant strain 
glc7-12 x leo1Δ as indicated on the left for different temperatures as indicated on the right. E) 
Complete experiment showing growth of strains glc7-10, glc7-13, rtf1Δ and the double mutant strains 
glc7-10 x rtf1Δ and glc7-13 x rtf1Δ as indicated on the left for different temperatures as indicated on 
the right.  
 
 
 
4.3.5 Glc7 mutants are not inositol auxotroph 
Inositol auxotrophy is often indicative of defects in the transcription apparatus, 
presumably because the INO1 gene is extremely sensitive to transcriptional 
perturbations in general. An Ino- phenotype is often an important clue that a mutant is 
defective in a component of the RNAP II transcriptional machinery (Hampsey, 1997). 
Interestingly, the paf1Δ and ctr9Δ mutations exhibit strong Ino- phenotypes (Squazzo 
et al., 2002), indicating that the Paf1 complex is part of the RNAP II transcriptional 
machinery. However mutations in other members of the Paf1 complex, such as leo1Δ 
and rtf1Δ show only weak inositol auxotrophy.  
We therefore asked whether mutations in Glc7p have an Ino- phenotype, linking 
Glc7p more closely to the RNAP II transcriptional machinery and also to the Paf1 
complex. 
Inositol auxotrophy is scored on synthetic medium lacking inositol. It is important to 
establish that impaired growth in the absence of inositol is indeed a consequence of 
inositol limitation; this is done by scoring for the ability of exogenous inositol to 
rescue the Ino- phenotype (Hampsey, 1997). None of the glc7 mutant strains that we 
tested were auxotroph for inositol (Fig. 4.5), suggesting that Glc7p is probably not 
permanently attached to the RNAP II general transcriptional machinery. As a control 
we used the ctr9Δ mutant strain, which shows strong inositol auxotrophy. 
Interestingly, glc7-12 and glc7-5 mutant strains grew better on medium lacking 
inositol. The cause for this was not known. Subsequently, microarray analysis with 
the glc7-12 mutant strain revealed that expression of INO1 was upregulated. The 
reason for this upregulation is unclear, but a higher level of INO1 could account for 
the enhanced growth of at least the glc7-12 mutant on medium lacking inositol.  
Altogether, our genetic tests suggest that Glc7p might only transiently interact with 
the RNAP II transcriptional machinery where it interacts and regulates the Paf1 
complex.  
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Figure 4.5. Growth of glc7 mutants is not affected on medium lacking inositol. 
Ten-fold serial dilutions of the strains indicated on the left were grown at RT in YPD and spotted on 
synthetic medium without inositol or on control medium containing 10mg/l inositol. The time of 
growth was 3 days for all panels at RT, 30º C, 33º C or 37º C as indicated. ctr9Δ was used as a positive 
control.  
 
 
4.3.6 The snoRNA transcription termination defect of glc7 mutant cells is 
suppressed by transcription elongation factors 
Recently, there have been several reports indicating that transcription elongation 
factors can influence transcription termination (Kaplan et al., 2005; Penheiter et al., 
2005; Sheldon et al., 2005). First, an spt4Δ mutant strain showed reduced levels of 
read-through at the poly(A) site of Gal 10, indicating that Spt4 may act as an anti-
terminator (Kaplan et al., 2005). In addition, ChIP experiments have demonstrated 
that Paf1C is required for the efficient recruitment of Nrd1 to a snoRNA gene and that 
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deletion of all subunits of the Paf1 complex leads to the accumulation of 3’ extended 
snoRNA transcripts (Sheldon et al., 2005). Finally, it has been shown that there is an 
exchange of elongation factors for 3’ end processing factors at the 3’ end of genes and 
therefore a reorganization of the RNAP II holoenzyme in response to 3’ end 
formation signals during transcription termination has been proposed (Kaplan et al., 
2005; Kim et al., 2004a). 
Considering these data we asked whether the partial suppression of the ts phenotype 
of glc7-12 and glc7-13 mutant strains in the glc7-13/spt4Δ, glc7-13/rtf1Δ and glc7-
12/leo1Δ double mutants was due to the fact that deletion of these elongation factors 
would influence snoRNA transcription termination in the double mutant.   
To study snoRNA transcription termination in the double mutants we performed 
Northern analysis with the same probes that led to the finding of 3’ extended 
snoRNAs in the glc7 mutants (see Chapter 3). To this end, we extracted total RNA 
before and after shift to 33ºC from the double mutant strains and also from the WT 
and respective single mutant strains. We shifted the cells to 33º C in this experiment 
and not to 37º C because we found that suppression of the ts phenotype of glc7-12 and 
glc7-13 mutant strains was limited to 33º C. As shown in Fig. 4.6 a, read-through 
products are readily detected for glc7-12 and glc7-13 mutants also at 33º C, not only 
at 37º C. In glc7-10 mutants read-through products are also visible at 33º C, however 
to a very low degree. In contrast, we could not detect any read-through products for 
any of the elongation factor mutants spt4, leo1 or rtf1 in the Northern analysis with 
several probes. We also did not observe read-through products for spt4, leo1 or rtf1 
when cells were grown at 37ºC (results not shown).  
Strikingly, the read-through observed in the glc7 mutants was completely suppressed 
in the glc7-12/leoΔ and glc7-13/rtfΔ double mutants and in part in the double mutant 
glc7-13/spt4Δ, indicating that the snoRNA transcription termination defect of the 
single glc7 mutants is suppressed by deletion of the elongation factors Leo1p, Rtf1p 
and to some extent Spt4p in the double mutants. 
Accordingly, similar suppression effects were observed when we probed the double 
mutants with Nrd1 or Mrpl7, indicating that also in this case transcription termination 
was restored (Fig. 4.6 b). In addition, accumulation of the Nrd1 message itself, a 
phenotype characteristic of mutated factors of the Nrd1-dependent pathway of 
snoRNA transcription termination, is not observed in the double mutants glc7-
12/leo1Δ, glc7-13/rtf1Δ and glc7-10/rtf1Δ, suggesting that autoregulation of Nrd1 
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expression is restored as well. However, although the double mutant glc7-13/spt4Δ 
has significantly less read-through product compared to the glc7-13 mutant, it shows a 
strong accumulation of the Nrd1 message. This suggests that the read-through 
phenotype and the Nrd1 accumulation phenotype seem to be uncoupled in glc7-
13/spt4Δ. 
Altogether, we conclude that suppression of the snoRNA transcription termination 
defect in the double mutants could be one of the possible reasons why growth of glc7-
12 and glc7-13 is restored in the double mutants glc7-12/leoΔ and glc7-13/rtfΔ at 
33°C.  
Moreover, we propose that the Paf1 complex subunits Rtf1 and Leo1 and to a much 
lower degree Spt4 can act as anti-terminators in snoRNA transcription. This 
supplements recent results for Spt4 as an anti-terminator in the transcription of protein 
coding genes (Kaplan et al., 2005). However, our results are in conflict with data that 
showed that members of the Paf1 complex have a transcription termination defect of 
snoRNAs (Sheldon et al., 2005; see discussion).  
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Figure 4.6. Accumulation of snoRNA-mRNA and Nrd1-Mrpl17 tandem transcripts is suppressed 
in double mutants of Glc7 with transcription elongation factors. 
A) The drawing on top illustrates the genomic arrangement of the analysed genes and the relative 
direction of transcription. Northern analysis (panel I – III) of 20µg total RNA extracted from WT, glc7-
10, glc7-12, glc7-13, glc7-13 x rtf1Δ, glc7-12 x leo1Δ, glc7-10 x rtf1Δ, glc7-13 x spt4Δ, spt4Δ, rtf1Δ 
and leo1Δ cells following growth in YPD medium at 25º C or after shift to 33º C for the indicated 
times. Blots were probed against Asn1 (panel I), Trs31 (panel II) and 18S (panel III; loading control). 
Migration of RNAs is indicated on the left. B) The drawing on top illustrates the genomic arrangement 
of the NRD1-MRPL17 locus and the relative direction of transcription. Northern analysis (panel I – III) 
of 20µg total RNA extracted from strains indicated on top following growth in YPD medium at 25º C 
or after shift to 33º C for the indicated times. Blots were probed against Nrd1 (panel I), Mrpl17 (panel 
II) and 18S (panel III; loading control). Migration of RNAs is indicated on the left. 
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4.4 Discussion 
 
Transcription elongation is a highly regulated process. Several transcription 
elongation factors have been identified that either stimulate or inhibit this process. 
Here, we propose that also Glc7p, an essential protein phosphatase, is involved in the 
regulation of transcription elongation. First indications came from TRO experiments, 
which revealed that poly(A)-dependent pausing was enhanced in glc7-12 mutants. 
Further investigations indicated that the glc7-13 and glc7-5 mutant strains were 
sensitive to 6AU, which is diagnostic of defects in transcription elongation. 
Interestingly, we also observed a strong resistance to 6AU for the glc7-10 mutant 
strain. Furthermore, Glc7p genetically interacted with the elongation factors Spt4, 
Rtf1p and Leo1. Double mutants of Glc7p and these factors partially restored growth 
of Glc7p at semi-restrictive and restrictive temperatures. In addition, the snoRNA 
transcription termination defect, observed in glc7 mutant strains was suppressed in 
these double mutants. This suggests that Glc7p is in fact a transcription termination 
factor that could be involved in the coupling of transcription elongation and 
termination. 
 
What function could Glc7p have in transcription elongation? 
Poly(A)-dependent pausing is a phenomenon thought to facilitate transcription 
termination of pre-mRNAs (Orozco et al., 2002). From our observation that Glc7p 
promotes poly(A)-dependent pausing we would expect that Glc7p is also required for 
transcription termination of pre-mRNAs. However, we did not observe a defect in 
transcription termination of pre-mRNAs in glc7 mutant strains. Perhaps poly(A)-
dependent pausing can also be considered as a checkpoint that ensures that 3’ end 
processing takes place efficiently before RNAP II terminates transcription. This idea 
is supported by the observation that transcriptional pausing activates polyadenylation 
in a coupled in vitro transcription-polyadenylation system (Yonaha and Proudfoot, 
1999). Similarly, promoter-proximal pausing was shown to be an important 
checkpoint to confirm that capping at the 5’ end of the pre-mRNA has occurred 
before RNAP II is released from this pause site. The phosphatase activity of Glc7p is 
required for proper polyadenylation of pre-mRNAs in vitro and in vivo (see Chapter 
2; (He and Moore, 2005). It is possible that the function of Glc7p to promote pausing 
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of RNAP II close to the poly(A) site is connected to its role in polyadenylation. 
Pausing could ensure that CPF was properly released from RNAP II and was able to 
attach to the poly(A) site. If pausing was blocked, CPF would only bind inefficiently 
to the poly(A) site resulting in a lack of polyadenylated mRNAs. 
One other possibility is that cleavage is reversible and commitment for 3’ end 
processing is only achieved after poly (A) tail formation has started. The poly(A)-
dependent pausing checkpoint would then only be released from RNAP II after 
polyadenylation had started. 
Chromatin represents a major block for RNAP II transcription and therefore has to be 
remodeled during transcription elongation (Sims et al., 2004a). Histone methylation at 
specific lysines appears to play a role in establishing both short-and long-term 
transcriptional regulation (Sims et al., 2004a). Transcriptionally active domains in 
chromatin are typically associated with methylation at H3-K4, H3-K36 and H3-K79 
(Sims et al., 2003). These lysines are methylated by specific methyl transferases 
called Set1p and Set2p. The PAF complex has been shown to be required for the 
recruitment of Set1p and Set2p and also for correct H3-K4, H3-K36 and H3-K79 
methylation (Krogan et al., 2003a; Krogan et al., 2003b; Ng et al., 2003b; Wood et al., 
2003). In addition, the PAF subunit Rtf1p is specifically required for the recruitment 
of the H2B monoubiquitinylation enzyme and therefore for monoubiquitinylation of 
H2B (Wood et al., 2003). This reaction was shown to be a prerequisite for H3-K4 and 
H3-K79 methylation (Ng et al., 2003a; Wood et al., 2003). In conclusion, all actions 
of the PAF complex create a transcriptionally permissive chromatin structure. Glc7p 
is a factor that promotes transcription termination of snoRNAs (Chapter 3 and 4). The 
genetic interactions of Glc7p with Rtf1p that result in a suppression of the snoRNA 
transcription termination defect of Glc7p may represent antagonistic interactions: Rtf1 
promotes an “open” chromatin structure that facilitates transcription elongation but in 
contrast does not support transcription termination. Glc7p on the other hand could 
counteract Rtf1p by regulating the activity of Rtf1p such that chromatin assumes a 
transcriptionally repressed state. The repressed chromatin state could act as a barrier 
for RNAP II forcing it to terminate. Therefore, Glc7p might be involved in coupling 
transcription elongation to termination.  
The interactions we observed between Glc7p and Spt4p were subtle. This might 
indicate that Glc7p’s function in transcription elongation does not completely overlap 
with the one of Spt4p in the process. Thus, Glc7p could rather be a transcription 
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termination factor that influences the activity of elongation factors such as Spt4p in 
the termination region. Because the activity of Spt4p was shown to be important for 
transcription of long GC rich regions of protein coding genes, Spt4p might not be so 
essential for transcription of the rather short snoRNA genes. Therefore, the interaction 
of Glc7p with Spt4p could be very limited (see below). It was reported that spt4Δ 
mutant strains show reduced levels of read-through at the poly(A) site of Gal 10, 
which may reflect an important role for this factor in promoting transcriptional read-
through of cryptic or weak polyadenylation signals within coding regions (Kaplan et 
al., 2005). We observed that read-through of snoRNA terminators was reduced in a 
glc7/spt4Δ double mutant, indicating that Spt4p is required for promoting read-
through of snoRNA terminators as well. Recently, it has been reported that at least 
some snoRNA terminators are bipartite in sequence, one motif having similarity to 
sequences required for 3’ end processing of pre-mRNAs including the poly(A) site 
(Steinmetz et al., 2006). An interesting implication of this is that Spt4p could also 
promote read-through of these cryptic poly(A) sites in snoRNA terminators to prevent 
polyadenylation of snoRNAs.  
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5 Microarray analysis of glc7-12 
5.1 Summary 
The catalytic subunit of Saccharomyces cerevisiae type 1 protein phosphatase is 
encoded by the essential gene GLC7. Glc7p is regulating diverse cellular processes. 
We sought to identify new functions of Glc7p by a whole genome analysis using 
Affymetrix microarrays. To this end, we compared the expression profile of the 
temperature-sensitive glc7-12 yeast mutant and the WT strain at the non-permissive 
temperature of glc7-12. By this approach, we found that Glc7p regulates transcription 
of ribosomal protein and also Ribi genes, which encode factors required for ribosome 
biogenesis. In addition, comparison of the expression profiles gave us some first 
indications that Glc7p could be involved in snoRNA transcription termination. 
 
5.2 Introduction 
Protein phosphatase type 1 (PP1) is a serine/threonine-specific phosphatase that is 
encoded by the essential gene GLC7 in S. cerevisiae (Feng et al., 1991). Glc7p is 
involved in diverse cellular processes ranging from glycogen accumulation and 
carbohydrate metabolism to translation initiation, transcription, mitosis, meiosis and 
histone modifications (Stark, 1996). The GLC7 gene encodes the catalytic subunit of 
PP1. The catalytic activity of Glc7 is controlled by association with a range of 
regulatory or targeting subunits that influence its intracellular localization and 
substrate specificity. There is evidence that almost all Glc7p is present in complexes 
with such proteins (Bollen, 2001). Understanding the many cellular roles of Glc7p 
therefore requires the identification and characterization of all Glc7p regulators. In the 
past, a number of proteins that interact with and regulate Glc7p in specific processes 
have been identified by genetical and biochemical studies (Bollen, 2001; Stark, 1996). 
These proteins include Sds22p, Reg1p, Gac1p, Glc8 and Ypi1p (Garcia-Gimeno et al., 
2003; MacKelvie et al., 1995; Nigavekar et al., 2002; Tu and Carlson, 1995; Wu et 
al., 2001). Genome-wide approaches in yeast using the two-hybrid system and 
systematic analysis of protein complexes have implicated many other potential Glc7p 
interacting proteins (Gavin et al., 2006; Gavin et al., 2002; Ito et al., 2001; Ito et al., 
2000; Uetz et al., 2000). In most cases however, the interactions with Glc7p have not 
been confirmed by independent approaches. The two-hybrid studies and analyses of 
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protein complexes were concentrated on finding direct protein-protein interactions 
that could help to find new functions for Glc7p. We sought to explore novel cellular 
functions of Glc7p by a different approach. We applied microarray analysis to study 
the expression pattern of genes in cells that lack Glc7 phosphatase activity. We 
thereby compared which genes were differentially expressed in glc7-12, a 
temperature-sensitive Glc7 allele, at the restrictive temperature compared to the WT. 
The rationale behind these experiments was that specific changes in the expression 
pattern could allow to draw conclusion as to which cellular process might have caused 
these changes. Many signaling pathways communicate extracellular and intracellular 
conditions to the cell nucleus, ultimately leading to a transcriptional response. 
Signaling pathways are often regulated by phosphorylation and dephosphorylation of 
pathway components. Also transcription factors can be regulated by phosphorylation. 
Interfering with this regulation by loss of a phosphatase activity should alter the 
expression of target genes of these signaling cascades. The target genes can therefore 
reveal the signaling pathway which was interupted by loss of the phosphatase activity. 
Thus, alterations in the expression pattern could pinpoint at previously non-identified 
novel cellular functions and targets of Glc7p. Microarray analysis also has been 
applied by several laboratories to identify defects in snoRNA transcription 
termination (see Chapter 3; Ganem et al., 2003; Steinmetz et al., 2001). 
Our previous work with the glc7-12 allele indicated that Glc7p is required for 
snoRNA transcription termination (Chapter 3) and transcription elongation (Chapter 
4). Here, we show that microarray analysis of glc7-12 identified a new role for Glc7p 
in the regulation of ribosomal protein and Ribi gene transcription (Chapter 5 and 6). 
In addition, this microarray analysis was helpful to detect a snoRNA transcription 
termination defect in glc7 mutants (Chapter 3).  
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5.3 Results 
5.3.1 Experimental Design 
The aim of this large-scale microarray study was to identify genes that show 
differential expression in the mutant strain glc7-12 at  37º C compared to the WT. 
The restrictive temperature for the ts mutant strain glc7-12 is 37º C, so Glc7p will be 
non-functional at this temperature. This leads to changes in numerous cellular 
processes that are regulated by Glc7p and will ultimately also lead to changes in gene 
expression since stress is known to elicit a transcriptional stress response. Therefore, 
new functions for Glc7p could be revealed by looking at the specific stress response 
and that might give a clue to which cellular process it connects. Glc7p could in 
addition directly regulate transcription factors. Their misregulation then would be 
apparent in an altered gene expression. 
For this purpose High Density Oligonucleotide Microarrays (S98 GeneChips) from 
Affymetrix were used. The arrays contain approximately 6400 ORFs and the 
transcript levels of these can be measured simultaneously in one experiment. To this 
end, total RNA is extracted from cells which is converted to cDNA and amplified by 
PCR. Finally, cRNA is transcribed from the amplified cDNA. The cRNA is 
subsequently fragmented to ensure better hybridization to the probe sets on the 
microarray chip and labeled with a fluorophor to allow later detection. A probe set 
refers to 16 oligonucleotides present on the microarray that are complementary to the 
3’ UTRs of one given transcript.  
Because RNA degradation could cause data to be less reproducible and make it more 
difficult to detect low-abundance transcripts the RNA quality is tested before the use 
in the microarray experiment. 
For this, extracted total RNA is purified on RNeasy Columns and analyzed with the 
Agilent Bioanalyzer RNA Chip (see materials and methods). Figure 5.1 a shows a 
compilation of the RNA profiles obtained from the Bioanalyzer and demonstrates that 
our total RNA was of very high quality, indicated by the two sharp peaks which 
represent 28S and 18S rRNA. A broad peak or additional peaks would denote RNA 
degradation. The data of the Bioanalyzer were also processed and displayed as a 
virtual gel (Fig. 5.1 b). Again, sharp bands indicated that there was no degradation of 
the RNA.  
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In addition, cRNA target molecule preparations had to be tested with the Agilent 
Bioanalyzer RNA Chip (Fig. 5.1 c). Ideally, the cRNA preparation should reflect the 
average size of the messenger RNAs with around 1500 to 2000 nucleotides on 
average. The computed virtual gel shows that target cRNA was successfully generated 
with a high concentration and on expected average size (Fig. 5.1 d). In conclusion, 
total RNA and cRNA preparations made from all strains and conditions were of 
premium quality. 
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Figure 5.1. Total RNA and cRNA target quality assessment  
Purified total RNA from (1) WT at RT; (2) WT at RT, replicate; (3) WT at 37º C; (4) WT at 37º C, 
replicate; (5) glc7-12 at RT; glc7-12 at RT, replicate; glc7-12 at 37º C; and glc7-12 at 37º C, replicate 
cells were analyzed for their concentration and overall length by using the Agilent Bioanalyzer RNA 
Chip. Fluorescence intensities measured with total RNA and cRNA target molecules are plotted against 
migration time in seconds as indicated in A) for total RNA and C) for cRNA. The peaks corresponding 
to the molecular weight RNA ladder are displayed (M). Virtual gels of the total RNA and cRNA 
samples as indicated are shown in B) and D), respectively. M, molecular weight markers. 
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5.3.2 Identification of differentially expressed transcripts in glc7-12 versus WT cells 
To identify genes that were differentially expressed in the mutant strain glc7-12 
versus the WT we had to investigate four different conditions, namely both WT and 
glc7-12 at RT and after shift to 37º C for 45 minutes (WT at RT, WT at 37º C, glc7-
12 at RT, glc7-12 at 37º C).  
Each condition is represented by one microarray experiment. To ensure 
reproducibility and therefore a high significance of the results, we performed each 
microarray experiment in duplicate. By comparing the outcomes of these eight 
experiments we could extract those genes that differed in transcript levels between RT 
and 37ºC and that clearly differed at 37ºC between the WT and glc7-12 mutant to 
exclude mere temperature effects. To filter for these genes we applied a p-value of < 
0.001. This means that the probability that the results observed could have occurred 
by chance is less than 1‰. With these criteria we found 826 genes to be differentially 
expressed of which 417 were upregulated and 409 were downregulated (Christa 
Wiederkehr, personal communication). 
Before gene filtering, the data had to be preprocessed to enable comparison of data 
obtained from different microarray chips. Preprocessing includes background 
correction, normalization, calculation of the expression measure and a quality control. 
Normalization is a process to reduce the variation of non-biological origin across 
arrays. Non-biological variations include variation introduced during sample 
preparation, manufacturing and processing of the arrays (labeling, hybridization and 
scanning). One way to demonstrate differences in the distribution of intensities 
between distinct microarray experiments can be done by a Box plot. A Box plot 
visualizes the need to normalize the data of different experiments. When we analyzed 
our unnormalized data in a Box plot, we observed very little alteration between the 
different microarrays, indicating that non-biological variations were reduced to a 
minimum (Fig. 5.2 a; Christa Wiederkehr, personal communication).  
Another test to analyze whether expression levels differ within replicates is the Scatter 
blot. For both the WT and glc7-12 at RT and 37º C the scatter plot matrix indicated 
that the duplicates were highly reproducible (Fig. 5.2 b; Christa Wiederkehr, personal 
communication). 
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Figure 5.2. Comparing gene expression levels of probes sets within replicates and different 
strains.  
Box plots in A) display the overall distribution of observed changes in signal intensities obtained from 
(1) WT at RT; (2) WT at RT, replicate; (3) WT at 37º C; (4) WT at 37º C, replicate; (5) glc7-12 at RT; 
glc7-12 at RT, replicate; glc7-12 at 37º C; and glc7-12 at 37º C, replicate cells. Shown are the absolute 
log2 fold change values. The features of clear outliers were manually inspected on the corresponding 
DAT image file to exclude artifacts. The scatter plot matrix in B) summarizes a systematic comparison 
of the log2-scaled expression signals from transcripts among all samples as indicated.  
 
 
5.3.3 Clustering gene expression profiles 
In order to obtain a better understanding of functional classes of the genes we 
identified, the two groups of upregulated or downregulated genes were further 
subdivided into three groups each, such that the 826 genes were finally grouped into 6 
clusters (Fig. 5.3; Christa Wiederkehr, personal communication). This way, genes in 
one cluster are more closely related to each other than to genes of a different cluster. 
Consequently, clustering can divide genes into functional classes on the basis of their 
expression pattern. 
In addition, we used the FatiGo Gene Ontology tool to analyze our data. With the help 
of this program the genes of each Cluster are assigned to groups according to their 
biological processes, molecular functions or as part of a cellular component. 
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Figure 5.3. Typical expression pattern of genes in the six clusters 
Numbers in graph indicate the respective cluster. Strains and conditions used as indicated below the 
graph.  
 
 
5.3.4 Microarray results 
5.3.4.1 Cluster 1 
Cluster 1 contains 159 ORFs with downregulated expression in glc7-12 mutant strains 
(see Table 5.1). From the 159 ORFs 22 are uncharacterized ORFs and 3 are not 
annotated yet. 
Interestingly, this cluster contains 25 genes of the Ribi regulon (PRS3, URA7, URA1, 
AAH1, URK1, DBP8, YBR267W, NOG1, PRP43, ARX1, NOC4, PNO1, KRR1, 
UTP15, NOC3, NSA1, DIM1, DBP6, RPB8, RPC34, RPA49, MES1, WRS1, 
TRM82, GCD10) equal to 44% of all Ribi genes detected in our microarray analysis. 
The Ribi regulon consists of 236 genes that have functions in ribosome biogenesis 
(Jorgensen et al., 2004). Other Ribi genes were found in Cluster 4 and 6 (for more 
information see also Chapter 6). 
We also found three ribosomal protein (RP) genes (RPL8A, RPS26A, RPL21B) in 
cluster 1. In addition a large amount of RP genes are found in cluster 4. It is likely that 
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cluster 1 and 4 are regulated in part by the same set of transcription factors (see 
Cluster 4). 
 
Table 5.1 
 
no. systematic 
name 
gene 
name 
description 
1 YLR295C ATP14 ATP synthase subunit h 
2 YLR292C SEC72 protein involved in membrane protein insertion into the ER 
3 YLR172C DPH5 diphthamide biosynthesis 
4 YLR179C  Hypothetical ORF 
5 YLR154C RNH203 Ribonuclease H2 subunit 
6 YLR056W ERG3 C-5 sterol desaturase 
7 YLR063W  Hypothetical ORF 
8 YLR073C  Hypothetical ORF 
9 YLR002C NOC3 Protein that forms a nuclear complex with Noc2p that binds to 
66S ribosomal precursors to mediate their intranuclear 
transport; also binds to chromatin to promote the association 
of DNA replication factors and replication initiation 
10 YLR008C PAM18 Constituent of the mitochondrial import motor associated with 
the presequence translocase, along with Ssc1p, Tim44p, 
Mge1p, and Pam16p; stimulates the ATPase activity of Ssc1p 
to drive mitochondrial import; contains a J domain; DnaJ-like 
protein, cochaperone 
11 YKR039W GAP1 general amino acid permease 
12 YKL029C MAE1 malic enzyme 
13 YKL128C PMU1 phosphomutase homolog 
14 YKL165C MCD4 Required for GPI anchor synthesis 
15 YKL216W URA1 dihydroorotate dehydrogenase 
16 YKL214C YRA2 Yeast RNA Annealing protein 
17 YJR112W NNF1 Spindle pole protein, required for accurate chromosome 
segregation 
18 YJR057W CDC8 thymidylate kinase 
19 YJR024C  Hypothetical ORF 
20 YJR003C  Hypothetical ORF 
21 YJL069C  U3 snoRNP protein|U3 snoRNA associated protein 
22 YJL061W NUP82 82 kDa protein, with putative coiled-coil domain, has  
carboxy-terminal domain, containing heptad repeats,  
that binds Nsp1p|nuclear pore complex subunit|nucleoporin 
23 YJL081C ARP4 54.8 kDa protein|actin related protein 
24 YJL131C  Hypothetical ORF 
25 YJL186W MNN5 golgi alpha-1,2-mannosyltransferase (putative) 
26 YJL181W  Hypothetical ORF 
27 YAL033W POP5 RNase MRP subunit (putative)|RNase P integral subunit 
28 YAL036C FUN11 Protein of unknown function, has similarity to Xenopus GTP-
binding protein DRG 
29 YIR026C YVH1 protein tyrosine phosphatase induced by nitrogen starvation 
30 YIL020C HIS6 phosphoribosyl-5-amino-1-phosphoribosyl-4-
imidazolecarboxiamide isomerase 
31 YIL016W SNL1 18.3 kDa integral membrane protein 
32 YIL044C AGE2 ARF GAP with effector function(s) 
33 YIL094C LYS12 homo-isocitrate dehydrogenase 
34 YHR197W RIX1 RIbosome eXport 
35 YHR179W OYE2 NAPDH dehydrogenase (old yellow enzyme), isoform 2 
36 YHR154W RTT107 Regulator of Ty1 Transposition; Establishes Silent Chromatin 
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37 YHR163W SOL3 weak multicopy suppressor of los1-1 
38 YHR169W DBP8 dead box protein 
39 YHR149C SKG6 Hypothetical ORF, found in the bud tip and bud neck, 
potential Cdc28p substrate; Skg6p interacts with Zds1p and 
Zds2p 
40 YHR098C SFB3 similar to SEC24 
41 YHR085W IPI1 Involved in Processing ITS2 
42 YHR049W FSH1 Serine hydrolase that localizes to both the nucleus and 
cytoplasm; sequence is similar to Fsh2p and Fsh3p 
43 YHR031C RRM3 DNA helicase 
44 YHR007C ERG11 cytochrome P450 lanosterol 14a-demethylase 
45 YHR013C ARD1 N alpha-acetyltransferase major subunit|complexes with 
Nat1p 
46 YHL011C PRS3 ribose-phosphate pyrophosphokinase 
47 YHL033C RPL8A ribosomal protein L8A (rp6) (YL5) (L4A) 
48 YGR264C MES1 methionine-tRNA ligase 
49 YGR234W YHB1 flavohemoglobin 
50 YGR147C NAT2 N alpha-acetyltransferase 
51 YGR128C UTP8 U3 snoRNP protein 
52 YGR090W UTP22 U3 protein 
53 YGR060W ERG25 C-4 sterol methyl oxidase 
54 YGR049W SCM4 Protein that suppresses ts allele of CDC4 when overexpressed 
55 YGR017W  Hypothetical ORF 
56 YGL027C CWH41 glucosidase I 
57 YGL120C PRP43 RNA helicase 
58 YGL111W NSA1 ribosome biogenesis 
59 YGL189C RPS26A ribosomal protein S26A 
0 YGL200C EMP24 type I transmembrane protein 
61 YGL246C RAI1 Product of gene unknown 
62 YFL017C GNA1 glucosamine-phosphate N-acetyltransferase 
63 YFL026W STE2 alpha-factor pheromone receptor|seven-transmembrane 
domain protein 
64 NC-001137 NA NA 
65 YER166W DNF1 Potential aminophospholipid translocase 
66 YER072W VTC1 S. pombe Nrf1p homolog (97% identical in predicted amino 
acid sequence) 
67 YER019C-A SBH2 Sbh1p homolog 
68 YDR465C RMT2 arginine methyltransferase 
69 YDR400W URH1 uridine nucleosidase (uridine ribohydrolase); EC 3.2.2.3 
70 YDR395W SXM1 karyopherin beta family member 
71 YDR368W YPR1 homologous to the aldo-keto reductase protein family 
72 YDR345C HXT3 low affinity glucose transporter 
73 YDR352W  Hypothetical ORF 
74 YDR292C SRP101 signal recognition particle receptor - alpha subunit 
75 YDR257C RMS1 Transcription regulator 
76 YDR226W ADK1 adenylate kinase 
77 YDR165W TRM82 Transfer RNA methyltransferase 
78 YDR101C ARX1 Shuttling pre-60S factor; involved in the biogenesis of 
ribosomal large subunit biogenesis; interacts directly with 
Alb1; responsible for Tif6 recycling defects in absence of 
Rei1; associated with the ribosomal export complex 
79 YDR056C  Hypothetical ORF 
80 YDL063C  Hypothetical ORF 
81 YDL095W PMT1 dolichyl phosphate-D-mannose:protein O-D-
mannosyltransferase 
82 YDL167C NRP1 Protein of unknown function, rich in asparagine residues 
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83 YDL236W PHO13 p-nitrophenyl phosphatase 
84 YCR087C-A LUG1 Hypothetical ORF 
85 YCL025C AGP1 amino acid permease 
86 YCL059C KRR1 Involved in cell division and spore germination 
87 YBR267W REI1 Cytoplasmic pre-60S factor; required for the correct recycling 
of shuttling factors Alb1, Arx1 and Tif6 at the end of the 
ribosomal large subunit biogenesis; involved in bud growth in 
the mitotic signaling network 
88 YBR261C  Putative S-adenosylmethionine-dependent methyltransferase 
of the seven beta-strand family 
89 YBR229C ROT2 glucosidase II 
90 YBR205W KTR3 alpha-1,2-mannosyltransferase (putative) 
91 YBR205W KTR3 alpha-1,2-mannosyltransferase (putative) 
92 YBR206W NA NA 
93 YBR106W PHO88 May be a membrane protein involved in inorganic phosphate  
transport and regulation of Pho81p function 
94 YBR085W AAC3 ADP/ATP translocator 
95 YBR092C PHO3 acid phosphatase 
96 YBR017C KAP104 karyopherin beta 2 
97 YBL039C URA7 CTP synthase 
98 YBL035C POL12 DNA polymerase alpha-primase complex B subunit 
99 YBL057C PTH2 peptidyl-tRNA hydrolase 
100 YBL081W  Hypothetical ORF 
101 YPR144C NOC4 U3 snoRNP protein 
102 YPR138C MEP3 NH4+ transporter 
103 YPR060C ARO7 chorismate mutase 
104 YPR062W FCY1 cytosine deaminase 
105 YPR036W VMA13 vacuolar H(+) ATPase V1 sector 54 kDa subunit 
106 YPL079W RPL21B ribosomal protein L21B 
107 YPL094C SEC62 ER protein translocation apparatus membrane component 
108 YPL093W NOG1 homologs identified in human and Trypanosoma 
brucei|nucleolar G-protein (putative) 
109 YPL103C FMP30 Hypothetical ORF 
110 YPL144W  Hypothetical ORF 
111 YPL207W TWY1 Hypothetical ORF 
112 YPL244C HUT1 similar to UDP-galactose transporter 
113 YPL266W DIM1 dimethyladenosine transferase 
114 YOR375C GDH1 NADP-specific glutamate dehydrogenase 
115 YOR307C SLY41 chloroplast phosphate transporter homolog 
116 YOR251C  catalyzes transfer of the sulfane atom of thiosulfate to 
cyanide to form sulfite and thiocyanate 
117 YOR212W STE4 G protein beta subunit|coupled to mating factor receptor 
118 YOR224C RPB8 16 kDa RNA polymerase subunit (common to polymerases I, 
II and III) 
119 YOR145C PNO1 Associated with Nob1 
120 YOR101W RAS1 ras homolog 
121 YOR112W  Hypothetical ORF 
122 YOR118W  Hypothetical ORF 
123 YOR039W CKB2 protein kinase CK2, beta' subunit 
124 YOL007C  Appears to be a structural component of the chitin synthase 3 
complex 
125 YOL022C CSI2 Protein required for cell viability 
126 YOL080C REX4 RNA EXonuclease; member of 3'->5' exonuclease family. See 
Moser et al. 1997 Nucleic acids Res. 25:5110-5118 
127 YOL097C WRS1 tryptophan-tRNA ligase 
128 YOL143C RIB4 6,7-dimethyl-8-ribityllumazine synthase (DMRL synthase) 
129 YOL136C PFK27 6-phosphofructo-2-kinase 
130 YNR046W TRM112 Subunit of an adoMet-dependent tRNA methyltransferase 
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(MTase) complex (Trm11p-Trm112p), required for the 
methylation of the guanosine nucleotide at position 10 
(m2G10) in tRNAs; putative zinc binding subunit of other 
MTase-related proteins  
131 YNR038W DBP6 RNA helicase (putative) 
132 YNR003C RPC34 RNA polymerase III (C) 34 kDa subunit 
133 YNR012W URK1 uridine kinase 
134 YNL026W SAM50 Essential component of the Sorting and Assembly Machinery 
(SAM or Tob complex) of the mitochondrial outer membrane, 
which binds precursors of beta-barrel proteins and facilitates 
their outer membrane insertion; homologous to bacterial 
Omp85  
135 YNL010W  Hypothetical ORF 
136 YNL049C SFB2 zinc finger protein (putative) 
137 YNL062C GCD10 RNA-binding protein|subunit of tRNA(1-methyladenosine)  
methyltransferase, along with Gcd14p 
138 YNL111C CYB5 cytochrome b5 
139 YNL102W POL1 DNA polymerase I alpha subunit p180 
140 YNL119W NCS2 Hypothetical ORF 
141 YNL145W MFA2 a-factor mating pheromone precursor 
142 YNL141W AAH1 adenine aminohydrolase (adenine deaminase) 
143 YNL182C IPI3 Protein required for cell viability; computational analysis of 
large-scale protein-protein interaction data suggests a 
possible role in assembly of the ribosomal large subunit; 
Involved in Processing ITS2 
144 YNL248C RPA49 RNA polymerase A 49 kDa alpha subunit 
145 YNL246W VPS75 Protein of unknown function involved in vacuolar protein 
sorting; detected in the nucleus 
146 YNL289W PCL1 G1 cyclin|associates with PHO85 
147 YNL316C PHA2 prephenate dehydratase 
148 SNR76 NA NA 
149 YNL333W SNZ2 Snooze: stationary phase-induced gene family 
150 YNL323W LEM3 membrane glycoprotein 
151 YMR316C-B NA NA 
152 YMR127C SAS2 zinc finger protein 
153 YMR093W UTP15 U3 snoRNP protein 
154 YML060W OGG1 43 kDa 8-oxo-guanine DNA glycosylase 
155 YML104C MDM1 intermediate filament protein 
156 YML125C PGA3 Essential protein required for maturation of Gas1p and Pho8p, 
protein trafficking; GFP-fusion protein localizes to the 
endoplasmic reticulum; null mutants have a cell separation 
defect  
157 YLR412W  Hypothetical ORF 
158 YLR420W URA4 dihydrooratase 
159 YLR351C NIT3 Nit protein, nitrilase superfamily member 
 
 
 
5.3.4.2 Cluster 2 
Cluster 2 contains 121 ORFs where expression is upregulated in glc7-12 mutant 
strains (Table 5.2). Out of the 121 ORFs 27 are uncharacterized and 10 are not 
annotated yet.  
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Two interesting genes in this cluster are TPK2 and MKK1. TPK2 is one of three 
redundant catalytic subunits of cAMP-dependent protein kinase PKA (Toda et al., 
1987b). We have seen mislocalization of TPK1, the other of the catalytic subunits, in 
glc7-13 mutant cells (see Chapter 6). The cells might therefore try to counteract this 
process by producing more TPK2 to abide the function of PKA in the control of RP 
gene transcription.  
MKK1 encodes the MAP kinase kinase (MEK). Signaling through the MAP kinase 
pathway also contributes to the regulation of RP gene transcription. Thus, both genes 
are involved in signaling cascades that can influence the transcription of RP genes. 
 
 
Table 5.2 
 
no. systematic 
name 
gene 
name 
description 
1 YLR312C  Hypothetical ORF 
2 YLR054C OSW2 Protein of unknown function proposed to be involved in the 
assembly of the spore wall  
3 YLR031W  Hypothetical ORF 
4 YLL026W HSP104 heat shock protein 104 
5 YKR098C UBP11 ubiquitin-specific protease 
6 YKL091C SFH1 Putative homolog of Sec14p, which is a 
phosphatidylinositol/phosphatidylcholine transfer protein involved 
in lipid metabolism; localizes to the nucleus  
7 YKL121W  Hypothetical ORF 
8 YKL151C  Hypothetical ORF 
9 YKL142W MRP8 ribosomal protein 
10 NC-001142 NA NA 
11 YJR096W  Protein with similarity to aldo-keto reductases 
12 YJL017W NA NA 
13 YJL082W IML2 Similar to Ykr018p 
14 YJL144W  Hypothetical ORF 
15 YJL126W NIT2 Nit protein, nitrilase superfamily member 
16 YJL149W  Hypothetical ORF; has similarity to F-box proteins 
17 YJL221C FSP2 similar to maltase (alpha-D-glucosidase) 
18 YAL028W FRT2 Tail-anchored endoplasmic reticulum membrane protein, interacts 
with homolog Frt1p but is not a substrate of calcineurin (unlike 
Frt1p), promotes growth in conditions of high Na+, alkaline pH, or 
cell wall stress; potential Cdc28p substrate    
19 YAL061W  putative polyol dehydrogenase 
20 YBLWTAU1 NA,long 
terminal 
repeat 
NA, Ty4 LTR 
21 YLRWDELTA15 NA, long 
terminal 
repeat 
NA ,Ty1 LTR 
22 YIL045W PIG2 30% identity to YER054C/GIP2 
23 YIL117C PRM5 pheromone-regulated membrane protein 
24 YIL099W SGA1 glucoamylase 
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25 YIL097W FYV10 Function required for Yeast Viability on toxin exposure 
26 YIL136W OM45 45 kDa mitochondrial outer membrane protein 
27 YIL153W RRD1 Resistant to Rapamycin Deletion 
28 YIL152W  Hypothetical ORF 
29 YHR161C YAP1801 Yeast Assembly Polypeptide, member of AP180 protein family, 
binds Pan1p and clathrin 
30 YHR087W  Protein involved in RNA metabolism, one of two yeast homologs 
(with Sdo1p/Ylr022cp) of the human protein SBDS responsible for 
autosomal recessive Shwachman-Bodian-Diamond Syndrome, also 
conserved in Archaea  
31 YHR096C HXT5 hexose transporter 
32 YHR009C  Hypothetical ORF 
33 NC-001139 NA NA 
34 YGR142W BTN2 Gene/protein whose expression is elevated in a btn1 minus/Btn1p 
lacking yeast strain. 
35 YGR146C  Hypothetical ORF 
36 YGR161C RTS3 Hypothetical ORF, Putative component of the protein phosphatase 
type 2A complex 
37 YGR127W  Hypothetical ORF 
38 YGR138C TPO2 Polyamine transport protein 
39 YGR043C  Hypothetical ORF 
40 YGL153W PEX14 Peroxisomal peripheral membrane protein (peroxin) involved in 
import of peroxisomal matrix proteins 
41 YGL158W RCK1 Serine/threonine protein kinase 
42 YGL156W AMS1 alpha mannosidase 
43 YGL248W PDE1 3',5'-cyclic-nucleotide phosphodiesterase, low affinity 
44 YFR017C  Hypothetical ORF 
45 YFL014W HSP12 heat shock protein 12 
46 YER103W SSA4 HSP70 family 
47 YER101C AST2 Protein involved in targeting of plasma membrane [H+]ATPase 
48 YER079W  Hypothetical ORF 
49 YER035W EDC2 Enhancer of mRNA Decapping 
50 YER015W FAA2 acyl-CoA synthetase (fatty acid activator 2) 
51 YDR479C PEX29 peroxin 
52 YDR425W SNX41 sorting nexins Snx4p, Snx41p, and Snx42p mediate distinct  
retrieval pathways from endosomes. 
53 YDR436W PPZ2 serine-threonine phosphatase Z 
54 YDR171W HSP42 Similar to HSP26; expression is regulated by stress conditions 
55 YDR124W  Hypothetical ORF 
56 YDR069C DOA4 ubiquitin isopeptidase 
57 YDR074W TPS2 trehalose-6-phosphate phosphatase 
58 YDR043C NRG1 binds to UAS-1 in the STA1 promoter and can interact with 
Ssn6p|transcriptional repressor 
59 YDL085W NDE2 Mitochondrial external NADH dehydrogenase, catalyzes the 
oxidation of cytosolic NADH; Nde1p and Nde2p are involved in 
providing the cytosolic NADH to the mitochondrial respiratory 
chain  
60 YDL080C THI3 alpha-ketoisocaproate decarboxylase 
61 YDL134C PPH21 serine-threonine protein phosphatase 2A 
62 YDL169C UGX2 Product of gene unknown 
63 YDL233W  Hypothetical ORF 
64 YDL223C HBT1 Hub1 target 
65 YCL044C MGR1 Subunit, with Yme1p, of the mitochondrial inner membrane i-AAA 
protease complex, which is responsible for degradation of 
unfolded or misfolded mitochondrial gene products; required for 
growth of cells lacking the mitochondrial genome  
66 NC-001134 NA NA 
67 NC-001134 NA NA 
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68 YBR299W MAL32 maltase 
69 YBR214W SDS24 Similar to S. pombe SDS23, suppresses DIS2, localized to the 
nucleus 
70 YBR169C SSE2 HSP70 family|SSE1 homolog 
71 YBR182C SMP1 Second MEF2-like Protein 1Transcription factor of the MADS  
(Mcm1p, Agamous, Deficiens, SRF) box family; closely related to 
RLM1 
72 YBR148W YSW1 Spore-specific protein 
73 YBR149W ARA1 D-arabinose dehydrogenase 
74 YBR126C TPS1 trehalose-6-phosphate synthase/phosphatase complex 56 kDa 
synthase subunit 
75 YBR116C NA NA 
76 YBL064C PRX1 also called mTPx I, a mitochondrial isoform of thioredoxin  
peroxidase (EC 1.11.1.-) 
77 YBL101C ECM21 ExtraCellular Mutant 
78 NC-001148 NA NA 
79 YPR154W PIN3 [PSI+] induction 
80 YPR079W MRL1 Mannose 6-phosphate Receptor Like 
81 YPR026W ATH1 acid trehalase 
82 YPR030W CSR2 Nuclear protein with a potential regulatory role in utilization of 
galactose and nonfermentable carbon sources; overproduction 
suppresses the lethality at high temperature of a chs5 spa2 
double null mutation 
83 YPL166W ATG29 Hypothetical ORF, Protein specifically required for autophagy; may 
function in autophagosome formation at the pre-autophagosomal 
structure in collaboration with other autophagy proteins  
84 YPL156C PRM4 pheromone-regulated membrane protein 
85 YPL147W PXA1 ABC transporter of long-chain fatty acids 
86 YPL203W TPK2 cAMP-dependent protein kinase catalytic subunit 
87 YPL223C GRE1 Induced by osmotic stress 
88 YOR273C TPO4 Polyamine transport protein 
89 YOR275C RIM20 Protein involved in proteolytic activation of Rim101p in response 
to alkaline pH; member of the PalA/AIP1/Alix family; interacts 
with the ESCRT-III subunits Snf7p, suggesting a relationship 
between the response to pH and multivesicular body formation  
90 YOR231W MKK1 MAP kinase kinase (MEK) 
91 YOR227W  Hypothetical ORF 
92 YOR173W DCS2 Similar to mRNA decapping enzyme, HIT superfamily. 
93 YOR185C GSP2 GTP-binding protein|Gsp1p homolog 
94 YOR162C YRR1 transcription factor 
95 YOR106W VAM3 syntaxin family 
96 YOR057W SGT1 G2 allele of skp1 suppressor; subunit of SCF ubiquitin ligase  
complex; essential regulator of cell cycle; essential component of 
kinetochore assembly pathway. 
97 YOL117W RRI2 COP9 signalosome (CSN) subunit 
98 NC-001146 NA NA 
99 YOL153C  Hypothetical ORF 
100 YNR006W VPS27 cysteine rich putative zinc finger essential for function| 
hydrophilic protein 
101 YNR007C ATG3 Protein involved in autophagocytosis during starvation 
102 YNL194C  Integral membrane protein localized to eisosomes, large immobile 
protein structures at the cell cortex associated with endocytosis; 
sporulation and plasma membrane sphingolipid content are 
altered in mutants; has homologs SUR7 and FMP45  
103 YNL230C ELA1 elongin A transcription elongation factor 
104 YNL325C FIG4 Protein required for efficient mating, member of a family of  
eukaryotic proteins that contain a domain homologous to Sac1p 
105 YMR316W DIA1 may be involved in invasive growth, pseudohyphal growth 
106 YMR291W  Hypothetical ORF 
107 YMR196W  Hypothetical ORF 
108 YMR173W DDR48 contains >35 repeats of the amino acid sequence NNNDSYGS 
flocculent specific protein 
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109 YMR174C PAI3 inhibitor of proteinase Pep4p 
110 YMR175W SIP18 Salt-Induced Protein 
111 YMR169C ALD3 aldehyde dehydrogenase 
112 YMR139W RIM11 Required for Ime1p phosphorylation, association of the  
Ime1p-Ume6p meiotic activator, early meiotic gene expression, 
and sporulation 
113 YMR118C  Hypothetical ORF 
114 YMR092C AIP1 actin cortical patch component 
115 YMR110C HFD1 Hypothetical ORF 
116 YMR087W  Putative ADP-ribose-1''-monophosphatase that converts ADP-
ribose-1''-monophosphate to ADP-ribose; may have a role in tRNA 
splicing; contains an A1pp domain  
117 YMR034C  Hypothetical ORF 
118 YML002W  Hypothetical ORF 
119 YML054C CYB2 L-lactate cytochrome c oxidoreductase|cytochrome b2 
120 YML100W TSL1 similar to TPS3 gene product|trehalose-6-phosphate  
synthase/phosphatase complex 123 kDa regulatory subunit 
121 YLR345W  Hypothetical ORF 
 
 
 
5.3.4.3 Cluster 3 
Cluster 3 contains 220 ORFs with upregulated expression in glc7-12 mutant strains 
(Table 5.3). From the 220 ORFs 44 are uncharacterized and 59 are not annotated yet. 
Interestingly, this cluster contains Sds22p and Reg2p, two known Glc7p regulatory 
subunits (Hong et al., 2000; MacKelvie et al., 1995), suggesting that the cell could try 
to rescue the absence of Glc7p by overexpressing subunits that target or regulate 
Glc7p in specific cellular processes. This also suggests that it is possible to identify 
regulatory subunits of Glc7p by our approach. 
Intriguingly, we also find Yak1p and Crf1p in this cluster, two proteins implicated in 
the repression of RP genes (Martin et al., 2004). The location of Yak1p and Crf1p is 
redirected to the nucleus in glc7-12 and glc7-13 mutant cells, indicating that this 
might be the reason for the downregulation of RP genes in glc7-12 mutants (see 
Chapter 6 and Chapter 5, Cluster 4). 
In addition, Ino1p is listed in this cluster. Upregulation of Ino1p explains the INO 
resistant phenotype in glc7-12 mutants and is probably also the reason for the 
resistance of the other glc7 mutants. 
Furthermore, we found Rec104p and Trs31p in cluster 3. The upregulation of these 
genes is due to their location in the genome downstream of snR71 and snR13. 
Transcription termination of these snoRNAs does not occur in glc7-12, thus tandem 
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transcripts (snoRNA-mRNA) are produced, leading to a higher number of the mRNA 
transcripts (see Chapter 3). 
Finally, Hrp1p/Nab4p, a component of CF I is found in this cluster. 
 
 
Table 5.3 
 
no. systematic 
name 
gene 
name 
description 
1 YLR281C  Hypothetical ORF 
2 YLR284C ECI1 d3,d2-Enoyl-CoA Isomerase 
3 YLR267W  bypass of PAM1 
4 YLR193C UPS1 Mitochondrial intermembrane space protein that regulates  
alternative processing and sorting of Mgm1p and other 
proteins;required for normal mitochondrial morphology; ortholog 
ofhuman PRELI  
5 YLR194C  Hypothetical ORF, Structural constituent of the cell wall attached 
to the plasma membrane by a GPI-anchor; expression is 
upregulated in response to cell wall stress 
6 YLR202C NA NA 
7 YLR205C HMX1 Homology to heme oxygenases 
8 YLR206W ENT2 Epsin-like protein required for endocytosis and actin patch  
assembly, functionally redundant with Ent1p; contains  
clathrin-binding motif at C terminus 
9 YLR174W IDP2 NADP-dependent isocitrate dehydrogenase 
10 YLR177W  Hypothetical ORF 
11 YLR149C  Hypothetical ORF 
12 YLL020C NA NA 
13 YLL020C NA NA 
14 YLL019C KNS1 protein kinase homolog 
15 YLL057C  similar to Fe(II)-dependent sulfonate/alpha-ketoglutarate  
dioxygenase; EC 1.14.11.17 
16 NC-001143 NA NA 
17 NC-001143 NA NA 
18 YKR091W SRL3 Suppressor of Rad53 null Lethality 
19 YKR096W  Hypothetical ORF 
20 YKR064W OAF3 Hypothetical ORF 
21 YKR045C  Hypothetical ORF 
22 YKR058W GLG1 glycogen synthesis initiator 
23 YKR014C YPT52 rab5-like GTPase involved in vacuolar protein sorting and  
endocytosis 
24 YKL086W  ATP-dependent cysteine sulfinic acid reductase 
25 YKL124W SSH4 Suppressor of SHR3; confers leflunomide resistance when  
overexpressed 
26 YKL159C RCN1 calcineurin inhibitor 
27 YKL171W  Hypothetical ORF 
28 YKL193C SDS22 Glc7p regulatory subunit 
29 YKL187C  Hypothetical ORF 
30 YKL217W JEN1 carboxylic acid transporter protein homolog 
31 YJR149W  Hypothetical ORF 
32 YJR091C JSN1 benomyl dependent tubulin mutant 
33 YJL142C NA NA 
34 YJL142C NA NA 
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35 YJL141C YAK1 Serine-threonine protein kinase 
36 YJL153C INO1 L-myo-inositol-1-phosphate synthase 
37 NC-001133 NA NA 
38 YAR029W  Hypothetical ORF 
39 YAR033W MST28 Multicopy suppressor of Sec Twenty one 
40 YAL017W PSK1 contains serine/threonine protein kinase domain and shows 
homology with the SNF1 serine/threonine protein kinase 
41 YAL051W OAF1 transcription factor 
42 NC-001148 NA NA 
43 NC-001148 NA NA 
44 NC-001147 NA NA 
45 YERWDELTA12 NA NA 
46 YDRCDELTA9 NA NA 
47 TV(UAC)B NA NA 
48 TA(UGC)O NA NA 
49 TG(UCC)N NA NA 
50 YNLWSIGMA2 NA NA 
51 RDN37-1 NA NA 
52 RDN25-1 NA NA 
53 RDN5-1 NA NA 
54 TA(UGC)L NA NA 
55 TL(UAA)J NA NA 
56 TA(UGC)A NA NA 
57 SUC4 NA NA 
58 NC-001141 NA NA 
59 NC-001141 NA NA 
60 YIL162W SUC2 invertase (sucrose hydrolyzing enzyme) 
61 YIR041W  Hypothetical ORF 
62 YIL024C  Hypothetical ORF 
63 YIL046W MET30 contains five copies of WD40 motif and interacts with and 
regulates Met4p 
64 YIL059C NA NA 
65 YIL057C  Hypothetical ORF 
66 YIL056W VHR1 Hypothetical ORF, Transcriptional activator, required for the 
vitamin H-responsive element (VHRE) mediated induction of VHT1 
(Vitamin H transporter) and BIO5 (biotin biosynthesis 
intermediate transporter) in response to low biotin concentrations 
67 YIL050W PCL7 cyclin 
68 YIL077C  Hypothetical ORF 
69 YIL108W  Hypothetical ORF 
70 YIL105C SLM1 Phosphoinositide PI4,5P(2) binding protein, forms a complex with 
Slm2p; acts downstream of Mss4p in a pathway regulating actin 
cytoskeleton organization in response to stress; subunit of and 
phosphorylated by the TORC2 complex, AVO2 interactor 
71 YIL101C XBP1 transcriptional repressor 
72 YIL099W SGA1 glucoamylase 
73 YIL160C POT1 3-oxoacyl CoA thiolase 
74 NC-001140 NA NA 
75 NC-001140 NA NA 
76 YHR157W REC104 meiosis-specific protein 
77 YHR139C SPS100 sporulation-specific cell wall maturation protein 
78 YHR097C  Hypothetical ORF 
79 YHL022C SPO11 early meiosis-specific recombination protein 
80 YHL021C  Mitochondrial protein of unknown function 
81 YHL047C ARN2 triacetylfusarinine C transporter 
82 NC-001139 NA NA 
83 NC-001139 NA NA 
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84 YGR236C SPG1 Protein required for survival at high temperature during stationary 
phase; not required for growth on nonfermentable carbon sources  
85 YGR243W FMP43 Hypothetical ORF 
86 YGR197C SNG1 Involved in nitrosoguanidine resistance 
87 YGR122W  Hypothetical ORF 
88 YGR088W CTT1 catalase T 
89 YGR067C  Hypothetical ORF; has similarity to Adr1p DNA-binding domain 
90 YGR052W FMP48 Hypothetical ORF 
91 YGL052W NA NA 
92 YGL051W MST27 protein with COPI and COPII bindng motifs 
93 YGL046W NA NA 
94 YGL045W RIM8 Regulator of IME2 (RIM) Involved in proteolytic processing of 
Rim1p 
95 YGL184C STR3 cystathionine beta-lyase 
96 YGL180W ATG1 protein kinase 
97 YGL247W BRR6 nuclear envelope protein 
98 NC-001138 NA NA 
99 NC-001138 NA NA 
100 NC-001138 NA NA 
101 YFR022W ROG3 Protein that binds to Rsp5p, which is a hect-type ubiquitin ligase, 
via its 2 PY motifs; has similarity to Rod1p; mutation suppresses 
the temperature sensitivity of an mck1 rim11 double mutant  
102 RPR1 NA NA 
103 NC-001137 NA NA 
104 NC-001137 NA NA 
105 NC-001137 NA NA 
106 YER179W DMC1 meiosis-specific protein related to RecA and Rad51p. Dmc1p 
colocalizes with Rad51p to discrete subnuclear sites in nuclear 
spreads during mid prophase, briefly colocalizes with Zip1p, and 
then disappears by pachytene 
107 YER144C UBP5 ubiquitin-specific protease (putative) 
108 YER067W  Hypothetical ORF 
109 YER020W GPA2 nucleotide binding regulatory protein 
110 NC-001136 NA NA 
111 NC-001136 NA NA 
112 NC-001136 NA NA 
113 NC-001136 NA NA 
114 NC-001136 NA NA 
115 NC-001136 NA NA 
116 YDR525W-A SNA2 Homology to PMP3/SNA1 (Sensitivity to Na+) 
117 YDR472W TRS31 targeting complex (TRAPP) component involved in ER to Golgi 
membrane traffic 
118 YDR402C DIT2 catalyzes oxidation of N-formyl tyrosine to N,N-bisformyl  
dityrosine in vitro|cytochrome P450 56 
119 YDR247W VHS1 Gene whose overexpression suppresses the synthetic lethality of 
the hal3 sit4 double mutation 
120 YDR253C MET32 highly homologous to Met31p|transcriptional regulator of sulfur 
amino acid metabolism|zinc finger protein 
121 YDR256C CTA1 catalase A 
122 YDR223W CRF1 Transcriptional corepressor involved in the regulation of ribosomal 
protein gene transcription via the TOR signaling pathway and 
protein kinase A, phosphorylated by activated Yak1p which 
promotes accumulation of Crf1p in the nucleus  
123 YDR213W UPC2 zinc finger transcription factor of the Zn(2)-Cys(6) binuclear 
cluster domain type 
124 YDR129C SAC6 actin filament bundling protein|fimbrin homolog 
125 YDR044W HEM13 coproporphyrinogen III oxidase 
126 YDR042C  Hypothetical ORF 
127 YDR006C SOK1 gene dosage suppressors of the conditional growth defect of 
several temperature-sensitive A kinase mutants 
128 YDL010W  Hypothetical ORF 
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129 YDL008W APC11 anaphase promoting complex (APC) subunit 
130 YDL059C RAD59 the RAD59 gene product has homology to the Rad52 protein 
131 YDL079C MRK1 MDS1 related protein kinase 
132 YDL215C GDH2 NAD-dependent glutamate dehydrogenase 
133 YDL234C GYP7 GTPase activating protein (GAP) 
134 YCR101C  Hypothetical ORF 
135 YCL039W GID7 Involved in proteasome-dependent catabolite inactivation of 
fructose-1,6-bisphosphatase 
136 YCL027W FUS1 cell-surface protein required for cell fusion 
137 YCL048W SPS22 Protein of unknown function, redundant with Sps2p for the 
organization of the beta-glucan layer of the spore wall  
138 NC-001134 NA NA 
139 YBR109w-a NA NA 
140 YBR284W  Hypothetical ORF 
141 YBR298C MAL31 maltose permease 
142 YBR280C SAF1 F-Box protein involved in proteasome-dependent degradation of 
Aah1p during entry of cells into quiescence; interacts with Skp1  
143 YBR150C TBS1 Probable Zn-finger protein 
144 YBR099C NA NA 
145 YBR071W  Hypothetical ORF 
146 YBR050C REG2 Glc7p regulatory subunit 
147 YBR016W  Hypothetical ORF 
148 YBR005W RCR1 Protein of the endoplasmic reticulum membrane involved in chitin 
deposition in the cell wall; overproduction confers resistance to 
Congo Red  
149 NC-001148 NA NA 
150 YPR152C URN1 Hypothetical ORF, Pre-mRNA splicing factor that is associated with 
the U2-U5-U6 snRNPs, the RES complex, and the Prp19-
associated complex (NTC); null mutation displays synthetic 
genetic interactions with mutations affecting U2 snRNA and pre-
mRNA splicing factors 
151 YPR038W NA NA 
152 YPR039W NA NA 
153 YPR002W PDH1 prpD homologue; (62% identical to the prpD genes of Escherichia 
coli and Salmonella typhimurium, which play an unknown but 
essential role in propionate catabolism) 
154 YPL054W LEE1 Product of gene unknown 
155 YPL100W ATG21 Maturation of pro-AmInopeptidase I (proAPI) defective; protein 
similar to Aut10p and YGR223Cp with three putative WD repeats 
156 YPL201C YIG1 Protein that interacts with glycerol 3-phosphatase and plays a role 
in anaerobic glycerol production; localizes to the nucleus and 
cytosol  
157 YPL200W CSM4 Protein required for accurate chromosome segregation during 
meiosis 
158 YPL230W  Up in StarVation 
159 YPL247C  Hypothetical ORF 
160 NC-001147 NA NA 
161 NC-001147 NA NA 
162 NC-001147 NA NA 
163 NC-001147 NA NA 
164 YOR385W  Hypothetical ORF 
165 NC-001147 NA NA 
166 YOR374W ALD4 aldehyde dehydrogenase 
167 YOR343C NA NA 
168 YOR328W PDR10 ABC transporter (putative)|highly similar to Pdr5p 
169 YOR278W HEM4 uroporphyrinogen III synthase 
170 YOR219C STE13 dipeptidyl aminopeptidase 
171 YOR220W WSP1 Hypothetical ORF, protein that interacts genetically with the Pat1 
mRNA-decapping factor 
172 YOR186W  Hypothetical ORF 
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173 YOR134W BAG7 GTPase activating protein (GAP) 
174 YOR050C NA NA 
175 YOR018W ROD1 Membrane protein; overexpression confers resistance to the GST 
substrate o-dinitrobenzene as well as to zinc and calcium; 
contains a PY-motif, which is required for Rod1p interaction with 
Rsp5p, a hect-type ubiquitin ligase 
176 YOR019W  Hypothetical ORF 
177 YOR023C AHC1 Ada histone acetyltransferase complex component 
178 YOL015W IRC10 Hypothetical ORF 
179 YOL016C CMK2 calmodulin-dependent protein kinase 
180 YOL089C HAL9 contains zinc finger|transcription factor (putative) 
181 YOL126C MDH2 malate dehydrogenase 
182 YOL123W HRP1 cleavage and polyadenylation factor CF I component involved in 
pre-mRNA 3' end processing 
183 YOL113W SKM1 Serine/threonine protein kinase with similarity to Ste20p and 
Cla4p 
184 YOL162W  Hypothetical ORF, member of the Dal5p subfamily of the major 
facilitator family 
185 YOL154W ZPS1 Zinc and pH regulated Surface protein. Similar to Candida  
albicans protein Pra1, a pH-regulated cell surface glycoprotein 
with weak similarity to zinc metalloproteinases. 
186 YNR073C  Hypothetical ORF 
187 YNR001C CIT1 citrate synthase 
188 YNL020C ARK1 serine/threonine kinase (putative) 
189 YNL008C ASI3 Amino acid Sensor-Independent (ASI) genes encode membrane 
proteins Asi1p, Asi2p and Asi3p. Asi1p and Asi3p have conserved 
ubiquitin ligase-like RING domains at their C-termini 
190 YNL077W APJ1 J-protein co-chaperone family 20 kDa 
191 YNL120C NA NA 
192 YNL207W RIO2 Protein required for cell viability 
193 YNL195C  Hypothetical ORF 
194 YNL192W CHS1 chitin synthase 1 
195 NC-001145 NA NA 
196 NC-001145 NA NA 
197 NC-001145 NA NA 
198 NC-001145 NA NA 
199 YMR280C CAT8 zinc-cluster protein involved in activating gluconeogenic genes; 
related to Gal4p 
200 YMR206W  Hypothetical ORF 
201 YMR152W YIM1 protease|similar to E. coli leader peptidase 
202 YMR161W HLJ1 Homologous to E coli dnaJ protein 
203 YMR135C GID8 Dose-dependent Cell cycle Regulator 
204 YMR136W GAT2 Similar to GATA-family of DNA binding proteins 
205 YMR096W SNZ1 highly conserved 35 kDa protein that shows increased expression 
after entry into stationary phase 
206 YMR101C SRT1 cis-prenyltransferase 
207 YMR102C  Hypothetical ORF 
208 YMR103C NA NA 
209 YMR107W SPG4 Protein required for survival at high temperature during stationary 
phase; not required for growth on nonfermentable carbon sources  
210 YMR081C ISF1 May regulate NAM7 function, possibly at level of mRNA turnover 
211 YMR084W  Hypothetical ORF 
212 YMR085W  Hypothetical ORF 
213 YML014W  mcm5U/mcm5s2U tRNA carboxyl methyltransferase 
214 NC-001144 NA NA 
215 NC-001144 NA NA 
216 NC-001144 NA NA 
217 YLR414C  Hypothetical ORF 
218 YLR350W ORM2 Endoplasmic reticulum membrane-anchored protein 
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219 YLR327C TMA10 Protein of unknown function that associates with ribosomes  
220 Z73326 NA NA 
 
 
 
5.3.4.4 Cluster 4 
This cluster contains 182 ORFs the expression of which is downregulated in glc7-12 
mutant strains (Table 5.4). From the 182 ORFs 9 are uncharacterized ORFs and 8 are 
not annotated yet. 
Most striking about cluster 4 is that it contains a large amount of RP (34) and Ribi 
genes (32; see Table 6.1, Chapter 6), which corresponds to ~36% of the genes in this 
cluster. RP and Ribi genes function in ribosome biogenesis. Because these two groups 
of genes are found in the same cluster, it is likely that they have a common 
transcriptional response to changes in the environment, suggesting that their 
expression is controlled by the same transcription factor(s). A transcription factor 
known to regulate the Ribi regulon and the RP regulon is Sfp1p (Jorgensen et al., 
2004). Therefore, it is tempting to speculate that Glc7p might regulate Sfp1p to 
coordinate transcription of RP and Ribi genes. 
 
Table 5.4 
 
no. systematic 
name 
gene 
name 
description 
1 YLR293C GSP1 GTP-binding protein 
2 YLR249W YEF3 Translation elongation factor 3 (EF-3) 
3 YLR195C NMT1 N-myristoyl transferase 
4 YLR186W EMG1 ribosome biogenesis 
5 YLR188W MDL1 ATP-binding cassette (ABC) transporter family member 
6 YLR129W DIP2 U3 snoRNP protein 
7 YLR075W RPL10 ribosomal protein L10 
8 YLR061W RPL22A ribosomal protein L22A (L1c) (rp4) (YL31) 
9 YLR048W RPS0B ribosomal protein S0B 
10 YLR048W RPS0B ribosomal protein S0B 
11 YLR017W MEU1 Protein that regulates ADH2 gene expression 
12 YLL045C RPL8B ribosomal protein L8B (L4B) (rp6) (YL5) 
13 YKR043C  Hypothetical ORF 
14 YKR026C GCN3 eIF2B 34 kDa alpha subunit 
15 YKL056C TMA19 Protein of unknown function that associates with ribosomes; 
homolog of translationally controlled tumor protein; green 
fluorescent protein (GFP)-fusion protein localizes to the 
cytoplasm; YKL056C is not an essential gene  
16 YKL081W TEF4 translation elongation factor EF-1gamma 
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17 YKL113C RAD27 42 kDa 5' to 3' exonuclease required for Okazaki fragment  
processing 
18 YKL130C SHE2 Required for mother cell-specific HO expression 
19 YKL152C GPM1 phosphoglycerate mutase 
20 YKL181W PRS1 ribose-phosphate pyrophosphokinase 
21 YKL180W RPL17A ribosomal protein L17A (L20A) (YL17) 
22 YKL180W RPL17A ribosomal protein L17A (L20A) (YL17) 
23 YJR123W RPS5 ribosomal protein S5 (S2) (rp14) (YS8) 
24 YJR069C HAM1 Product of gene unknown 
25 YJR041C URB2 Nucleolar protein required for normal metabolism of the rRNA 
primary transcript, proposed to be involved in ribosome 
biogenesis; Protein required for cell viability 
26 YJR031C GEA1 GDP/GTP exchange factor 
27 YJR007W SUI2 Translation initiation factor eIF-2 alpha subunit 
28 YJL111W CCT7 chaperonin containing T-complex subunit seven component 
29 YJL109C UTP10 U3 snoRNP protein 
30 YJL104W PAM16 Constituent of the mitochondrial import motor associated with 
the presequence translocase, along with Ssc1p, Tim44p, Mge1p, 
and Pam18p; has similarity to J-domain containing proteins 
mitochondrial protein of unknown function 
31 YJL138C TIF2 translation initiation factor eIF4A subunit 
32 YJL177W RPL17B ribosomal protein L17B (L20B) (YL17) 
33 YJL177W RPL17B ribosomal protein L17B (L20B) (YL17) 
34 YJL200C ACO2 Hypothetical ORF, Putative mitochondrial aconitase isozyme; 
similarity to Aco1p, an aconitase required for the TCA cycle; 
expression induced during growth on glucose, by amino acid 
starvation via Gcn4p, and repressed on ethano 
35 YJL198W PHO90 Low-affinity phosphate transporter 
36 YJL190C RPS22A ribosomal protein S22A (S24A) (rp50) (YS22) 
37 NC-001139 NA NA 
38 NC-001139 NA NA 
39 NC-001134 NA NA 
40 YIL043C CBR1 cytochrome b reductase 
41 YIL078W THS1 threonine-tRNA ligase 
42 YHR208W BAT1 branched-chain amino acid transaminase|highly similar to  
mammalian ECA39, which is regulated by the oncogene myc 
43 YHR108W GGA2 ARF-binding protein 
44 YHR128W FUR1 UPRTase 
45 YHR089C GAR1 small nucleolar RNP protein 
46 YHR092C HXT4 high affinity glucose transporter 
47 YHR072W ERG7 2,3-oxidosqualene-lanosterol cyclase 
48 YHR020W  Protein required for cell viability 
49 YHR024C MAS2 mitochondrial processing protease 53 kDa subunit 
50 YGR214W RPS0A ribosomal protein S0A 
51 YGR214W RPS0A ribosomal protein S0A 
52 YGR159C NSR1 nuclear localization sequence binding protein 
53 YGR123C PPT1 serine/threonine phosphatase 
54 YGR082W TOM20 20 kDa mitochondrial outer membrane protein import receptor 
55 YGL008C PMA1 plasma membrane H+-ATPase 
56 YGL076C RPL7A ribosomal protein L7A (L6A) (rp11) (YL8) 
57 YGL123W RPS2 ribosomal protein S2 (S4) (rp12) (YS5) 
58 YGL148W ARO2 chorismate synthase 
59 YGL143C MRF1 mitochondrial polypeptide chain release factor 
60 YFR031C-A RPL2A ribosomal protein L2A (L5A) (rp8) (YL6) 
61 YFR009W GCN20 ATP-binding cassette (ABC) family 
62 YFL022C FRS2 phenylalanine-tRNA ligase subunit 
63 YFL045C SEC53 phosphomannomutase 
64 YER156C  Hypothetical ORF 
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65 YER055C HIS1 ATP phosphoribosyltransferase 
66 YER056C FCY2 purine-cytosine permease 
67 YER023W PRO3 delta 1-pyrroline-5-carboxylate reductase 
68 YER025W GCD11 translational initiation factor eIF-2 gamma subunit 
69 YER003C PMI40 mannose-6-phosphate isomerase 
70 YEL001C  Hypothetical ORF 
71 YEL040W UTR2 (alias: Congo Red Hypersensitivity) 
72 YDR492W IZH1 Membrane protein involved in zinc metabolism, member of the 
four-protein IZH family; transcription is regulated directly by 
Zap1p, expression induced by zinc deficiency and fatty acids; 
deletion increases sensitivity to elevated zinc  
73 YDR487C RIB3 3,4-dihydroxy-2-butanone 4-phosphate synthase 
74 YDR454C GUK1 guanylate kinase 
75 YDR429C TIF35 translation initiation factor eIF3 subunit 
76 YDR399W HPT1 hypoxanthine guanine phosphoribosyltransferase 
77 YDR418W RPL12B ribosomal protein L12B (L15B) (YL23) 
78 YDR382W RPP2B ribosomal protein P2B (YP2beta) (L45) 
79 YDR361C BCP1 Hypothetical ORF 
80 YDR341C RRS1 Cytoplasmic arginyl-tRNA synthetase; Protein required for cell 
viability 
81 YDR260C SWM1 Spore Wall Maturation 1 
82 YDR237W MRPL7 Mitochondrial ribosomal protein of the large subunit 
83 YDR174W HMO1 high mobility group (HMG) family 
84 YDR091C  ATP-binding cassette (ABC) superfamily nontransporter group  
(putative) 
85 YDR064W RPS13 ribosomal protein S13 (S27a) (YS15) 
86 YDR033W MRH1 Membrane protein related to Hsp30p; Localized by  
immunofluorescence to membranes, mainly the plasma  
membr. punctuate immunofluorescence pattern observed  
in buds. The nuclear envelope, but not vacuole or  
mitochondrial membranes also stained 
87 YDL081C RPP1A acidic ribosomal protein P1A (YP1alpha) (A1) 
88 YDL112W TRM3 tRNA (Gm18) ribose methylase 
89 YDL130W RPP1B ribosomal protein P1B (L44') (YP1beta) (Ax) 
90 YDL130W RPP1B ribosomal protein P1B (L44') (YP1beta) (Ax) 
91 YDL155W CLB3 B-type cyclin 
92 YDL158C NA NA 
93 YDL192W ARF1 ADP-ribosylation factor 
94 YCR034W FEN1 Fatty acid elongase, involved in sphingolipid biosynthesis; acts 
on fatty acids of up to 24 carbons in length; mutations have 
regulatory effects on 1,3-beta-glucan synthase, vacuolar 
ATPase, and the secretory pathway 
95 YBR249C ARO4 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) 
synthase isoenzyme 
96 YBR196C PGI1 glucose-6-phosphate isomerase 
97 YBR189W RPS9B ribosomal protein S9B (S13) (rp21) (YS11) 
98 YBR127C VMA2 vacuolar ATPase V1 domain subunit B (60 kDa) 
99 YBR133C HSL7 Has homology to arginine methyltransferases 
100 YBR143C SUP45 eRF1 (eukaryotic Release Factor 1) homolog 
101 YBR146W MRPS9 ribosomal protein S9 (putative) 
102 YBR104W YMC2 Mitochondrial carrier protein 
103 YBR093C PHO5 acid phosphatase 
104 YBR069C TAT1 amino acid transport protein for valine, leucine, isoleucine, and 
tyrosine 
105 YBR078W ECM33 ExtraCellular Mutant 
106 YBR043C QDR3 Multidrug transporter required for resistance to quinidine, 
barban, cisplatin, and bleomycin; member of the major 
facilitator superfamily of transporters conferring multiple drug 
resistance (MFS-MDR)  
107 YBR048W RPS11B ribosomal protein S11B (S18B) (rp41B) (YS12) 
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108 YBR025C  Hypothetical ORF 
109 YBR031W RPL4A ribosomal protein L4A (L2A) (rp2) (YL2) 
110 YBL004W UTP20 Component of the small-subunit (SSU) processome, which is 
involved in the biogenesis of the 18S rRNA; U3 snoRNP protein 
111 YPR114W  Hypothetical ORF 
112 YPR074C TKL1 transketolase 1 
113 YPR033C HTS1 histidine-tRNA ligase 
114 YPR010C RPA135 RNA polymerase I subunit 
115 YPL019C VTC3 polyphosphate synthetase (putative) 
116 YPL037C EGD1 pol II transcribed genes regulator 
117 YPL086C ELP3 histone acetyltransferase|RNA polymerase II Elongator subunit 
118 YPL131W RPL5 ribosomal protein L5 (L1a)(YL3) 
119 YPL211W NIP7 Nip7p is required for 60S ribosome subunit biogenesis 
120 YPL198W RPL7B ribosomal protein L7B (L6B) (rp11) (YL8) 
121 YPL226W NEW1 This gene encodes a protein with an Q/N-rich amino terminal  
domain that acts as a prion, termed [NU]+. 
122 YPL220W RPL1A ribosomal protein L1A, forms part of the 60S ribosomal subunit 
123 YPL256C CLN2 G1 cyclin 
124 YPL273W SAM4 AdoMet-homocysteine methyltransferase 
125 YOR341W RPA190 RNA polymerase I subunit 
126 YOR323C PRO2 gamma-glutamyl phosphate reductase 
127 YOR335C ALA1 Cytoplasmic alanyl-tRNA synthetase gene 
128 YOR272W YTM1 microtubule-associated protein 
129 YOR243C PUS7 pseudouridine synthase 
130 YOR247W SRL1 Suppressor of Rad53 null Lethality 
131 YOR248W NA NA 
132 YOR229W WTM2 transcriptional modulator 
133 YOR063W RPL3 ribosomal protein L3 (rp1) (YL1) 
134 YOL040C RPS15 ribosomal protein S15 (S21) (rp52) (RIG protein) 
135 YOL039W RPP2A 60S acidic ribosomal protein P2A (L44) (A2) (YP2alpha) 
136 YOL077C BRX1 Essential nucleolar protein required for biogenesis of the 60S 
ribosomal subunit 
137 YOL112W MSB4 Multicopy Suppressor of Bud Emergence 
138 NC-001146 NA NA 
139 YNR050C LYS9 Seventh step in lysine biosynthesis pathway 
140 YNL112W DBP2 ATP dependent RNA helicase|dead box protein 
141 YNL137C NAM9 mitochondrial S4 ribosomal protein (putative) 
142 YNL135C FPR1 peptidyl-prolyl cis-trans isomerase (PPIase) 
143 YNL123W NMA111 Protein of unknown function which may contribute to lipid 
homeostasis and/or apoptosis; sequence similarity to the 
mammalian Omi/HtrA2 family of serine proteases  
144 YNL178W RPS3 ribosomal protein S3 (rp13) (YS3) 
145 YNL218W MGS1 Maintenance of Genome Stability 1 
146 YNL209W SSB2 SSB1 homolog|heat shock protein of HSP70 family 
147 YNL256W FOL1 dihydro-6-hydroxymethylpterin pyrophosphokinase| 
dihydroneopterin aldolase|dihydropteroate synthetase 
148 YNL255C GIS2 GIG3 suppressor 
149 YNL302C RPS19B ribosomal protein S19B (rp55B) (S16aB) (YS16B) 
150 YNL301C RPL18B ribosomal protein L18B (rp28B) 
151 SNR72 NA NA 
152 NC-001145 NA NA 
153 YMR321C  Hypothetical ORF 
154 YMR307W GAS1 cell surface glycoprotein 115-120 kDa 
155 YMR308C PSE1 karyopherin 
156 YMR314W PRE5 20S proteasome alpha-type subunit 
157 YMR290C HAS1 RNA-dependent helicase (putative) 
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158 YMR241W YHM2 DNA binding protein|mtDNA stabilizing protein, mitochondrial 
inner membrane protein with low homology to RIM2 
159 YMR217W GUA1 GMP synthase 
160 YMR202W ERG2 C-8 sterol isomerase 
161 YMR146C TIF34 translation initiation factor eIF3 p39 subunit 
162 YMR116C ASC1 G-beta like protein 
163 YMR116C ASC1 G-beta like protein 
164 YMR129W POM152 membrane glycoprotein|nuclear pore complex subunit 
165 YMR079W SEC14 phosphatidylinositol transfer protein 
166 YMR049C ERB1 Protein required for maturation of the 25S and 5.8S ribosomal 
RNAs; homologous to mammalian Bop1 
167 YMR033W ARP9 actin related protein|chromatin remodeling Snf/Swi complex 
subunit 
168 YML022W APT1 adenine phosphoribosyltransferase 
169 YML056C IMD4 IMP dehydrogenase homolog 
170 YML078W CPR3 cyclophilin|peptidyl-prolyl cis-trans isomerase (PPIase) 
171 YML106W URA5 orotate phosphoribosyltransferase 1 
172 YML123C PHO84 inorganic phosphate transporter 
173 YML116W ATR1 very hydrophobic, has many membrane-spanning regions, 
several potential glycosylation sites, potential ATP-binding site 
174 YLR448W RPL6B ribosomal protein L6B (L17B) (rp18) (YL16) 
175 YLR409C UTP21 Possible U3 snoRNP protein involved in maturation of pre-18S 
rRNA, based on computational analysis of large-scale protein-
protein interaction data; U3 snoRNP protein 
176 YLR413W  Hypothetical ORF 
177 YLR418C CDC73 accessory factor associated with RNA polymerase II by affinity 
chromatography 
178 YLR384C IKI3 RNA polymerase II Elongator subunit 
179 YLR367W RPS22B ribosomal protein S22B (S24B) (rp50) (YS22) 
180 YLR372W SUR4 elongase 
181 YLR359W ADE13 adenylosuccinate lyase 
182 YLR325C RPL38 ribosomal protein L38 
 
 
 
 
5.3.4.5 Cluster 5 
Cluster 5 contains 76 ORFs with upregulated expression in glc7-12 mutant strains 
(Table 5.5). From the 76 ORFs, 3 are uncharacterized ORFs and 28 are not annotated 
yet. 
This cluster contains Nrd1p, a component of the Nrd1 complex that is involved in 
snoRNA transcription termination (Steinmetz et al., 2001). A consequence of 
mutations in subunits of the Nrd1 complex is that in addition to the snoRNA 
transcription termination defect the Nrd1 message itself accumulates. The 
upregulation of Nrd1 mRNA levels observed in this microarray experiment was 
verified by Northern analysis (see Chapter 3). Strong accumulation of Nrd1 was 
observed in several glc7 mutants. Therefore, two independent experiments implicate 
Glc7p in the transcriptional autoregulation mechanism of Nrd1p. 
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Table 5.5 
 
no. systematic 
name 
gene 
name 
description 
1 YLR256W HAP1 zinc finger transcription factor of the Zn(2)-Cys(6) binuclear 
cluster domain type 
2 YLR134W PDC5 pyruvate decarboxylase 
3 YLR136C TIS11 Zinc finger containing homolog of mammalian TIS11, glucose 
repressible gene 
4 YLR099C ICT1 Increased Copper Tolerance; Similar to Ecm18p 
5 YLR042C  Hypothetical ORF 
6 NC-001143 NA NA 
7 NC-001143 NA NA 
8 YKR069W MET1 Methionine metabolism 
9 YKR052C MRS4 carrier protein highly homologous to Mrs3p 
10 YKR011C  Hypothetical ORF 
11 YKL044W NA NA 
12 YKL116C PRR1 protein kinase 
13 YKL164C PIR1 contains tandem internal repeats 
14 NC-001133 NA NA 
15 NC-001133 NA NA 
16 YAL001C TFC3 138 kDa|transcription factor tau (TFIIIC) subunit 
17 YAL016W TPD3 protein phosphatase 2A regulatory subunit A 
18 YAL040C CLN3 G1 cyclin 
19 NC-001137 NA NA 
20 NC-001144 NA NA 
21 NC-001145 NA NA 
22 TG(GCC)D2 NA NA 
23 TG(CCC)D NA NA 
24 TP(AGG)C NA NA 
25 TG(GCC)C NA NA 
26 TG(GCC)B NA NA 
27 TS(UGA)P NA NA 
28 TG(GCC)O1 NA NA 
29 TP(AGG)N NA NA 
30 RDN5-1 NA NA 
31 RDN37-1 NA NA 
32 TH(GUG)K NA NA 
33 TR(ACG)J NA NA 
34 YIR017C MET28 transcriptional activator in the Cbf1p-Met4p-Met28p complex 
35 YIL109C SEC24 vesicle coat component 
36 YHR029C YHI9 Protein of unknown function that is a member of the PhzF 
superfamily, although unlike its bacterial homolog, is most likely 
not involved in phenazine production; possibly involved in a 
membrane regulation metabolic pathway 
37 YHL036W MUP3 very low affinity methionine permease 
38 YGR055W MUP1 high affinity methionine permease 
39 YGL062W PYC1 pyruvate carboxylase 
40 YGL125W MET13 methylenetetrahydrofolate reductase (mthfr) (putative) 
41 YFR015C GSY1 glycogen synthase (UDP-glucose-starch glucosyltransferase) 
42 YER091C MET6 vitamin B12-(cobalamin)-independent isozyme of methionine 
synthase (also called N5-methyltetrahydrofolate homocysteine 
methyltransferase or 5-methyltetrahydropteroyl triglutamate  
homocysteine methyltransferase) 
43 YER093C-A  Hypothetical ORF 
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44 YEL071W DLD3 D-lactate dehydrogenase 
45 NC-001136 NA NA 
46 YDR516C EMI2 Early Meiotic Induction 
47 YDR488C PAC11 Protein required in the absence of Cin8p 
48 YDR380W ARO10 Phenylpyruvate decarboxylase, catalyzes decarboxylation of 
phenylpyruvate to phenylacetaldehyde, which is the first 
specific step in the Ehrlich pathway 
49 YDR381W YRA1 RNA-binding RNA annealing protein 
50 YDR207C UME6 C6 zinc finger URS1-binding protein 
51 YDR046C BAP3 valine transporter 
52 YDR011W SNQ2 ABC transporter 
53 YDL022W GPD1 glycerol-3-phosphate dehydrogenase 
54 YCR030C SYP1 Suppressor of Yeast Profilin deletion 
55 YCR005C CIT2 citrate synthase 
56 NC-001134 NA NA 
57 YBR212W NGR1 glucose-repressible RNA binding protein 
58 YBR179C FZO1 Drosophila melanogaster fuzzy onions gene homolog integral 
protein of the mitochondrial outer membrane; can be isolated 
as part of a high molecular weight complex 
59 YBL045C COR1 coenzyme QH2 cytochrome c reductase 44 kDa core protein 
subunit 
60 NC-001148 NA NA 
61 YPR038W NA NA 
62 YPL192C PRM3 pheromone-regulated membrane protein 
63 YOR264W DSE3 Daughter Specific Expression 3 
64 YOR176W HEM15 ferrochelatase (protoheme ferrolyase) 
65 NC-001146 NA NA 
66 YNL078W NIS1  
67 YNL212W VID27 Vacuole import and degradation 
68 YNL251C NRD1 RNA-binding protein that interacts with the C-terminal domain 
of the RNA polymerase II large subunit (Rpo21p), required for 
transcription termination and 3' end maturation of 
nonpolyadenylated RNAs 
69 YNL241C ZWF1 glucose-6-phosphate dehydrogenase 
70 YNL277W MET2 homoserine O-trans-acetylase 
71 NC-001145 NA NA 
72 NC-001145 NA NA 
73 YMR301C ATM1 ABC transporter 
74 YMR141C NA NA 
75 YMR004W MVP1 Protein required for sorting proteins to the vacuole 
76 YML092C PRE8 proteasome component Y7 
 
 
 
5.3.4.6 Cluster 6 
Cluster 6 contains 68 ORFs with downregulated expression in glc7-12 mutant strains 
(Table 5.6). From the 68 ORFs 14 are uncharacterized and six are not annotated yet. 
In addition to two known genes of the Ribi regulon, RNT1 and PUS6, cluster 6 also 
contains RPC25, a RNAP III subunit. Several subunits of RNAP I and III are 
accredited to the Ribi regulon since they transcribe distinct classes of rRNA, 
important components of ribosomes. We also identified different RNAP I subunits 
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(RPA190, RPA135, RPA49) and one RNAP III subunit (RPC34) in cluster 1 and 4 in 
our microarray experiment. It is most likely that RPC25 also belongs to the Ribi 
regulon but has not yet been identified as a member of this regulon. Interestingly, 
Rpa190p, the largest subunit of RNAP I contains a canonical RVXF motif, found in 
the majority of protein phosphatase type I interacting proteins (Walsh et al., 2002). In 
addition, Rpa190p is known to be a phospho-protein (Bell et al., 1976). Both proteins, 
Glc7p and Rpa190p, are enriched in the nucleolus. Taken together, it is highly likely 
that Rpa190p might be a Glc7p substrate.  
RNT1 encodes an endonuclease involved in snoRNA transcription termination. 
Downregulation of RNT1 in glc7-12 cells could contribute or even be the cause of the 
snoRNA transcription termination defect observed in this mutant (see Chapter 3).  
Moreover, cluster 6 contains a component of the TRAMP complex, TRF5 that is 
involved in polyadenylation-mediated RNA surveillance (Vanacova et al., 2005). It 
was shown that this complex plays a part in processing of snoRNAs and therefore 
downregulation of TRF5 might impair this function. This could also add to the 
snoRNA transcription termination defect observed in glc7 mutants. 
 
 
Table 5.6 
 
no. systematic 
name 
gene 
name 
description 
1 YLR237W THI7 thiamine transporter 
2 YLR244C MAP1 methionine aminopeptidase 
3 YLR018C POM34 integral membrane protein|nuclear pore complex subunit 
4 YLR021W  Hypothetical ORF 
5 YKR063C LAS1 May regulate expression of genes involved in bud formation and 
morphogenesis 
6 YKL069W  Hypothetical ORF 
7 YKL144C RPC25 RNA polymerase III subunit 
8 NC-001142 NA NA 
9 YJR097W JJJ3 Protein of unknown function, contains a J-domain, which is a 
region with homology to the E. coli DnaJ protein  
10 YJL073W JEM1 DnaJ-like protein of the endoplasmic reticulum membrane 
11 YDRWDELTA10 NA NA 
12 NC-001141 NA NA 
13 YIR032C DAL3 ureidoglycolate hydrolase 
14 NC-001140 NA NA 
15 YHR144C DCD1 dCMP deaminase 
16 YHR057C CPR2 cyclophilin|peptidyl-prolyl cis-trans isomerase (PPIase) 
17 YHL009C YAP3 bZIP protein; transcription factor 
18 NC-001139 NA NA 
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19 YGR275W RTT102 Regulator of Ty1 Transposition 
20 YGR251W  Protein required for cell viability 
21 YGR169C PUS6 RNA:Psi-synthase 
22 YGR125W  Hypothetical ORF 
23 YGR079W  Hypothetical ORF 
24 YGR021W  Hypothetical ORF 
25 YGL079W  Hypothetical ORF 
26 YGL157W  Oxidoreductase, catalyzes NADPH-dependent reduction of the 
bicyclic diketone bicyclo[2.2.2]octane-2,6-dione (BCO2,6D) to the 
chiral ketoalcohol (1R,4S,6S)-6-hydroxybicyclo[2.2.2]octane-2-
one (BCO2one6ol)  
27 YGL221C NIF3 similar to Listeria monocytogenes major sigma factor (rpoD gene 
product) 
28 YGL220W  Hypothetical ORF 
29 YER163C  Hypothetical ORF 
30 NC-001136 NA NA 
31 YEL066W HPA3 Histone and other Protein Acetyltransferase; Has sequence  
homology to known HATs and NATs 
32 YDR506C  Hypothetical ORF 
33 YDR415C  Hypothetical ORF 
34 YDR291W HRQ1 Hypothetical ORF, Putative DNA helicase 
35 YDR179W-A  Hypothetical ORF 
36 YDR137W RGP1 Ric1p-Rgp1p is an exchange factor, and peripheral membrane 
protein complex restricted to the Golgi. 
37 YDR140W  Putative S-adenosylmethionine-dependent methyltransferase of 
the seven beta-strand family 
38 YDR075W PPH3 protein phosphatase type 2A 
39 YDR034C LYS14 Transcriptional activator of lysine pathway genes with  
2-aminoadipate semialdehyde as co-inducer; saccharopine  
reductase synthesis 
40 YDL219W DTD1 D-Tyr-tRNA(Tyr) deacylase 
41 YDL219W DTD1 D-Tyr-tRNA(Tyr) deacylase 
42 YCR060W TAH1 HSP90 cofactor; interacts with Hsp82p, Pih1p, Rvb1 and Rvb2, 
contains a single TPR domain with at least two TPR motifs  
43 YCL036W  Great for FULL DEAD box protein activity 
44 YBR176W ECM31 ExtraCellular Mutant 
45 YBR188C NTC20 splicing factor 
46 YBR157C ICS2 Increased Copper Sensitivity 
47 YBR054W YRO2 Homolog to HSP30 heat shock protein Yro1p 
48 YPR162C ORC4 origin recognition complex (ORC) 56 kDa subunit 
49 YPR083W MDM36 Mitochondrial Distribution and Morphology 
50 YPL115C BEM3 rho GTPase activating protein (GAP) 
51 YPL214C THI6 TMP pyrophosphorylase|hydroxyethylthiazole kinase 
52 YOR337W TEA1 Mutants are defective in Ty1 Enhancer-mediated Activation 
53 YOR302W  CPA1 uORF , Arginine attenuator peptide, regulates translation of 
the CPA1 mRNA 
54 YOR303W CPA1 arginine specific|carbamoyl phosphate synthetase 
55 YOR144C ELG1 Enhanced Level of Genomic instability, Repressor of Ty1  
Transposition 
56 YOL026C  Protein required for cell viability 
57 YNL023C FAP1 transcription factor homolog; similarity to Drosophila  
melanogaster shuttle craft protein; similarity to human  
NFX1 protein; similarity to human DNA-binding protein tenascin 
58 YNL022C  Non-essential protein with similarity to S. pombe hypothetical 
protein E349594 
59 YNL065W AQR1 multidrug resistance transporter 
60 YNL299W TRF5 DNA polymerase sigma 
61 YMR319C FET4 low affinity Fe2+ transport protein 
62 YMR264W CUE1 Ubc7p binding and recruitment protein 
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63 YMR236W TAF9 TFIID subunit 
64 YMR239C RNT1 ribonuclease III 
65 YMR226C  NADP(+)-dependent dehydrogenase; acts on serine,  
L-allo-threonine, and other 3-hydroxy acids 
66 YMR074C  Hypothetical ORF 
67 YLR376C  Platinum Sensitivity 
68 YLR326W  Hypothetical ORF 
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5.4 Discussion 
 
Microarray analysis has extensively been employed to identify targets of transcription 
factors or to study gene expression patterns under different environmental conditions. 
The great advantage of microarray analysis is that the expression patterns of virtually 
all genes of a genome can be investigated in one experiment. We applied this method 
to explore novel functions of the essential protein phosphatase Glc7p. Interestingly, 
we found that in glc7-12 mutants transcription of a large number of RP and Ribi 
genes is downregulated at the restrictive temperature compared to the WT. 
Comparison to the WT reveals which genes are up- or downregulated and is important 
to exclude effects that are merely due to the heatshock treatment. The expression 
profiles of several other genes, such as Trs31, Nrd1 and Rec104 gave first indications 
that Glc7p could also be involved in snoRNA transcription termination (described in 
more detail in Chapter 3). Thus, this microarray analysis was instrumental in the 
discovery of new cellular functions of Glc7p.  
 
Analysis of the microarray data 
Because Glc7p is not a transcription factor that directly influences transcription of 
genes but a protein phosphatase, it is more intricate to determine what could have 
been the cause of an altered gene expression pattern in the glc7-12 mutant. Protein 
phosphatase Glc7p has many different functions in the cell that not necessarily ever 
affect gene transcription. However, many pathways in a cell are regulated by 
phosphorylation that do ultimately impinge on the transcription of specific genes. 
Specific changes in the cell are expected to result in a common transcriptional 
response of genes belonging to a functional group. For example, genes that encode 
proteins which are required for the synthesis of a ribosome should all respond to an 
environmental change in the same way. It was therefore instrumental to cluster genes 
according to their expression pattern to identify specific cellular processes affected by 
Glc7p. We divided the 826 genes that were differentially expressed in glc7-12 
mutants into six clusters. Each cluster contains the genes that have an expression 
pattern that is more similar to the genes in their cluster than to genes in any other 
cluster. Three of the clusters contained genes that were upregulated and three 
contained genes that were downregulated in glc7-12 mutants. We became most 
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interested in a subset of genes in cluster 1 and cluster 4, which are RP and Ribi genes. 
Both clusters comprise genes that are downregulated in glc7-12 mutants. It has been 
reported that the transcription factor Sfp1p is involved in the regulation of both, the 
RP gene and the Ribi gene regulon (Jorgensen et al., 2004). In conclusion, Sfp1p 
could be a prime target for Glc7p in the regulation of RP and Ribi gene transcription. 
One of the reasons why RP and Ribi genes are not detected in the same cluster could 
be that regulation of RP gene transcription involves an additional number of 
transcription factors. These could integrate different signal inputs and evoke a slightly 
different transcriptional response. Thus, the expression pattern of RP genes could be 
distinct from the one of Ribi genes. 
Microarray analysis in our hands was a great tool to gain a genome wide overlook of 
transcriptional responses under certain conditions. It is however recommended to 
cross-check microarray results by independent approaches such as Northern analysis.  
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6 Glc7p is involved in transcription regulation of ribosomal protein 
genes 
6.1 Summary 
The transcription of genes that encode for factors required for ribosome biogenesis is 
tightly controlled and responds to extracellular and intracellular changes. The target of 
rapamycin (TOR) and the Ras/PKA signaling pathways both regulate transcription of 
RP and Ribi genes in response to nutrient conditions. Here, we show that the essential 
protein phosphatase Glc7p is involved in regulation of RP and Ribi gene transcription. 
Firstly, transcription of RP and Ribi genes is downregulated in glc7 mutant strains as 
observed by both, microarray and northern analysis. Secondly, Glc7p controls the 
nuclear localization of two downstream targets of PKA, Yak1p and Crf1p, which have 
been implicated in RP gene transcription regulation. In addition, we show that PKA is 
active in glc7 mutant strains and that Glc7p most likely acts downstream of PKA or in 
parallel to Yak1p. Furthermore, Glc7p regulates the phosphorylation level of a 
specific isoform of Bcy1p. This regulation however, is not required in the regulation 
of RP gene transcription. Therefore, the direct target of Glc7p in the transcription 
regulation of RP and Ribi genes remains unknown. 
  
6.2 Introduction  
Growing cells increase the number of ribosomes to adjust to the rising demand for 
proteins. Therefore, regulation of ribosome synthesis is crucial for the control of cell 
growth. Ribosomes consist of ribosomal proteins (RP) and ribosomal RNA (rRNA). 
There are 138 genes encoding 79 different RPs in S. cerevisiae. Transcription of RP 
genes is regulated coordinately in response to growth stimuli and environmental stress 
(Warner, 1999). RP gene transcription is stimulated under favorable growth 
conditions and approximately 50% of RNAP II transcription is devoted to RP genes 
(Warner, 1999). Under non-favorable conditions RP gene transcription is rapidly and 
coordinately repressed (Warner, 1999). A number of transcription factors have been 
identified that regulate the transcription of RP genes. One of them, Rap1p, 
constitutively binds to Rap1 binding sites present at most RP gene promoters 
(Cardenas et al., 1999; Warner, 1999). However, Rap1p also binds and activates many 
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non-RP promoters in a manner not coordinated with those of RP gene promoters. 
These include glycolytic genes (Morse, 2000). Rap1p also acts as the major duplex 
DNA binding protein of telomeres (Morse, 2000; Pina et al., 2003). Therefore, to 
achieve specificity, Rap1p works together with specific cofactors to activate 
transcription of RP genes. Such cofactors have recently been identified as Fhl1p, 
Ifh1p and Crf1p (Martin et al., 2004; Schawalder et al., 2004; Wade et al., 2004). A 
global chromatin localization analysis in yeast revealed the forkhead-like protein 
Fhl1p as a factor highly specific for RP gene promoters (Lee et al., 2002). Ifh1 is 
recruited to RP gene promoters by binding to Fhl1p (Martin et al., 2004; Schawalder 
et al., 2004; Wade et al., 2004). Together these factors activate the transcription of RP 
genes. Crf1p was described as a co-repressor of RP gene transcription that competes 
with Ifh1p for binding to Fhl1p under non-favorable nutrient conditions (Martin et al., 
2004). Both, the association of Fhl1p and Ifh1p are dependent on Rap1p (Wade et al., 
2004). Binding of Crf1p to Fhl1p represses transcription of RP genes (Martin et al., 
2004). However, the potential of Crf1p to repress transcription of RP genes might be 
restricted to certain strain-backgrounds (Zhao et al., 2006) and thus may not be part of 
an essential ”core” repression mechanism. The current model is that Rap1p and Fhl1p 
are constitutively bound at RP gene promoters, however activation of RP gene 
transcription is achieved only by further binding of Ifh1p to Fhl1p. This suggests that 
Ifh1p plays a central role in the regulation of RP gene transcription (Martin et al., 
2004; Rudra et al., 2005; Schawalder et al., 2004; Wade et al., 2004).  
A large number of genes called Ribi genes, show nearly identical transcriptional 
responses to environmental perturbations as do RP genes (Jorgensen et al., 2002; 
Wade et al., 2001). Most of the Ribi genes encode proteins that are accessory in 
ribosome synthesis and modify rRNA and RPs in the nucleolus (Fatica and Tollervey, 
2002; Jorgensen et al., 2002; Wade et al., 2001). The promoters of Ribi genes are 
strongly enriched for two motifs, which are absent in RP gene promoters, termed 
RRPE and PAC. Therefore, Ribi gene promoters appear to constitute a distinct 
regulon (Jorgensen et al., 2002; Wade et al., 2001). The transcription factor Sfp1p, 
previously shown to play a role in the control of cell size (Jorgensen et al., 2002), is 
an activator of the RP and Ribi gene regulons (Jorgensen et al., 2004; Marion et al., 
2004). The nuclear concentration of Sfp1p responds rapidly to changes in nutrients 
and environmental conditions. Under optimal growth conditions, Sfp1p is localized in 
the nucleus (Jorgensen et al., 2004).  
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Two central nutrient-sensing signaling pathways can activate the transcription of 
rRNA, RP and Ribi genes: the target of rapamycin (TOR) and the Ras/PKA signaling 
pathway (Cardenas et al., 1999; Klein and Struhl, 1994; Neuman-Silberberg et al., 
1995; Powers and Walter, 1999; Wang et al., 2004). These two signaling pathways 
control the localization of Rap1p, Fhl1p, Ifhl1p and Crf1p to RP and Ribi gene 
promoters (Martin et al., 2004).  
Core components of the Ras/PKA signaling pathway are the RAS-GTPase(s), the 
adenylate cyclase and the cAMP-dependent protein kinase A (PKA). Ras proteins 
belong to a superfamily of GTP-bound proteins (Broach and Deschenes, 1990). In S. 
cerevisiae, the Ras proteins are encoded by the RAS1 and RAS2 genes (Broach and 
Deschenes, 1990). Neither Ras1p nor Ras2p is essential for cell growth, however 
deletion of both genes is lethal (Broach and Deschenes, 1990). Ras proteins are 
localized at the plasma membrane were they receive information about the 
nutritional/environmental extracellular conditions (Broach and Deschenes, 1990). Ras 
proteins are activated by Cdc25p, which promotes the exchange of GDP to GTP 
within the Ras-GTPase (Lai et al., 1993; Robinson et al., 1987). Ira1p and Ira2p 
function as GAPs that stimulate the RAS GTPase leading to inactivation of Ras 
(Tanaka et al., 1990a; Tanaka et al., 1990b). When activated, Ras activates the 
adenylate cyclase, encoded by the CDC35 gene (Toda et al., 1985). Adenylate cyclase 
converts ATP to the second messenger cAMP (Toda et al., 1985). cAMP in turn 
activates PKA. PKA is a heterotetramer consisting of two inhibitory subunits encoded 
by BCY1 and two catalytic subunits, redundantly encoded by TPK1, TPK2 and TPK3 
(Toda et al., 1987a; Toda et al., 1987b). Binding of cAMP to Bcy1 leads to the 
dissociation of the catalytic subunits from Bcy1p. The catalytic subunits of PKA can 
then phosphorylate their different cellular targets. One of these targets is the kinase 
Yak1p. PKA also negatively regulates the transcription of many stress-responsive 
genes by phosphorylating and thereby inactivating the transcription factor Msn2 
(Gorner et al., 1998). Mutations that render Bcy1 inactive still yield conditionally 
active PKA. Cells that carry such a mutation fail to accumulate carbohydrates and do 
not arrest in the G1 phase upon nutrient limitation. In addition, regulatory enzymes of 
glycolysis and of gluconeogenesis are stimulated or inhibited, respectively, by high 
PKA activity. Therefore, it was proposed that the Ras/PKA signaling pathway 
communicates nutritional conditions to the cell (Thevelein and de Winde, 1999). 
Inactivation of Ras or PKA or depletion of cAMP leads to the arrest of yeast cells in 
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G1 of the cell cycle. Interestingly, nutrient-starved cells arrest at the same point in G1. 
Subsequently cells with inactivated Ras/PKA signaling enter the stationary phase 
(G0) and display physiological changes normally associated with nutrient limitation. 
These changes include an altered transcription pattern and changes in expression of 
RP genes, the accumulation of carbohydrates, and also increased resistance towards 
heat and oxidative stress (Thevelein and de Winde, 1999; Werner-Washburne et al., 
1996). 
The conserved phosphatidylinositol kinase TOR controls many aspects of cell growth. 
In yeast two Tor proteins exist, Tor1p and Tor2p, which are highly homologous 
(Helliwell et al., 1994). They stimulate cap-dependent translation initiation, 
membrane traffic, protein degradation, ribosome biogenesis and transcription in 
response to nutrients. TOR kinases are Ser/Thr protein kinases. Tor1p and Tor2p are 
inhibited by the immunosuppressant and antibiotic rapamycin, which binds to a 
domain adjacent to the catalytic kinase domain (Chen et al., 1995). Rapamycin 
treatment or TOR depletion results in several physiological changes characteristic of 
starved (G0) cells, including accumulation of storage carbohydrates and an altered 
transcription pattern. This includes downregulation of RP gene transcription (Barbet 
et al., 1996). The striking similarities between starved and rapamycin-treated cells 
suggest that the TOR signaling pathway controls cell growth in response to nutrients 
(Barbet et al., 1996; Thomas and Hall, 1997). How the nutrient signal is transduced to 
TOR however is still unknown. Under favorable nutrient conditions TOR globally 
represses transcription of starvation-specific genes by preventing nuclear localization 
of several nutrient-responsive transcription factors (Crespo and Hall, 2002). How 
TOR impinges on RP gene transcription has only recently become clearer. As 
described above, Fhl1p, Ifh1p and Crf1p were identified as transcription factors that 
among others control the transcription of RP genes. Several reports indicated that 
TOR controls the association of Ifh1p and Crf1p with RP gene promoters leading to 
activation or repression of RP genes, respectively (Martin et al., 2004; Schawalder et 
al., 2004; Wade et al., 2004; Figure 6.1). Inhibition of the TOR pathway by rapamycin 
causes a rapid dissociation of Ifh1p, but not Fhl1p or Rap1p from RP gene promoters 
(Martin et al., 2004; Schawalder et al., 2004; Wade et al., 2004). In addition, Crf1p 
associates with RP promoters under these conditions (Martin et al., 2004). Moreover, 
in response to inhibition of TOR, also Sfp1p is released from RP gene promoters and 
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leaves the nucleus leading to downregulation of RP gene transcription (Marion et al., 
2004). 
Connections between the TOR and the Ras/PKA pathways have been described 
(Schmelzle et al., 2004). For instance, the rapamycin-induced downregulation of RP 
gene transcription can be counteracted by activation of the Ras/PKA pathway 
(Schmelzle et al., 2004). In addition, TOR controls the subcellular localization of 
PKA and the PKA target Yak1p and a yak deletion confers rapamycin resistance 
(Schmelzle et al., 2004). Moreover, Yak1p was shown to phosphorylate Crf1p in cells 
treated with rapamycin leading to nuclear localization of Crf1p and RP gene 
repression (Martin et al., 2004). These findings led to the proposition that the 
Ras/PKA pathway might be a novel TOR effector branch (Schmelzle et al., 2004). 
Here, we report, that the essential protein phosphatase Glc7p is involved in the 
regulation of RP and Ribi gene transcription. Glc7p controls the nuclear localization 
of Crf1p and Yak1p. In addition, in studies using the hyperactive Ras2val19 allele and 
localization experiments with the PKA subunits Bcy1p and Tpk1p suggested that 
Glc7p acts downstream of PKA or in parallel to Yak1p. Interestingly, we found that 
Glc7p regulates the phosphorylation state of one of the Bcy1 phospho-isoforms. 
However regulation of this specific phospho-isoform does not affect RP gene 
transcription.  
 
 
 
Figure 6.1. TOR regulates ribosomal protein gene expression via PKA and the granscription 
factor Fhl1 (Martin et al., 2004). 
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6.3 Results 
6.3.1 Mutations in Glc7p lead to the downregulation of RP and Ribi gene 
transcription 
To find out whether the expression of specific subsets of genes are affected in a glc7 
mutant, we performed expression profiling of poly(A)+ RNA derived from glc7-12, a 
temperature sensitive glc7 allele, and the WT (chapter 5; Materials and Methods). 
We analyzed our data using a stringent p-value of < 0.001. This means that the 
probability that the results observed could have occurred by chance is less than 1‰. 
We found 826 genes to be differentially expressed of which 417 were upregulated and 
409 were downregulated. We noticed that the latter group contained a large amount of 
ribosomal protein (RP) and Ribi genes, namely 36 RP and 57 Ribi genes (Table 6.1). 
Transcription of RP mRNA represents ~50% of the total RNAP II transcription 
initiation events, which consume much of the cells energy and therefore must be 
tightly controlled. S. cerevisiae has 138 genes encoding for 79 different ribosomal 
proteins (Zhao et al., 2006) and 236 Ribi genes (Jorgensen et al., 2004). Analysis of 
the raw data of our microarray revealed that all RP genes were downregulated in glc7-
12 under non-permissive conditions, indicating that a p-value of <0.001 is highly 
stringent. The mRNA of RP and Ribi genes is very unstable (Grigull et al., 2004). As 
a result, a decrease in the mRNA level of these genes is indicative of a failure to 
initiate transcription. We therefore assume that Glc7p is involved in the regulation of 
RP and Ribi gene transcription.  
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Table 6.1 
RP genes downregulated in glc7-12 
MRPL7
MRPS9
YDR237W
YBR146W
Mitochondrial RP genes
RPP1A
RPP1B
RPP2A
RPP2B
YDL081C
YDL130W
YOL039W
YDR382W
RPP
RPS0A
RPS0B
RPS2
RPS3
RPS5
RPS9B
RPS11B
RPS13
RPS15
RPS19B
RPS22A
RPS22B
RPS26A
YGR214W
YLR048W
YGL148W
YNL178W
YJR123W
YBR189W
YBR048W
YDR064W
YOL040C
YNL302C
YJL190C
YLR367W
YGL189C
RPS
RPL1A
RPL2A
RPL3
RPL4A
RPL5
RPL6B
RPL7A
RPL7B
RPL8A
RPL8B
RPL10
RPL12B
RPL17A
RPL17B
RPL18B
RPL21B
RPL22A
RPL38
YPL220W
YFR031C-A
YOR063W
YBR031W
YPL131W
YLR448W
YGL076C
YPL198W
YHL033C
YLL045C
YLR075W
YDR418W
YKL180W
YJL177W
YNL301C
YPL079W
YLR061W
YLR325C
RPL
Gene nameYORF
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Table 6.1 continued 
Ribi genes that are downregulated in glc7-12 
DBP8
DBP2
-
GAR1
NOG1
PRP43
ARX1
ERB1
NOC4
PNO1
HAS1
KRR1
UTP15
UTP10
BRX1
NOC3
ASC1
YTM1
NIP7
NSA1
DIM1
DIP2
NSR1
DBP6
RNT1
YHR169W
YNL112W
YBR267W
YHR089C
YPL093W
YGL120C
YDR101C
YMR049C
YPR144C
YOR145C
YMR290C
YCL059C
YMR093W
YJL109C
YOL077C
YLR002C
YMR116C
YOR272W
YPL211W
YGL111W
YPL266W
YLR129W
YGR159C
YNR038W
YMR239C
Ribosome biogenesis
IMD4
PRS3
GUA1
PRS1
URA7
URA5
URA1
AAH1
HPT1
FCY2
APT1
FUR1
URK1
TKL1
YML056C
YHL011C
YMR217W
YKL181W
YBL039C
YML106W
YKL216
YNL141W
YDR399W
YER056C
YML022W
YHR128W
YNR012W
YPR074C
Nucleotide metabolism
Gene nameYORF
GCD10
GCD11
GCN20
GCN3
TEF4
TIF2
TIF34
TIF35
SUI2
YEF3
YNL062C
YER025W
YFR009W
YKR026C
YKL081W
YJL138C
YMR146C
YDR429C
YJR007W
YLR249W
Translation initiation and 
elongation factors
MES1
WRS1
TRM82
PUS6
HTS1
YGR264C
YOL097C
YDR165W
YGR169C
YPR033C
tRNA synthetases or met abolism
RPB8
RPC34
RPA190
RPA49
RPA135
YOR224C
YNR003C
YOR341W
YNL248C
YPR010C
RNA Polymerase I and III
Gene nameYORF
 
 
6.3.2 Northern analysis of a subset of RP and of one Ribi gene confirms the 
downregulation of these genes in several glc7 mutant alleles 
To confirm that RP and Ribi gene transcription was downregulated in glc7-12 
mutants, we carried out Northern analysis with probes against several RP mRNAs 
(Rps11, Rps13, Rps16, Rpl 28) and the mRNA of Asc1, a Ribi gene (Fig. 6.2). Rps11, 
Rps13 and Asc1p were among the RP and Ribi genes identified in the microarray 
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(p<0,001), whereas Rps16 and Rpl28 were not. We extracted total RNA from glc7-12 
at the permissive and the non-permissive temperature. In addition, we collected total 
RNA from several other temperature sensitive glc7 mutant strains to find out whether 
the transcriptional downregulation of RP genes would be allele-specific. Whereas 
glc7-10 showed a modest decrease in mRNA levels, glc7-12, glc7-13 and glc7-5 
showed a strong or complete loss of mRNAs of all the mRNAs tested. The fact that 
Rps 16 and Rpl 28 mRNA levels are decreased as clearly as levels for Rps11 and 
Rps13 reinforces the notion that downregulation applies to all RP genes. Therefore, 
this Northern analysis shows that we applied very stringent conditions in our 
microarray that do not reveal the complete set of genes that are differentially 
expressed in glc7-12. This also indicates that the microarray data are highly 
significant. Furthermore, we conclude that transcription of RP genes is repressed in 
several glc7 mutant strains.  
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Figure 6.2. Expression of ribosomal protein genes is downregulated in glc7 mutants. 
Northern analysis of 20µg total RNA extracted from WT, glc7-10, glc7-12, glc7-13, glc7-5 and  
ssu72-2 cells following growth at RT or after shift to 37º C for the indicated times. Filters were probed 
with random-primed labeled oligonucleotides directed against the RNAs indicated on the left. 18S 
served as loading control.  
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6.3.3 The CTD of RNAP II is most likely not involved in the transcription regulation 
of RP and Ribi genes 
Transcription of genes is regulated at many levels. We wanted to exclude the 
possibility that the downregulation of RP and Ribi genes results from a general 
transcription failure due to misregulation of the transcription apparatus. The CTD of 
RNAP II constitutes a “landing platform” for factors that associate with it and co-
transcriptionally process the nascent transcript (Proudfoot, 2000a). However, the 
function of these processing factors is not limited to the production of mature 
mRNAs, but they also influence the transcriptional activity of RNAP II (Zorio and 
Bentley, 2004). By providing a platform for transcription processing factors the CTD 
is an important link in the communication between RNAP II transcription and 
maturation of the transcripts.  
The highly dynamic phosphorylation pattern of the CTD ensures that specific 
processing factors bind the CTD at specific phases in the transcription cycle (see 
chapter 1.6). The phosphorylation pattern of the CTD is achieved by a set of kinases 
and phosphatases. Among the know phosphatases is Ssu72, a component of CPF. 
Ssu72 dephosphorylates serine-5 of the RNAP II CTD to release RNAP II from a 
transcriptional pause site and to promote productive transcription (Krishnamurthy et 
al., 2004).  
We asked whether interfering with the CTD phosphorylation pattern would disturb 
RP gene transcription. Therefore, we were interested if the mRNA levels of RP and 
Ribi genes would decrease in the ssu72-2 mutant. However, we detected normal 
levels of the respective mRNAs (Rps11, Rps16 and Asc1) in ssu72-2 after shift to the 
non-permissive temperature (Fig. 6.2). We did not test Rps13 and Rpl28 in this 
mutant. This indicates that a disturbed CTD phosphorylation pattern is not sufficient 
to cease transcription of RP genes. Moreover, we and others (He and Moore, 2005) 
could not find any proof that Glc7p dephosphorylates the CTD in vivo (see Fig.3.8 
chapter 3.3.10). Altogether, this could suggest that the CTD is not the target of 
regulation in the control of RP gene transcription.  
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6.3.4 Crf1 accumulates in the nucleus of glc7-12 and glc7-13 mutants under non-
permissive conditions  
Recently, it has been shown that a set of transcription factors consisting of Fhl1p, 
Ifh1p and Crf1p, specifically regulate the transcription of RP genes (Martin et al., 
2004; Schawalder et al., 2004; Wade et al., 2004). Fhl1 acts in concert with the co-
activator Ifh1p or the co-repressor Crf1p to activate or repress the transcription of RP 
genes. The binding of Crf1p to Fhl1p represses transcription of RP genes. 
Rapamycin treatment of cells, which mimics nutrient depletion, leads to a 
downregulation of RP gene transcription. One consequence of rapamycin treatment is 
the rapid import of Crf1p from the cytoplasm to the nucleus. While phosphorylation 
of Crf1p is crucial for nuclear localization it is probably not needed for the interaction 
with Fhl1p (Martin et al., 2004).  
We asked whether mislocalization of Crf1p to the nucleus might be one of the reasons 
for the downregulation of RP genes in our glc7 mutants. To analyze the sub cellular 
localization of Crf1p, we carried out indirect immunofluorescence experiments with 
cells expressing HA-tagged Crf1p. In contrast to WT, we see a fast and strong 
accumulation of HA-Crf1p in the nucleus in glc7-12 and glc7-13 mutant cells after 
shift to the non-permissive temperature (Fig. 6.3). In glc7-13 we readily detect HA-
Crf1p in the nucleus after a 15 min shift to 33º C. Also glc7-12 accumulates HA-
Crf1p in the nucleus after a 30 min shift to 37ºC. We did not test shorter time points 
for glc7-12.  
These experiments show that inactivating the phosphatase activity of Glc7p by heat 
has the same effect on the localization of Crf1p as rapamycin addition. We can 
exclude that this effect is due to the heat shock, because WT cells do not accumulate 
Crf1p in the nucleus.  
Taken together these experiments suggest that the high concentration of Crf1p in the 
nucleus could contribute to the repression of RP gene transcription which we observe 
in these mutants. However, while it was clearly demonstrated that Crf1p acts as a co-
repressor of RP gene transcription when using strains with an TB50 background 
(Martin et al., 2004), the W303 strain background used in this study does not depend 
on Crf1p. It has recently been reported that Crf1p does not associate with the 
promoter region of an RP gene and that deletion of Crf1p does not abolish repression 
of RP gene transcription by rapamycin in this strain background (Zhao et al., 2006). 
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Since we work in a W303 background, a function of Crf1p in RP gene repression may 
not be a general phenomenon. Nevertheless, this experiment indicates that nuclear 
accumulation of Crf1p can be controlled by Glc7p. 
WT glc7-13
DAPI DAPIHA-Crf1 HA-Crf1 at 33ºC
0 min
15 min
30 min
WT glc7-12
DAPI DAPIHA-Crf1 HA-Crf1 at 37ºC
0 min
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Figure 6.3. Glc7 controls CRF1 nuclear localization 
A) Cells were grown in SD medium to OD600 0.8 and shifted to 33ºC for the indicated times. CRF1 
localization was examined by indirect immunofluorescence on whole fixed cells. In all cases, plasmid-
borne CRF1 was tagged with the HA epitope and a monoclonal anti-HA antibody was used as a 
primary antibody for indirect immunofluorescence. Strains were as follows: WT and glc7-13 
transformed with pDM40. B) Experimental procedures as in A) except cells were shifted to 37ºC for 
the indicated times. Strains were as follows: WT and glc7-12 transformed with pDM40. 
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6.3.5 Nuclear accumulation of Yak1p is regulated by Glc7p 
Under non-favorable nutrient conditions the kinase Yak1p phosphorylates Crf1p. 
Subsequently, Crf1p translocates to the nucleus and competes with Ifh1p for binding 
to Fhl1p (Martin et al., 2004). Yak1p kinase activity is regulated negatively, probably 
directly, by PKA (Garrett and Broach, 1989; Griffioen et al., 2001; Moriya et al., 
2001; Zappacosta et al., 2002). Therefore, the activity of Yak1p is greatly enhanced 
when cells are treated with rapamycin or when starved for glucose. In addition, these 
conditions lead to nuclear accumulation of Yak1p (Moriya et al., 2001; Schmelzle et 
al., 2004). In an attempt to test whether nuclear localization of Crf1p was caused by 
an enhanced activity of its kinase Yak1p, we looked at the sub cellular localization of 
Yak1p, as it accumulates in the nucleus when it is activated. To this end, we 
performed indirect immunofluoresence microscopy on WT and glc7-13 cells 
expressing plasmid-borne HA-tagged Yak1p. We found that Yak1p accumulates in 
the nucleus of glc7-13 cells but not in WT cells after a shift to the non-permissive 
temperature of 33º C for 30 min (Fig. 6.4, WT not shown).  
This indicates that Yak1p is active in our mutant strain at 33ºC and is therefore able to 
promote nuclear localization of Crf1p likely by phosphorylating Crf1p.  
glc7-13
DAPI DAPIHA-Ifh1 HA-Yak1 at 33ºC
0 min
30 min
glc7-13
 
Figure 6.4. Yak1 accumulates in the nucleus in glc7-13 mutant cells 
Cells were grown in SD medium to OD600 0.8 and shifted to 33ºC for the indicated times. YAK1 and 
IFH1 localization was examined by indirect immunofluorescence on whole fixed cells. Plasmid-borne 
YAK1 and IFH1 was tagged with the HA epitope and a monoclonal anti-HA antibody was used as a 
primary antibody for indirect immunofluorescence. Strains were as follows: glc7-13 transformed with 
pDM55 (IFH1; left panel) or pDM57 (YAK1; right panel). IFH1 served as a nuclear marker. 
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6.3.6 Constitutively active Ras signaling suppresses RP gene transcription failure in 
glc7-12 but not in glc7-13 
In S. cerevisiae, the RAS/cAMP and the TOR signaling pathway play important roles 
in communicating nutrient conditions to the cell. It has been shown that the two 
pathways share the regulation of RP gene transcription, because the hyperactive 
Ras2val19 allele of Ras2, is able to suppress a TOR deficiency and restores RP gene 
transcription after rapamycin treatment (Schmelzle et al., 2004). Consequently, under 
favorable nutrient conditions both pathways support the transcription of RP genes. We 
were interested if Ras2val19 could suppress the downregulation of RP gene 
transcription in glc7 mutants. Therefore, we transformed glc7-12 and glc7-13 with a 
plasmid expressing Ras2val19 or an empty vector control and extracted total RNA from 
cells before and after shift to the non-permissive temperature. RP gene transcription is 
transiently downregulated in response to heat shock but thereafter increases constantly 
until reaching normal levels (see results for WT with empty vector control; Fig. 6.5 a, 
D. Martin unpublished). Hyperactive Ras signaling however suppresses this transient 
downregulation in the WT and also in glc7-12 mutant cells. Interestingly, hyperactive 
Ras signaling does not result in transcription of RP genes in glc7-13 at the non-
permissive temperature, indicating that Glc7p acts downstream or in parallel to 
Ras/TOR. However, we observed the complete opposite for glc7-12, which suggests 
that Glc7p acts upstream of Ras and/or TOR. We suspect that there could be more 
than one function for Glc7p in these signaling cascades. In addition, Glc7p could act 
independent of this signaling. Taken together, we conclude that Glc7p acts 
downstream or in parallel to Ras/TOR and in addition functions independent of this 
signaling pathway to regulate the transcription of RP genes.  
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Figure 6.5. Allele-specific effect of Ras2val19 on expression of RPL30 in glc7 mutant cells 
WT, glc7-12 and glc7-13 cells were transformed with pTS 118 (Ras2val19) or with an empty vector 
control. Northern analysis of 20µg total RNA extracted from WT, glc7-12, glc7-13 cells was performed 
following growth at RT or after shift to 37º C for the indicated times. Filters were probed with random-
primed labeled oligonucleotides directed against RPL30. A) Ras2val19 does not suppress 
downregulation of RPL30 in glc7-13 mutant cells. B) Ras2val19 does suppress downregulation of 
RPL30 in glc7-12 mutant cells. 
 
 
6.3.7 PKA is active in glc7-12 and glc7-13 suggesting that Glc7p acts downstream 
of PKA or in parallel to Yak1 
From the experiments with the hyperactive Ras val19 allele we could not firmly 
conclude that Glc7p is part of the Ras/PKA and the TOR signaling pathways. We 
therefore decided to investigate PKA. The kinase PKA was shown to be important for 
signal transmission to the nucleus in the TOR as well as in the cAMP/Ras signaling 
pathway. Importantly, PKA negatively regulates the kinase Yak1p (Martin et al., 
2004), which is active in our glc7-13 mutant cells.  Since Yak1p is active in glc7-13 
under non-permissive conditions this would imply that PKA itself is inactive.  
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PKA consists of a catalytic subunit, redundantly encoded by the genes Tpk1p, Tpk2p 
and Tpk3p (Toda et al., 1987b) and the regulatory subunit Bcy1p. Dissociation of 
Bcy1 from Tpk1p leads to activation of the catalytic subunit, which takes place when 
cAMP binds to Bcy1p. cAMP production is triggered by glucose. At least two 
different mechanisms determine the sub cellular localization of PKA: first, cAMP 
controls the localization of Tpk1p. When cAMP is abundant Tpk1 is distributed 
equally all over the cell. If cAMP levels drop, Tpk1 accumulates in the nucleus. 
Second, the carbon source determines the localization of Bcy1p. Whereas Bcy1p is 
predominantly nuclear in cells grown on glucose, it is also found in the cytoplasm in 
cells grown on ethanol (Griffioen et al., 2000). In addition, rapamycin induces the 
nuclear localization of both Tpk1p and Bcy1p. To understand the function of Glc7p in 
the regulation of RP gene transcription, it was important to see whether PKA was 
active in our glc7 mutants and if localization of PKA would give any hint for the 
involvement of Glc7p in either the TOR or cAMP/Ras signaling pathways or both. 
We first looked at the cellular distribution of HA-tagged Bcy1 by indirect 
immunofluoresence microscopy and followed it over six hours at the non-permissive 
temperature in glc7-13 cells. In agreement with published reports (Griffioen et al., 
2003), we find that after shift to the non-permissive temperature Bcy1p is 
redistributed throughout the cell in WT cells (Fig. 6.6 a). In contrast, Bcy1 remained 
in the nucleus in glc7-13 cells. This suggests that inactivating glc7-13 has the same 
effect as rapamycin treatment on the intracellular localization of Bcy1p. This also 
suggests that Glc7p is part of one of the two signaling pathways.  
Next, we compared localization of HA-tagged Tpk1p in WT and glc7-13 cells after 
shift to the non-permissive temperature by indirect immunofluoresence microscopy. 
At RT Tpk1p is distributed equally within the cell in WT as well as in glc7-13 cells 
(Fig. 6.6 b). Growing the cells at the non-permissive temperature leads to nuclear 
accumulation of Tpk1p in some cells in both the WT and in glc7-13 mutant cells. This 
resembles the situation after rapamycin treatment. However, after one hour at the non-
permissive temperature, Tpk1p did not show a predominantly nuclear localization 
anymore in glc7-13 cells, but was detected all over the cell. In WT, many cells 
continued to show nuclear localization of Tpk1p. Therefore, in a time window of 
around half an hour at the restrictive temperature, WT and glc7-13 mutant cells 
behave similar concerning the localization of Tpk1p. Within this time scale of half an 
hour however, we observe severe defects in RP gene transcription.  
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In conclusion, it is unlikely that Tpk1p is the target of Glc7p in the regulation of RP 
gene transcription. It is more likely that Glc7p regulates the activity of Tpk1p as a 
component of the glucose starvation signaling cascade because glucose starvation 
leads to nuclear export of Tpk1p. We conclude that Glc7p does not regulate Tpk1p 
activity via signal input of the TOR or cAMP/Ras signaling cascades but rather 
through signal input of the glucose starvation signaling cascade. 
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Figure 6.6. Glc7 controls nuclear localization of BCY1 and TPK1  
A) Cells were grown in SD medium to OD600 0.8 and shifted to 37ºC for the indicated times. BCY1 
localization was examined by indirect immunofluorescence on whole fixed cells. Plasmid-borne BCY1 
was tagged with the HA epitope and a monoclonal anti-HA antibody was used as a primary antibody 
for indirect immunofluorescence. Strains were as follows: WT and glc7-13 transformed with pTS137. 
B) Experimental procedures as in A). Localization of TPK1 was examined in cells shifted to 37ºC for 
the indicated times. Strains were as follows: WT and glc7-13 transformed with pTS134. 
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6.3.8 Glc7p controls phosphorylation of a distinct phosphoisoform of Bcy1p 
The cytoplasmic localization of Bcy1 induced by heat stress requires phosphorylation 
of serines located in its localization domain (Griffioen et al., 2003). Interestingly these 
modifications do not affect PKA activity as such. In previous studies, Yak1p kinase 
was found to be required for cytoplasmic localization of Bcy1p in glucose deprived 
cells (Griffioen et al., 2001). However, it was suggested that this kinase is not 
important for temperature-dependent Bcy1p localization (Griffioen et al., 2003). In 
conclusion there seem to be two functionally independent phosphorylation events at 
the localization domain of Bcy1p that prompt Bcy1 to localize predominantly in the 
cytoplasm. To test whether mislocalization of Bcy1 in glc7-13 cells to the nucleus at 
the non-permissive temperature was due to an alteration in the phosphorylation status 
of Bcy1p, we performed Western analysis of purified HA-tagged Bcy1p from WT, 
glc7-12 and glc7-13 cells, grown at the permissive and non-permissive temperature. 
An antibody directed against the HA-tag revealed the presence of slower migrating 
forms of Bcy1 within 15 min in the WT and in the mutant cells (Fig. 6.7).  
Therefore, we conclude that phosphorylation of Bcy1 in response to heat stress is not 
significantly altered in glc7-12 and glc7-13 and thus cannot be the reason for the 
mislocalization of Bcy1 in glc7-13 cells at 37ºC. 
In addition to the phosphoisoform of Bcy1 induced by heat stress, there are at least 
two additional phosphoisoforms of Bcy1p visible in glc7-12 and glc7-13 after growth 
for 1 hour at 37ºC or more. These additional isoforms are only very weak in WT. This 
suggests that Glc7p regulates the formation of a distinct set of phosphoisoforms of 
Bcy1 and that this phosphorylation does not occur in response to heat stress. In 
addition, the kinase Yak1 is not responsible for this phosphorylation, since 
phosphorylation by Yak1p leads to cytoplasmic localization of Bcy1p. Finally, we 
suggest that the additional phosphorylation of Bcy1 observed in the glc7 mutants, 
reverts the effect of the heat shock phosphorylation concerning localization of Bcy1p.  
Western analysis of heat-stressed cells producing an HA-tagged version of Bcy1p 
with an antibody directed against the phosphorylated target region of PKA showed an 
increase in the signal in glc7-12 and glc7-13 compared to the WT. However, we 
consider these results to be preliminary because WT and mutant extracts were not 
assayed on the same gel (data not shown). Although we see a strong difference 
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between the WT and the mutants this could in part be due to variations between 
experiments. Nevertheless, these experiments suggest that Tpk1p is phosphorylating 
Bcy1p, but that the phosphate is not removed anymore in the mutants under 
conditions when Glc7p is inactive, meaning that Glc7p could be the responsible 
phosphatase. This also suggests that Tpk1 is active and responsible for the nuclear 
localization of Bcy1p to the nucleus.   
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Figure 6.7. Specific phospho-isoforms of Bcy1 accumulate in glc7 mutant cells 
HA-tagged BCY1 was immunoprecipitated from WT, glc7-12 (A) and glc7-13 (B) cell extracts before 
and after shift to 37ºC for the indicated times. Purified HA-BCY1 was subjected to immunoblotting 
analysis using an anti-HA antibody. Arrows on the right hand side indicate phospho-isoforms of 
BCY1.  
 
 
6.3.9 Phosphorylation of Tpk1p does not increase in glc7-12 or glc7-13 mutants 
Phosphorylation of Tpk1p increases its affinity to bind to the regulatory subunit 
Bcy1p. In association with Bcy1p Tpk1p is inactive. Although there have been 
numerous indications that Tpk1p is active, we wanted to investigate the 
phosphorylation status of Tpk1p in the WT and the glc7 mutants. Any increase in the 
phosphorylation level of Tpk1 in the glc7 mutants under non-permissive conditions 
would indicate that Glc7p regulates the phosphorylation status of Tpk1p and therefore 
also the activity of Tpk1p. However, no increase in the signal was observed in glc7-13 
with an antibody against the phosphorylated region of PKA in a Western analysis on 
HA–tagged Tpk1p. glc7-12 even showed a reduction in phosphorylation of Tpk1p at 
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shift to 37º C (Fig. 6.8). We tested the same blots with an antibody directed against 
the HA-tag to determine whether equal amounts of protein were loaded. Altogether, 
these experiments suggest that Glc7p does not regulate the phosphorylation levels of 
Tpk1p and that Tpk1p is active in glc7-12 and glc7-13 under non-permissive 
conditions. 
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Figure 6.8. Glc7 does not regulate the phosphorylation state of TPK1 
HA-tagged TPK1 was immunoprecipitated from WT, glc7-12 (A) and glc7-13 (B) cell extracts before 
and after shift to 37ºC for the indicated times. Purified HA-TPK1 was subjected to immunoblotting 
analysis using an anti-HA antibody or an antibody directed against the phosphorylated target region of 
PKA as indicated on the left.  
 
 
6.3.10 Pgk1p mRNA levels are decreased in glc7-12 and glc7-13 mutants 
The transcription factor Rap1p not only controls transcription of RP genes but also 
regulates expression of glycolytic genes such as Pgk1p. To achieve this Rap1p works 
in concert with different sets of transcription factors. For the transcription of RP genes 
Rap1p collaborates with Fhl1 and Ifh1p, whereas for the transcription of glycolytic 
genes Rap1 cooperates with the transcription factor Gcr1 (Drazinic et al., 1996).  
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To determine whether Glc7p in general influences transcription that is regulated by 
Rap1p, we carried out Northern analysis on total RNA extracted from the WT, glc7-
10, glc7-12, glc7-13, glc7-5 and ssu72-2 mutant strains with a probe directed against 
Pgk1p after shift to the non-permissive temperature (Fig. 6.9). Indeed, we find that 
two of the glc7 alleles, glc7-12 and glc7-13, show a decrease in the Pgk1p mRNA. 
However, glc7-10 and glc7-5 have equal levels of the RNA over time, indicating that 
the downregulation of Pgk1 is allele specific. Interestingly glc7-5 appears to influence 
only transcription of RP and Ribi genes but not of glycolytic genes. This experiment 
suggests that Glc7p is involved in transcription regulation of genes that depend on 
Rap1. 
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Figure 6.9. Pgk1 expression is altered in glc7 mutant strains 
Northern analysis of 20µg total RNA extracted from WT, glc7-10, glc7-12, glc7-13, glc7-5 and ssu72-
2 cells following growth at RT or after shift to 37º C for the indicated times. Filters were probed with 
random-primed labeled oligonucleotides directed against Pgk1. 18S served as loading control.  
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6.4 Discussion 
 
Two signaling pathways control transcription of RP and Ribi genes in response to 
nutrient conditions: the TOR and the PKA pathways. Only recently, the transcription 
factors that are activated by these signaling pathways have been identified (Martin et 
al., 2004; Schawalder et al., 2004; Wade et al., 2004). These include Fhl1p, Ifh1p and 
Crf1p. We find that Glc7p is involved in the regulation of RP and Ribi gene 
transcription based on the finding that in glc7 mutant strains RP and Ribi genes are 
downregulated as observed by both, microarray experiments and Northern analysis. 
Further investigation led to the observation that two downstream components of the 
TOR and Ras/PKA pathways, Crf1p and Yak1p, accumulated in the nucleus in glc7 
mutant strains. The mislocalization of Crf1p might be one of the reasons for the 
downregulation of RP genes in glc7 mutant strains as its nuclear localization is known 
to repress RP gene transcription. An epistasis analysis indicated that Glc7p acts 
downstream of Ras. In addition, the activity of PKA was not compromised in glc7 
mutant strains at the restrictive temperature suggesting that PKA is not regulated by 
Glc7p. Therefore, we propose that Glc7p regulates a factor downstream of PKA or in 
parallel to Yak1p.  
 
Relocalization of signaling components: a common feature in ribosome biogenesis  
Localization of transcription factors to RP and/or Ribi gene promoters in response to 
changes in environmental conditions appears to be a common feature in the regulation 
of RP and Ribi gene transcription. Transcription factors that regulate transcription of 
RP and/or Ribi genes, such as Fhl1p, Ifh1p, Crf1p and Sfp1p have all been shown to 
shuttle between the nucleus and the nucleolus or the nucleus and the cytoplasm, 
respectively. Only for Crf1p it was clearly shown that its cellular localization is 
regulated via phosphorylation (Martin et al., 2004). Phosphorylation of Crf1p results 
in nuclear import of Crf1p and localization to RP gene promoters where it acts as a 
co-repressor of RP gene transcription (Martin et al., 2004). Working with the essential 
protein phosphatase Glc7p, we therefore considered Crf1p a prime target of Glc7p in 
the regulation of RP gene transcription. We find that localization of Crf1p is indeed 
regulated by Glc7p. Therefore, it could be possible that under optimal growth 
conditions Glc7p dephosphorylates nuclear Crf1p to dislocate this repressor from RP 
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promoters thus maintaining RP gene transcription. However, in glc7 mutants, we also 
observe nuclear accumulation of Yak1p, a signaling component downstream of PKA. 
Yak1p is the kinase that phosphorylates Crf1p under non-favorable nutrient 
conditions and therefore acts upstream of Crf1p. Thus, it seems more likely that 
Glc7p influences localization of Crf1p via the regulation of the activity of Yak1p. We 
do not exclude the possibility that both, Yak1p and Crf1p are substrates for Glc7p. It 
was proposed that repression of RP gene transcription was mediated via the co-
repressor Crf1p (Martin et al., 2004). However, the repressive property of Crf1p 
seems to be dependent on the strain background because deletion of Crf1p only in a 
TB50 strain background but not in a W303 strain background leads to a de-repression 
of RP gene transcription in the presence of rapamycin (Zhao et al., 2006). Presently, it 
is not clear what the molecular and genetic basis for the difference in Crf1p function 
in these two strains is (Zhao et al., 2006). In conclusion, Crf1p might not be an 
essential repressor of RP gene transcription.  
The localization of Sfp1, a transcription factor that is involved in the regulation of 
both RP and Ribi genes, is also remarkably responsive to the environment (Marion et 
al., 2004). Under optimal growth conditions, Sfp1p is localized to the nucleus, 
promoting RP and Ribi gene transcription. In response to inhibition of TOR signaling 
or changes in nutrient availability, Sfp1p is directed to the cytoplasm. As Sfp1p is 
never completely excluded from the nucleus, the RP and Ribi promoters may be quite 
sensitive to the nuclear concentration of Sfp1p. Remarkably, the kinetics of Sfp1 
relocalization to the cytoplasm matches the kinetics of RP repression (Marion et al., 
2004). Sfp1 has two putative phosphorylation sites. Phosphorylation of these sites 
seem to be absent in rapamycin treated cells (H. Lempiainen, poster abstract). This 
suggests that also localization of Sfp1p is regulated by phosphorylation. We therefore 
plan to test whether Sfp1p is the target of Glc7p in the regulation of RP and Ribi gene 
transcription. Recently, it was shown that Sfp1p influences the nuclear localization of 
Fhl1 and Ifh1p, which are bound to RP promoters under favorable nutrient conditions 
(Jorgensen et al., 2004). Starvation or the absence of Sfp1p causes Fhl1p and Ifh1p to 
localize to nucleolar regions resulting in reduced RP gene transcription (Jorgensen et 
al., 2004). This observation emphasizes the important role of Sfp1p in transcription of 
RP genes. Mislocalization of Sfp1p in glc7 mutant strains could therefore lead to the 
observed downregulation of RP genes in glc7 mutants.  
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We also tested the possibility that PKA could be regulated by Glc7p. Indeed, we 
found that Glc7p regulates the phosphorylation status of Bcy1p, the inhibitory subunit 
of PKA. However, the kinetics of this regulation do not fit the kinetics of RP gene 
downregulation. We observed that RP gene transcription is downregulated within 15 
min in glc7 mutants, whereas a difference in the phosphorylation status of Bcy1p was 
only visible after one hour. Thus, we concluded that regulation of RP gene 
transcription does not involve the dephosphorylation of Bcy1p by Glc7p. It remains to 
be elucidated what the function of Glc7p in regulating the phosphorylation status of 
Bcy1p is. 
 
How is transcription of RP and Ribi genes regulated? 
Based on recent work, a simple model evolved how RP gene transcription is 
regulated. In this model, Rap1p is constitutively bound to RP gene promoters and 
recruits Fhl1p. These two factors however are not sufficient to activate transcription 
of RP genes. At least the recruitment of Ifh1p by Fhl1p is required to fully activate 
transcription of RP genes. Several lines of evidence indicate that this model is 
oversimplified and that transcription of RP genes requires further factors. First, cells 
lacking Sfp1p do not properly regulate RP mRNA levels in response to environmental 
conditions (Marion et al., 2004). Secondly, residual transcription of RP genes was 
observed in cells without Fhl1p and Ifh1p (Rudra et al., 2005). Rapamycin represses 
this residual transcription suggesting that this residual transcription occurs 
independently of the Rap1-Fhl1-Ifh1 transcription complex (Zhao et al., 2006). These 
observations lead to a refined model in which inputs from both, the Sfp1p and the 
Rap1-Fhl1-Ifh1p complex are required for the proper activation of RP gene 
transcription. The localization of all of these factors to RP promoters is controlled by 
the TOR and the Ras/PKA pathway.  
Does RP gene transcription require an repressor at all? It is possible that transcription 
of RP genes is repressed simply by the lack of transcriptional activators, such as, 
Ifh1p and Sfp1p. For example, if Ifh1p is absent only very little RP gene transcription 
is observed. However, transcription of RP genes has to be controlled tightly to 
respond to changes in the environment quickly. Therefore, it seems not appropriate 
that downregulation of RP gene transcription would not require a repressor. Perhaps 
Crf1p is only one of several redundant repressors that all respond to slightly different 
conditions. This could explain why a Crf1 deletion affects RP gene expression only in 
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certain strain backgrounds but not in others. However, the strain background-specific 
effect of Crf1p made it more difficult to interpret our results. Since we worked in a 
W303 background, it seems unlikely that the strong downregulation of RP gene 
transcription observed in the glc7 mutants is only due to the nuclear accumulation of 
Crf1p in these strains.  
Finding the real target of Glc7p in the regulation of RP gene transcription will be 
challenging, but important to shed light on how RP gene expression is regulated by a 
phosphorylation/dephosphorylation event.  
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7 Final Discussion 
 
The aim of this thesis was to identify novel functions for the essential protein 
phosphatase Glc7p in transcription and processing of RNAP II transcripts. Glc7p is a 
serine/threonine protein phosphatase highly conserved in evolution that has been 
implicated in a quite diverse set of reactions throughout the cell.  
Transcription of genes by RNAP II is a well regulated process. In order to obtain a 
mature, functional mRNA, the primary transcript is co-transcriptionally capped at the 
5’end, spliced and 3’ end processed. 3’ end processing of pre-mRNAs which includes 
cleavage at the poly(A) site followed by polyadenylation of the upstream cleavage 
product requires the concerted action of the multiprotein complex CPF, CF IA and CF 
IB. However, the function of the different CPF subunits is not restricted to the actual 
cleavage and polyadenylation reaction. Many subunits of CPF are also involved in 
processes such as transcription elongation and termination or in coupling of 3’ end 
formation to transcription. First indications that Glc7p could also be required for 
functions associated with CPF came from the finding that Glc7p co-purifies with 
CPF. This encouraged us to investigate a possible function of Glc7p in 3’ end 
processing of pre-mRNAs. Indeed, we could show that Glc7p is required for the 
polyadenylation but not for the cleavage step of 3’ end processing (Chapter 2). He and 
coworkers identified the CPF subunit Pta1p as the substrate of Glc7p in the regulation 
of polyadenylation. However, the mechanism by which phosphorylated Pta1p inhibits 
polyadenylation is not understood. Most likely, the phosphate-group disturbs crucial 
interactions between CPF subunits that are required for polyadenylation.  
In addition, our investigation of Glc7p suggests that Glc7p is involved in transcription 
termination of snoRNAs. snoRNAs are encoded by genes that are transcribed by 
RNAP II. Transcription of genes terminates when RNAP II dissociates from the DNA 
template. Among the trans-acting factors required for snoRNA transcription 
termination are the Nrd1 complex, a subcomplex of CPF called APT, the nuclear 
exosome and the transcription elongation complex PAF. Glc7p is part of the APT 
subcomplex. Interestingly, glc7 mutants show identical mutant phenotypes as mutants 
in all Nrd1 complex subunits, indicating that Glc7p functions in the Nrd1 complex-
dependent pathway of snoRNA transcription termination. To find out how Glc7p 
influences snoRNA transcription termination on the molecular level it was, intriguing 
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to test whether the subunits of the Nrd1p complex, which are all phospho-proteins, are 
dephosphorylated by Glc7p. However, the phosphorylation status of none of these 
proteins turned out to be regulated by Glc7p. We also tested whether the 
phosphorylation status of Pta1p is increased in those glc7 mutants which show a 
snoRNA transcription termination defect. Surprisingly, also the phosphorylation 
status of Pta1p was not changed in these glc7 mutants compared to the WT, 
suggesting that Pta1p is not the target of Glc7p in the regulation of snoRNA 
transcription termination. This is interesting because it revealed that Pta1p seems to 
be exclusively targeted by Glc7p for the regulation of polyadenylation but not for 
regulation of snoRNA transcription termination. Since we have not identified the 
substrate of Glc7p in snoRNA transcription termination yet, it is still possible that an 
additional subunit of CPF is targeted by Glc7p. What complicates matters is the fact 
that for many CPF subunits it is not known whether they are phosphorylated or not. It 
would be necessary to clarify this question in order to test putative substrates of Glc7p 
within CPF. The question still remains which protein is regulated by Glc7p in 
snoRNA transcription termination. It could be one of those factors that are directly 
involved in snoRNA transcription termination, like a subunit of APT, one of the 
factors of the nuclear exosome or another still unknown factor. In addition, these 
factors might interact with additional factors that are needed in snoRNA transcription 
termination, for example for the coupling of different processes or the integration of 
signaling inputs. The lack of regulating the phosphorylation status of these factors 
could influence snoRNA transcription termination as well by disrupting important 
protein-protein interactions. This implicates, that the actual target of Glc7p in the 
regulation of snoRNA transcription termination does not necessarily have to be a 
factor directly involved in snoRNA transcription termination. Consequently, this 
complicates the search for the target in a process.  
Two main problems have slowed down our efforts to elucidate the processes Glc7p is 
involved in and also the substrates of Glc7p.  
One problem was that we did not have a conditional null allele of Glc7p to work with. 
Instead, we worked with temperature-sensitive (ts) glc7 alleles. It was not predictable 
which ts allele has a defect in a specific process. At worst, it is possible to miss a 
function completely with a certain allele. We observed many allele-specific effects 
with the glc7 mutant alleles we used, indicating that these alleles were not complete 
null alleles. As an example, only one, glc7-13, out of four glc7 ts alleles showed a 
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polyadenylation defect. If we would not have had glc7-13 at hand, we would have 
missed the fact that Glc7p is required for polyadenylation. glc7-10 was one of the 
mutant alleles which mostly showed no phenotype in the processes we tested. 
Therefore, this allele was not useful in our analysis, although we spent much time 
testing all these alleles in the processes we were interested to find the one allele which 
showed the strongest effect.  
A much more targeted approach would have been to use a conditional knock down 
allele, that completely abolishes any activity of the enzyme and any interactions with 
other proteins. With such an allele it should have been possible to test for the 
involvement of Glc7p directly in different processes. In addition, only one allele, the 
conditional knock down allele, would have to be tested and not several, as was the 
case for the ts alleles.  
An other obstacle was that we used a candidate approach to search for the putative 
substrate. This means that we picked our targets based on educated guess and tested 
each one separately. This implies that each putative substrate had to be endogenously 
tagged, purified and analysed by Western analysis. This is time consuming and as 
described above we experienced that often the most obvious targets turned out not to 
be the substrates.  
It might have been easier to purify entire complexes via a tagged subunit and 
subsequently analyze this complex for its phosphorylation state by Western analysis. 
Complexes like CPF are likely to harbor more than one Glc7p substrate. By analysing 
the entire complex candidate substrates could be revealed in one single experiment. In 
addition, this would also answer the question as to which of the CPF subunits are 
phospho-proteins at all.  
Another possibility to identify substrates of Glc7p could be in vivo labeling with 
radioactive phosphorus of whole cell extracts of WT and mutant strains at the non-
permissive temperature. Subsequent affinity purification of complexes and analysis of 
the phosphorylation status of the complex components by autoradiography could have 
lead to the identification of Glc7p substrates. Radioactive labeling has the advantage 
that differences in the phosphorylation status of putative substrates between a WT and 
mutant strains can be quantitated. The disadvantage of this approach is the implication 
of high dosages of radioactive phosphate.  
Substrates identified with the approaches described should be considered with 
caution. This is because a change in the phosphorylation status of a protein detected 
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by Western or radiographic analysis does not prove that this change has been brought 
about by a direct dephosphorylation of this protein by Glc7p. It could be possible that 
Glc7p for example controls the activity of an upstream kinase that is required for the 
phosphorylation of this specific protein. Consequently, Glc7p would not directly 
regulate the phosphorylation status of this putative substrate but only indirectly 
influences its phosphorylation state by directly regulating the upstream kinase. The 
upstream kinase might not be part of the purified complex. Therefore, the substrates 
found by the approaches described could give misleading results and would have to 
be evaluated by independent approaches.  
During transcription elongation specific factors assist RNAP II to efficiently 
transcribe genes. Transcription elongation factors either alter the chromatin structure 
to a transcription permissive state or change the processivity of RNAP II. These 
stimulating activities have to be halted to facilitate transcription termination. We 
found that Glc7p is involved in both processes, transcription elongation and 
transcription termination. Chromatin immunoprecipitation experiments demonstrated 
that Glc7p is predominantly localized at the promoter regions and the 3’ UTRs of 
genes but not over the body of the gene where transcription elongation factors are 
mainly found. The influence of Glc7p on transcription elongation therefore might be 
restricted to 3’ ends to alter the activities of transcription elongation factors in this 
region in order to facilitate transcription termination. This could be an additional 
function of Glc7p besides its involvement in the Nrd1p-dependent pathway of 
transcription termination. Glc7p could represent a dedicated transcription termination 
factor that acts on transcription elongation factors to halt their stimulating activities. 
In conclusion, Glc7p might couple transcription elongation to transcription 
termination. However, we can not explain why this property of Glc7p only applies to 
snoRNA genes. A reason for this could be that snoRNA genes including their 3’UTRs 
are much shorter than those of protein coding genes, implicating that the activity of 
RNAP II has to be controlled tighter.  
Another interesting mechanism in which the function of Glc7p is involved is the 
transcriptional regulation of RP and Ribi genes. It could be most challenging to find 
the molecular function of Glc7p because many factors of the signaling pathways that 
control RP and Ribi gene transcription have not been identified. Nevertheless, it 
seems worthwhile to test one last putative substrate candidate, the transcription factor 
Sfp1p. Sfp1p is required for the transcription of the RP and the Ribi regulon. These 
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two regulons were downregulated in the glc7-12 strain. In addition, localization of 
Sfp1p most likely depends on a phosphorylation event. In conclusion, the 
misregulation of Sfp1p could account for the downregulation of RP and Ribi genes, 
which we have observed in glc7-12 and glc7-13 mutant strains. Therefore, I am most 
tempted to test this hypothesis. 
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8 Materials and Methods 
 
Yeast strains 
Yeast strains were maintained on YPD (1% yeast extract, 2% peptone, 2% glucose) or 
on a selective YNB medium (0.67% yeast nitrogen base without amino acids, 2% 
glucose or galactose) supplemented with the appropriate nutritional ingredients. 
Plasmids were introduced into yeast cells using the modified lithium acetate method 
(Gietz et al., 1995). Loss of URA3-marked plasmids from yeast cells was 
accomplished by plasmid shuffling on solid medium containing 5-FOA (5-fluoro-
orotic acid).    
 
Genotypes of yeast strains used in this study were: 
Glc7 strains: 
PAY704-1 MATa his3 leu2 ura3 ade2 glc7::LEU2 trp1::GLC7::TRP1 
PAY703-1 MATa his3 leu2 ura3 ade2 glc7::LEU2 trp1::glc7-5::TRP1 
PAY700-4 MATa his3 leu2 ura3 ade2 glc7::LEU2 trp1::glc7-10::TRP1 
PAY701-1 MATa his3 leu2 ura3 ade2 glc7::LEU2 trp1::glc7-12::TRP1 
PAY702-1 MATa his3 leu2 ura3 ade2 glc7::LEU2 trp1::glc7-13::TRP1 
Research genetics, deletion strain library:  
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 rtf1Δ   
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 leo1Δ   
Spt5 and Spt4 strains 
GHY92 MATα his4-912Δ lys2-128Δ leu2Δ1 ura3-52 spt5-242 
GHY180 MATα his4-912Δ lys2-128Δ leu2Δ1 ura3-52 spt4Δ2::HIS3 
 
Plasmids used in this study 
pFA6a-CBP-TEV-protA-HIS3MX6: derived from pFA6a-HIS3MX6 (Longtine et al., 
1998). Has TAP tagging cassette. 
pRS416 (Sikorski and Hieter, 1989) yeast expression vector, URA3 marker 
pRS426 (Sikorski and Hieter, 1989) yeast 2µ vector, URA3 marker 
pKGGURA (Morillon et al., 2003b) 
pKGGΔTEF (Morillon et al., 2003b) 
pUGCYC1 (Birse et al., 1998b) 
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pDM40: CRF1 HA-tagged, 2µ, URA3, backbone YCplac33  
pDM55: IFH1 HA-tagged, 2µ, URA3, backbone YCplac33 
pDM77: YAK1 HA-tagged, 2µ, URA3, backbone YCplac33 
pTS134: TPK1 HA-tagged, 2µ, URA3, backbone YCplac33 
pTS137: BCY1 HA-tagged, 2µ, URA3, backbone YCplac33 
pTS118: Ras2val19, 2µ, URA3, backbone YCplac33 
M13mp18 phage vector (New England Biolabs) 
 
Cloning experiments were performed according to established protocols (Sambrook et 
al., 1989). 
 
Oligonucleotids used in this study 
1) for endogenous TAP-tagging:  
Sen1:  
R1 5’ accaatatatatgcaggtataattcctaacacttttacttcaagagaattcgagctcgtttaaac 3’  
F2 5’ gcttcatctagcccatttatcccaaaaaaaagaaagcctagatcacggatccccgggttaattaa 3’ 
Spt5:  
R1 5’ ttgatttcttcttgggtgatattggttctccttttggtgagaattcgagctcgtttaaac 3’ 
F2 5’ taagtcaaactatggtggtaacagtacatggggaggtcatcggatccccgggttaattaa 3’ 
Pti1:  
F2 5’ gcaacttatggtggaaaactttagaaaagaatatataatccggatccccggttaattaa 3’ 
R1 5’ aattaggtgtggttttctgatacgctatggctctgattacgaattcgagctcgtttaaac 3’ 
Pta1: 
F2 5’ cttacacaagcagtgcgattcactgcttgacaggctaaaacggatccccgggttaattaa 3’ 
R1 5’ gcctacacatgcgtatatatgatgtatgtaatggttgtgagaattcgagctcgtttaaac 3’ 
Pfs2: 
F2 5’ caggcatcgattcaaacatcaagagttccacattgccaggtttaagcatacggatccccgggttaattaa 3’ 
R1 5’ gcctgtggggtacattccccagaaatgagagatattatcacaaataatagaattcgagctcgtttaaac 3’ 
Nrd1:  
F2 5’ gaatatgcttaaccaacagcagcagcaacaacaacaaagccggatccccgggttaattaa 3’  
R1 5’ ttttatgtactatgagcaaataaagggtggagtaaagatcgaattcgagctcgtttaaac 3’ 
Nab3: 
F2 5’ ctggcaataatgttcaaagtctattagatagtttagcaaaactacaaaaacggatccccgggttaattaa 3’  
R1 5’ agaattcaagtataatgtacaagaaatggaaaagattgaaaaaagggagtgaattcgagctcgtttaaac 3’ 
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2) for Northern probes: 
Act: 5’ atggtcggtatgggtcaaaa 3’ 
        5’ ccaaacccaaaacagaagga 3’ 
Mrpl17: 5’ gggcttgctactgcaactgc 3’ 
              5’ ccgctaaaagaaattctgttttg 3’ 
Ycr015c: 5’ gcaccattgctaaattaccg 3’ 
                5’ cccctatataccaatagctgc 3’ 
Trs31: 5’ gcgcatctgaccaacaattc 3’ 
           5’ gccaaatctcaaaccttccc 3’ 
Nrd1: 5’ gcagcaggacgacgattttc 3’ 
          5’ ggggaggtgcgactgtac 3’ 
Pur5: 5’ ccgcactagactttacca 3’ 
          5’ gggtagttctgatttttcat 3’ 
 
3) Cloning of Glc7:  
Glc7NdeI: 5’ ggaactcatatggactcacaaccagttgac 3’ 
Glc7BamHI: 5’ tcgcggatccttattttttctttctacccccag 3’ 
 
4) Cloning into 2μ vector: 
PtiHind3 5’ gcgaagcttgcatcacatcagtgttt 3’ 
PtiXma1 5’ cgcccgggcacatgtgtcggagat 3’ 
Pta1Hind3 5’ gcgaagcttggcgtggtttccactcca 3’ 
Pta1Not1 5’ gggcggccgcccctttcccattagata 3’ 
Syc1Sal1 5’ ccgtcgacccgtcaccgatgctcat 3’ 
Syc1BamHI 5’ cgggatccggggataaaagatataaa 3’ 
 
Coimmunoprecipitation and immunoblotting 
Whole-cell extracts for SDS-PAGE analysis were prepared by glass bead lysis as 
described previously (Beck and Hall, 1999). Lysis buffer containing phosphatase and 
protease inhibitors were used as described previously (Schmelzle et al., 2004). For 
detection of HA-tagged proteins, a mouse anti-HA antibody (clone 12CA5) was used 
in a dilution of 1:5000. For detection of threonine phosphorylation an 
antiphosphothreonine antibody (Q7, Qiagen) was used. Signals were detected using 
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horseradish peroxidase-conjugated secondary goat anti-mouse antibodies and ECL 
reagents (Amersham Pharmacia Biotech). 
 
Fluorescence microcopy 
Fluorescence microscopy and indirect immunofluorescence on whole fixed cells were 
performed as described previously (Schmelzle et al., 2004). Monoclonal anti-HA 
(12CA5; diluted 1:500) was used as the primary antibody to detect HA-tagged 
proteins . Antibodies were always checked for specificity in each experiment using 
wild-type cells lacking the corresponding epitope.  
 
Extract preparation and in vitro cleavage and polyadenylation assays 
Extracts competent for in vitro processing were prepared following the procedure 
previously described (Ohnacker et al., 2000). Internally 32P-labeled CYC1 RNA was 
produced by in vitro run-off transcription and gel purification as described previously 
(Minvielle-Sebastia et al., 1994; Preker et al., 1995).The cleavage and 
polyadenylation assays were carried out as described by (Minvielle-Sebastia et al., 
1994). To restrict the assay to cleavage only, EDTA replaced MgAc and CTP 
replaced ATP. For reactions at elevated temperature, reaction mix and protein extracts 
were first preincubated separately at 37º C for 10 min, combined and assayed at 37º C 
for 50 min.  
 
RNA isolation and Northern Analysis 
Total RNA was isolated from 50ml yeast cultures grown to OD600 0,5-1,0. RNA was 
isolated by hot acid phenol extraction (Collart and Oliviero, 1994). Northern analyses 
was carried out as described (Dichtl et al., 2002b). High molecular weight RNA was 
resolved on 1.2% denaturing formaldehyde/agarose gel. Random primed probe were 
generated using α32P-dATP and the Roche random prime labeling kit. Templates were 
produced by PCR on yeast genomic DNA covering around 700 bp of coding sequence 
of the following ORF: Nrd1, Mrpl17, Pur5, Trs31, Ycr015c 
 
Primer extension 
The reverse transcription analysis was performed as described (Dichtl et al., 2002) 
with primers downstream of snoRNA genes as previously described (Steinmetz et al., 
2001). 
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Expression of recombinant proteins in E.coli 
BL21 E.coli cells carrying the respective plasmid were grown at 25° C in 2xYT until 
they reached an OD600 of approximately 1. Following induction by 0.5 mM IPTG 
incubation was continued for 6 hours. The proteins were purified at 4° C on 
gluthathione-Sepharose 4B as recommended (Pharmacia) and the protein was eluted 
with GST-elution buffer (75 mM KCl, 50 mM Tris-HCl (pH 7.9), 10% glycerol, 10 
mM glutathione (reduced), 0.01% NP40, 1 mM DTT).  
 
GST pull down experiments 
In vitro translations were performed with the TNT-coupled transcription-translation 
system (Promega). 100 ng GST fusion protein was incubated with in 3 µl of in vitro 
translated [35S]methionine labeled proteins for 1 hour at RT. The mixture was bound 
in a total volume of 1000 μl to 20 μl glutathione sepharose (Pharmacia), which was 
previously equilibrated in 1 ml PBS, 0.01% NP40 and 0,1mg/ml BSA. The matrix 
was washed 3 times with IPP150 (150 mM KCl, 20 mM Tris-Cl (pH 8,0), 0.01% 
NP40) and the proteins were eluted by addition of protein loading buffer and 
incubation at 95° C. Bound proteins were separated by 10% SDS-PAGE and 
visualized by autoradiography.  
 
Droplet test 
The strains were grown over night in YPD or the respective selective medium and 
diluted to an OD600 of 0.1, 0.001, 0.0001 and 0.00001. 5μl of each dilution was 
spotted on YPD plates or on selective medium and incubated at 25, 30, 33 and 37° C. 
 
3’ end labeling of total RNA 
Labeling of total RNA at their 3’ ends was carried out as described previously (Dichtl 
et al., 2002b). 6µg of total yeast RNA was labeled with α32P-cordycepin (Amersham) 
at their 3’-ends and Rnase treated using the method of (Lingner and Keller, 1993) 
modified according to (Preker et al., 1995). Nuclease-resistant poly(A) tails were 
resolved on denaturing 8.3M urea/10% polyacrylamide gels and visualized by 
autoradiography. 
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Generation of double mutants 
To generate double mutants, Glc7 strains were first transformed with plasmid pRS416 
carrying GLC7 WT. Transformed strains were crossed to mutant strains GHY180, 
BY4742rtf1Δ, or BY4742leo1Δ. Diploid cells were sporulated and the spores were 
dissected. The resulting haploid strains were tested for growth on different selective 
media and temperatures to select the strain that had both mutations. Growth on 5FOA 
removed the WT plasmid from these strains and was used to investigate the effect of 
the double mutation on growth at different temperatures.  
The genotype of the double mutants was verified by PCR and Southern analysis. 
 
PCR-based gene modification 
Plasmid pFA6a-CBP-TEV-protA-HIS3MX6 and the oligonucleotides R1 (5’-gene 
specific sequence-GAATTCGAGCTCGTTTAAAC-3’) and F2 (5’-gene specific 
sequence-CGGATCCCCGGGTTAATTAA-3’) were used to PCR amplify the C-
terminal-TAP-tagging cassette (Longtine et al., 1998). The gene specific sequences of 
the forward primer were chosen to end just upstream of the stop codon preserving the 
reading frame of the tag, whereas those of the reverse primer were chosen to end just 
downstream of the stop codon. The products of six to eight PCR reactions were 
pooled, extracted once with phenol:chloroform:isoamyl alcohol (25:24:1), 
precipitated, and resuspended in 15µl of water. 5µl of this concentrated DNA was 
transformed into WT, glc7-12 and glc7-13 strains using the lithium acetate procedure. 
Transformants growing on SD-His medium were picked and integration of the TAP-
tag cassette was confirmed by PCR.  
 
Western analysis 
Western analysis was performed according to standard protocols (Maniatis). 3% BSA 
was used in blocking buffer instead of milk powder in cases where anti- phospho 
antibodies were used.  
Antibody dilutions:  
8WG16 1:1000 
H14 1:1000 
H5 1:1000 
anti-PKA 1:2000 
all antibodies against CPF and CFIA subunits 1:1000 
 186
 
Transcriptional run-on analysis 
The multi-copy plasmid pUGCYC1, in which the CYC1 gene is controlled by the 
strong GAL1/10 promoter, was introduced into cells of the wild-type (W303), glc7-
10, glc7-12, glc7-13 and glc7-5 mutant strains to achieve high levels of transcription. 
TRO analysis was carried out as described previously (Birse et al., 1998a). 
Importantly, cells were grown in SD-ura, 2% galactose medium 2 days before 
experiment to accommodate to this medium.  
 
Transcriptional interference analysis 
Transcriptional interference was performed as described (Morillon et al., 2003b). 
 
Overexpression of yeast proteins 
The coding regions plus 500 bp up and downstream of proteins Pta1, Pti1p and Syc1p 
were subcloned in 2μ vector pRS 426 (Sikorski and Hieter, 1989) and transformed 
into Glc7 strains. Transformed yeast strains were grown on selective medium at 25, 
30, 33 and 37° C for 3 days. 
 
cRNA Target Synthesis and GeneChip Hybridization 
Following RNA isolation, the total RNA was mixed with RLT buffer. After addition 
of 70% ethanol, the mixture was loaded onto an RNeasy column. The total RNA was 
then washed and eluted in 50 μl of distilled water. Total RNA quality was monitored 
by loading 200 ng onto an RNA Nano 6000 Chip that was processed with the 2100 
Bioanalyzer (Agilent, Palo Alto, CA). Biotin labeling of RNA was performed as 
described in the Expression Analysis Technical Manual (Affymetrix) with minor 
modifications as indicated below. To synthesize single-stranded cDNA, 5 μg of total 
RNA was mixed with oligo-dT and incubated with SuperScript II reverse 
transcriptase (Invitrogen) at 42°C for 1 h. After synthesis of the second cDNA strand 
by using the SuperScript double-stranded cDNA synthesis kit (Invitrogen), the 
material was extracted with phenol-chloroform-isoamyl alcohol, and co-precipitated 
with 10µg Glycogen and 0.5 volumes of 7.5 M ammonium acetate and 2.5 volumes of 
ethanol. cDNA was used for an in vitro transcription reaction by using the IVT 
labeling kit (Affymetrix, Santa Clara, USA) to synthesize cRNA in the presence of a 
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biotin-conjugated ribonucleotide analog. Approximately 100 μg of labeled cRNA 
from each reaction was purified by using RNeasy mini-spin columns, and roughly 300 
ng was analyzed on RNA Nano 6000 Chips. The cRNA targets were incubated at 
94°C for 35 min and the resulting fragments of 50–150 nucleotides were again 
monitored using the Bioanalyzer. All synthesis reactions were carried out using a 
PCR machine (T1 thermocycler; Biometra, Göttingen, Germany) to ensure the highest 
possible degree of temperature control.  
The hybridization cocktail (200μl) containing fragmented biotin-labeled target cRNA 
at a final concentration of 0.05μg/μl was transferred into Yeast S98 GeneChips 
(Affymetrix) and incubated at 45°C on a rotator in a hybridization oven 640 
(Affymetrix) for 16 h at 60 rpm. The arrays were washed and stained by using a 
streptavidine-phycoerythrin (SAPE) conjugate (Molecular Probes, Eugene, OR). To 
increase the signal strength the antibody amplification protocol was used (EukGE-
WS2v5_450; Affymetrix Expression Analysis Manual). The GeneChips were 
processed with an Affymetrix GeneChip® Scanner 3000 (Affymetrix) by using the 
current default settings. DAT image files of the microarrays were generated using 
GeneChip Operating Software (GCOS 1.1; Affymetrix). 
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